



Effect of age and pregnancy on the murine melanocortin system 
in the female reproductive system
Berruien, N.
 
This is an electronic version of a PhD thesis awarded by the University of Westminster. 
© Miss Nasrin Berruien, 2019.
The WestminsterResearch online digital archive at the University of Westminster aims to make the 
research output of the University available to a wider audience. Copyright and Moral Rights remain 
with the authors and/or copyright owners.
Whilst further distribution of specific materials from within this archive is forbidden, you may freely 
distribute the URL of WestminsterResearch: ((http://westminsterresearch.wmin.ac.uk/).
In case of abuse or copyright appearing without permission e-mail repository@westminster.ac.uk
 Effect of age and pregnancy on the murine 








A thesis submitted in partial fulfilment of the requirements of the 











The five melanocortin receptors (MC (1-5)) are part of the G-coupled protein receptor (GPCR) 
family and have been reported to have a role in controlling appetite, modulating inflammation 
and stress response.  The melanocortin receptor accessory proteins (MRAP1 and 2) influence 
MC receptor transport and signalling. The MCs are activated by proopiomelanocortin (POMC) 
derivatives: alpha-, beta-, and gamma-melanocyte stimulating hormones and 
adrenocorticotrophic hormone; while agouti signalling peptide (ASP) and agouti-related 
protein (AgRP) antagonise the peptide activity. The MCs were previously detected in the male 
mouse reproductive system, and their expression levels were found to be influenced by age. 
This thesis aims to investigate the expression of the MC system in the female mouse 
reproductive system and to determine the influence of age and pregnancy on the expression 
levels of MCs, accessory proteins, POMC and AgRP.  
The gene expression of the MC system in the reproductive axis using RT-qPCR revealed the 
differential MC expression in the female mouse hypothalamus, pituitary gland, ovary and 
uterus. Age influenced the expression of MC5 and POMC, whilst pregnancy altered the 
expression of MC2, MC4 and MC5. This research reports, for the first time, the characterisation 
of MRAP1 expression in the hypothalamus and the pituitary gland. The chromogenic RNA in 
situ hybridisation method (RNAscope®) enabled MC3, MC5 and MRAP2 localisation in the 
hypothalamus, in the preoptic (rostral and medial) areas and arcuate nucleus. Those areas 
are known to contain the gonadotropin-releasing hormone (GnRH) neuronal network in the 
female mouse hypothalamus.  The RNAscope® studies also detected the expression of MC3 
and MRAP2 in the gonadotrophs and the somatotrophs of the mouse anterior pituitary gland; 
these findings imply a modulatory role of MC3 in the anterior pituitary cellular network. The 
expression of MC3, MC5 and MRAP2 was influenced by age and pregnancy. The co-
expression of MC3 and MRAP2 in the hypothalamus and the anterior pituitary gland, implicate 
the potential regulation of MC3 responsiveness by MRAP2.  
An in vitro cell culture model of GPCR signalling “PRESTO-Tango” assay investigated the 
regulation of MC3 by the MRAPs and revealed a significant increase in the potency of MC3 to 
ACTH (1-39), and NDP-a-MSH MC3 in the presence of MRAP1. These studies also show a 
reduction in sensitivity of MC3 to ACTH (1-39) with 1:1 co-expression of MC3: MRAP2 whilst a 
1:10 MC3: MRAP2 expression ratio increased the sensitivity of MC3 to both ACTH (1-39) and 
NDP-a-MSH. The data obtained in this thesis indicates that the members of the MC system 
are in close association within areas controlling female reproduction and that the MC system 
expression is affected by age and pregnancy. Finally, this research reports the regulation of 
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OVLT Organum vasculosum of lamina terminalis 
P4 Progesterone  
PC 1/2   Prohormone convertases 1 and 2  
PBS Phosphate buffered saline 
pg Pico gram 
PGF2a Prostaglandin F2a 
Pi3K/ERK Phosphatidylinositol-3-Kinase/ Extracellular Signal-Regulated 
Kinase 
PND Postnatal day 
POMC  Proopiomelanocortin  
POLR2A DNA-directed RNA polymerase II subunit RPB1 
PPIB Peptidylprolyl Isomerase B 
PR Progesterone receptor 
R2 Coefficient of determination 
RPL13A Ribosomal protein L 13a 
rPOA Rostral preoptic area 
RT  Reverse transcriptase  
RT-qPCR  Reverse transcription-quantitative polymerase chain reaction  
SDHA Succinate dehydrogenase complex flavoprotein subunit A 
SNP Single nucleotide polymorphism 
SSC Saline-sodium-citrate 
SSTR2 Somatostatin receptor 2 








ST.DEV Standard deviation 
TBE Tris/Borate/EDTA (Ethylenediaminetetraacetic acid) 
TGF-b1 Transforming growth factor-beta1 
TNFα /TNF-γ Tumour necrosis factor alpha / Tumour necrosis factor - 
gamma 
TRH Thyroid-releasing hormone 
TSH Thyroid-stimulating hormone 
UBC Ubiquitin C 
UV Ultra violet 
W/V Weight/Volume 
V Volts 
VIP Vasoactive intestinal peptide 
VEGF Vascular endothelial growth factor 
YWHAZ Tyrosine-3-monooxygenase/tryptophan 5- monooxygenase 








1  The Female Reproductive System 
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1. 1 Background 
Effective reproductive activity in all mammalian females requires the coordinated 
activity of the hypothalamic-pituitary-ovarian (HPO) axis.  The female reproductive 
system comprises the ovaries, oviducts, uterus, external genitalia and the breast.  It 
also includes the hypothalamus and the pituitary gland to form an axis that controls 
the primary functions of the reproductive system. The primary functions are 
gametogenesis, folliculogenesis, steroidogenesis, the initiation and maintainenance of 
pregnancy and preparing for parturition and lactation. The HPO axis is responsible for 
coordinating the synchronised cyclicity of the hormonal events of the menstrual cycle 
in humans, primates, bats and elephant shrews; and the estrous cycle in other 
mammals. The HPO axis control is complex, since the 1930s, it was grossly postulated 
that the control involved a feedback mechanism which requires different elements 
within different cells, primarily the gonadotropin- releasing hormone (GnRH) from the 
hypothalamus, luteinizing hormone (LH) and follicular stimulating hormone (FSH) from 
the anterior pituitary gland and the sex steroid secreted mostly by the ovarian cells 
(Hohlweg and Junkmann, 1932). 
1. 1. 1 The reproductive life cycle of the female human 
From birth until puberty, primordial follicles commence growth but do not grow past 
the antral stage because there is not the correct endocrine milieu to support further 
growth.  Until puberty, the hypothalamic control is inhibited, and hence, the secretion 
of both FSH and LH is also suppressed. The onset of puberty is associated with the 
onset of pulses of hypothalamic hormone gonadotropin-releasing hormone (GnRH): 
these pulses tend to occur at night, and the frequency of release is initially erratic.  As 
puberty progresses, the pattern of release becomes more regular over the entire 24 h 
a day.  Each pulse of GnRH from the hypothalamus elicits a pulse of LH from the 
anterior pituitary gland (Plant et al., 2014). Different pathways have been found to be 
involved in stimulating the GnRH pulse generator in the hypothalamus, this will be 
discussed in more detail in Chapter 4. Although it is not possible to identify the exact 
day of the onset of puberty, the first day of menses defines the first day of the 
menstrual cycle.  
The menstrual cycle in women lasts for 28 ± 5 days. It is divided into three phases: 
menstrual (days 1-5), proliferative (days 6-14) and secretory (days 15-28). These three 
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phases reflect changes that are occurring within the uterus.  The cycle can also be 
divided into two phases if referring to ovarian activity: the follicular phase (days 1-14) 
and the luteal phase (days 15-28). The changes in hormones are illustrated in Figure 
1.1.  
Follicular phase: estrogen and progesterone are at low concentration due to loss of 
corpus luteum of previous cycle (about 150 pg/ml and almost 0 ng/ml respectively). 
The low estrogen concentration leads to the removal of the negative feedback on the 
FSH production causing a rise in the latter’s concentration (> 20 mIU/ml) while LH 
remains at concentrations lower than 10 mIU/ml (Espey and Richards, 2006).  
Approaching next menses, FSH starts to decline as it undergoes inhibition by the rising 
estrogen concentration (about 300 pg/ml), secreted by the maturing follicles. This 
dramatic rise in estrogen causes a sharp increase in LH concentration causing a LH 
surge (40 mIU/ml) and henceforth, ovulation (Espey and Richards, 2006).  
 
Luteal phase: following ovulation, the corpus luteum is formed and starts producing 
progesterone (reaching a concentration of 20 ng/ml). In case of pregnancy, 
progesterone concentrations remains high due to formation of the placenta which also 
secretes progesterone (Espey and Richards, 2006). If there is no pregnancy, the 
corpus luteum undergoes programmed atresia leading to the decline of progesterone 
at the end of the luteal phase. Estrogen is also secreted by the ovulatory corpus luteum 
but at lower concentration than that seen during ovulation (about 200 pg/ml) and also 
declines due to the loss of corpus luteum at the end of the cycle. Due to the effect of 
luteal estrogen and progesterone concentrations, LH drops sharply after the surge to 
about 5 mIU/ml while FSH gradually decrease reaching 7 mIU/ml. The latter starts to 
increase again at the end of the luteal phase due to the decrease in luteal estrogen 
and the start of the next menstrual cycle (Espey and Richards, 2006). 
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Figure 1.1: Hormone concentrations during the menstrual cycle in women. The menstrual cycle is 28 ±5 days. It 
is divided to ovarian phases: follicular (days 1-14) and luteal (days 15- 28). Reprinted from Espey (2006) with 
permission from Elsevier. 
 
If conception occurs, pregnancy in women lasts about 290 days.  Different tissues are 
involved in maintaining pregnancy. During the first 6-8 weeks, the progesterone and 
estrogen synthesised and secreted from the corpus luteum are responsible for the 
maintenance of the pregnancy until the placenta is formed and becomes fully 
functional, replacing the corpus luteum in secreting progesterone. Progesterone 
concentrations gradually increase, then remain constant throughout pregnancy once 
it reaches a plateau as it is produced by the placenta. Just before the onset of labour, 
progesterone concentrations fall dramatically (Griffin and Ojeda, 2004). 
Menopause is the cessation of menses which occurs due to the ovarian failure that is 
mediated by neuroendocrine hormonal fluctuations. The transition to menopause 
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occurs gradually and is characterised by shorter follicular phase leading to shorter 
cycles. Within the ovary, there are few, if any, mature follicles as well as reduced 
numbers of primary and secondary follicles. Peri-menopausal women with a regular 
menstrual cycle have lower circulating estradiol concentrations (Burger, 2002). 
Progesterone concentrations remain normal due to normal secretory phase. However, 
progesterone eventually declines in older women. There is also an increase in the 
circulating concentrations of FSH as a result of a decrease in ovarian estrogen 
synthesis and release and therefore a decrease in negative feedback (Sherman and 
Korenman, 1975). 
 Different types of studies use different species. In this research, the female mouse 
(strain C57BL/6) was the species of choice because of the large body of work which 
has been carried out on mice and the availability of transgenic and tissue specific 
knockouts. 
1. 1. 2 The reproductive life cycle of the female mouse 
The female inbred mouse (such as A/J, BALB/c and C57BL/6) has a lifespan of 
approximately 2-3 years. The mature female mouse is a spontaneous ovulator, and 
ovulation occurs every 4-5 days as part of the estrous cycle. The murine estrous cycle 
is divided into four phases with the length of the phase indicated parenthesis: 
proestrus (12-14 hours), estrus (25-27 hours), metestrus (6-8 hours), and diestrus (55-
57 hours). The female mouse is a fast breeder (producing 5-10 offspring per 
pregnancy) with a gestational period that lasts 19-21 days.  Post-partum ovulation 
occurs; however, if this does not result in pregnancy then regular estrous cycles and 
hence ovulation will not occur again until lactation has ceased (usually about 3 weeks) 
as reviewed by Bronson et al. (1968). The following sections will concentrate on the 
regulatory mechanisms that occur during the oestrous cycle of mice. Table 1.1 












30-38 years 16-20 months 
Formation of 
female ovaries 
16 weeks of gestation 9.5 days of gestation 
The timing of peak 
number of oogonia 
20 weeks of pregnancy (reaching 6-7 
million); most undergoes atresia before birth 
and only 1-2 million follicles persist after 
birth 
9-13 days of gestation (reaching 
20,000 on day 14 of gestation); 
most undergoes atresia leaving 
12,000 primordial follicles at birth 
The appearance of 
first primary 
follicles 
26 weeks of gestation Day 3 after birth 
The appearance of 
first secondary 
follicles 
26 weeks of gestation Day 21 after birth 
Onset of puberty 
12-14 years (first menstrual flow) but could 
occur as early as 9 years as ovaries are 
responsive to HPO axis 2-4 years earlier. 
30-35 days (vaginal opening and 
cornified epithelium on smear). 
Ovaries are responsive 16-20 days 
earlier. 
Cycle Menstrual Estrous 
Length 23-33 days 4-5 days 
Implantation of a 
fertilised ovum 
Day 7 after fertilisation Day 5 post-coitus (dpc) 
Gestation Period 270-290 days (38 weeks) 19-21days 
Corpus luteum of 
pregnancy 
Time CL of pregnancy required to maintain 
pregnancy: first 6 to 8 weeks until placenta 
is formed. 




First fertilisation is about 6 weeks after 
parturition if no lactation. If lactation occurs, 
then return to fertility is a function of the 
lactation stimulus and maternal nutritional 
status. 
First ovulation is 12-18 hours after 
giving birth. If conception does not 
occur then first estrus will be 3-4 
days after lactation ceases. 
CL: corpus luteum, dpc: days post coitus, HPO: hypothalamic-pituitary-ovarian axis. The content of the table 
informed by Bronson et al. (1968) and Johnson (2013). 
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1. 1. 2. 1 Hypothalamic regulation of fertility in the mouse 
The hypothalamus contributes to the regulation of the HPO axis through the release 
of gonadotropin-releasing hormone (GnRH) which stimulates the gonadotropin 
secretion (FSH and LH) from the anterior lobe of the pituitary glands. The pattern of 
the gonadotropin secretion depends mainly on the pattern through which GnRH is 
released. There are two patterns of GnRH release: the pulsatile GnRH release and 
GnRH surge. The regulation of GnRH release and its effect on gonadotropins 
secretion will be discussed in further detail in chapter 4.  
 
1. 1. 2. 2 Pituitary gland regulation of fertility in the mouse 
In the pituitary gland, GnRH stimulates gonadotrophs to synthesise and secrete two 
glycoproteins, FSH and LH. Stimulated FSH receptors on the granulosa cells of the 
ovaries activate a signal pathway that promotes follicular development in the form of 
cell differentiation and increased gene expression of the enzymes involved in estrogen 
and progesterone synthesis (Levine, 2014). During the later stage of the follicular 
phase of the ovulatory cycle, higher circulating concentrations of estradiol act upon 
the hypothalamic-pituitary axis which leads to the LH surge. This surge results in the 
production of more androgens by theca cells; it also stimulates the maturation of the 
oocyte and induces ovulation and the formation of the corpus luteum (Levine, 2014). 
 
1. 1. 2. 3 Ovarian roles in mouse female fertility  
The ovary is composed of three compartments, the follicular tissue, the interstitial 
stroma and the corpus luteum; the latter is formed from the follicle after the release of 
the ovum. All three compartments, upon gonadotropin stimulation, synthesise 
steroids, estrogen, progesterone and testosterone. When a steroid ligand binds to its 
receptor, usually in the cytoplasm, the bound receptor becomes a transcription factor. 
The bound receptor is translocated to the nucleus and binds to response elements on 
target genes to cause gene transcription. The regulation of the ovarian function is 
reviewed in chapter 6.  
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1. 1. 2. 4 Uterine roles in female mouse fertility 
In the murine uterus, the role of estradiol is pronounced during the proliferative phase 
of the estrous cycle leading to a proliferation of the luminal and glandular endometrial 
epithelia. Progesterone’s role is mainly detected in the luteal phase of the cycle (Wood 
et al., 2007). Progesterone causes a profound increase in the glandular epithelium, 
stroma and the myometrium. Progesterone also stimulates the gland to synthesise 
and release their secretions into their lumina preparing the uterine tissue for 
implantation and pregnancy (Johnson, 2013). The regulation of the uterine function is 
reviewed in chapter 7. In the mammary gland, there is a rise in progesterone receptor 
expression before ovulation, increased progesterone signalling, therefore leads to 
proliferation, branching and differentiation of the ductal and glandular system of the 
mammary gland preparing the mammary gland for pregnancy and lactation (McNeilly, 
2006).  
1. 1. 3 Regulation of the reproductive cycle in females 
Different physiological and pathological conditions could affect various aspects of the 
reproductive axis in all female species. In the hypothalamus, it has been demonstrated 
that the GnRH neurons and axons have communications with neuropeptide Y (NPY) 
and its role in stimulating food intake and inhibiting the GnRH release as revealed by 
NPY knockout female mice (Hill et al., 2008). Other neuropeptides could influence the 
three components of the reproductive axis, hypothalamus, pituitary gland and the 
ovaries; these include prolactin and growth hormone (GH). Both of which were found 
to stimulate male and female fertility. Prolactin maintains functional corpus luteum, 
increases expression of LH receptors and stimulates FSH and LH release. Prolactin 
was also found to effect the gonads, although the abnormally high level was shown to 
cause infertility (Bartke, 1999). The GH knockout studies on mice disclosed different 
mechanisms that resulted in infertility. The GH receptor knockout mice were found to 
have impaired oestrous cyclicity, and in males, there was decreased secretion of 
testosterone by the testes which were lighter in weight when compared with those of 
wild-type males (Bartke, 1999). This finding implies that GH is involved in fertility and 
growth of the male reproductive system. One other hormone was also found to be 
essential for the development of the reproductive system of female mice is the insulin-
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like growth factor (IGF-I). IGF-I receptor-deficient mice were found to be completely 
infertile and have a juvenile phenotype reproductive system (Bartke, 1999). 
The melanocortin (MC) systems were suggested to be involved in different functions 
of the reproductive system: such as, eliciting sexual behaviour in both males and 
females (Abdel-Malek, 2001) and restoring LH pulsatile secretion in lean animals 
(Backholer et al., 2010). MC system also, has a role in the growth of the ovarian 
follicles and corpora lutea in mice as suggested by melanocortin receptor 4 knockout 
mouse studies (Sandrock et al., 2009). According to the National health services 
(NHS) in the UK, there are about 3.5 million people having difficulty conceiving; of 
those, 25% have an unidentified cause of infertility. Different neuroendocrine elements 
could be affected on either level of the HPO axis causing infertility. The melanocortin 
system could be one of these neuroendocrine factors. The next section will discuss in 
detail the components and functions of the melanocortin system; it will also give a brief 
















2  The Melanocortin system  
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2. 1 Background 
The melanocortin system is found in both the central nervous system and peripheral 
tissues. It has important roles in both glucocorticoid and melanin synthesis, as well as 
functions in inflammation and appetite control. The melanocortin system consists of 
the melanocortin peptides, endogenous antagonists, melanocortin receptors and the 
melanocortin receptor accessory proteins. 
2. 1. 1 Proopiomelanocortin (POMC)  
The concept of the existence of a polypeptide precursor for adrenocorticotropic 
hormone (ACTH) and beta-lipotropin (β-LPH) was considered in the early 1960s. The 
suggestion was made after sequencing these small peptides, and after studying them, 
different groups had found that these small peptides shared a link (Roberts and 
Herbert, 1977). Evidence to support this hypothesis was provided when the Nakanishi 
group used immunoprecipitation with anti-ACTH, anti-beta-endorphin and anti-β-LPH 
on newly translated proteins of messenger ribonucleic acid (mRNA) taken from bovine 
pituitaries. The protein was precipitated by more than one antibody proving that they 
all come from the same precursor polypeptide (Nakanishi et al., 1979) 
This precursor peptide was named proopiomelanocortin (POMC). The Pomc gene is 
made of 5 exons in mouse with most of the coding region contained in the third largest 
exon; this region is highly conserved between species (Clark, 2016). Most of POMC 
expression is predominantly in the pituitary gland within the corticotrophs of the 
anterior lobe and the melanotrophs of the intermediate lobe in mice (humans have a 
rudimentary intermediate lobe). POMC mRNA is also expressed in the brain and other 
tissues such as the thyroid, pancreas, placenta and digestive system as reviewed by 
Smith and Funder (1988). The proteolytic cleavage of POMC occurs in a tissue-
specific manner depending on the presence of one or both of two prohormone 
convertases (PC1 and PC2). POMC is made of three domains: the amino terminus 
that comprises gamma-melanocyte stimulating hormone (γ-MSH) (Bicknell, 2008); the 
central domain includes adrenocorticotropic hormone (ACTH), α-MSH and 
corticotropin-like intermediate peptide (CLIP); and the last domain is the carboxyl 
terminus which is cleaved into β-MSH, β-endorphin, β- and γ-lipotropic hormone (LPH) 





Figure 2.1: Gene structure and post-translational processing of the pro-opiomelanocortin molecule (POMC). In the 
corticotrophs of the anterior pituitary lobe, PC1 mediate the cleavage of POMC to N-terminus fragment, 
adrenocorticotropic hormone (ACTH) and the beta – lipotropin (β-LPH) which in turn cleaved into beta-endorphin. 
In the melanotrophs of the intermediate pituitary lobe, PC1 and PC2 mediate the cleavage of POMC into N-
terminus; alpha-, beta- and gamma-melanocyte stimulating hormone (α-, β-, and γ-MSH); Corticotropin-like 
Intermediate Peptide (CLIP) which is cleaved further to ACTH (1-39); β-LPH and beta-endorphin. Image adapted 
from Bicknell (2008) with permission granted by John Wiley and sons. 
 
Through its end products [adrenocorticotropic hormone (ACTH) and alpha-, beta- and 
gamma-melanocyte stimulating hormone (α-, β-, and γ-MSH)], POMC is involved in 
diverse roles: including analgesia and cardiovascular protective functions (Krude and 
Grüters, 2000). Mutations within or deletion of the POMC gene manifests as a triad of 
early obesity, red hair and pale skin, and low circulating cortisol concentrations due to 
adrenal insufficiency (Clark, 2016). Genotyping analyses have identified five single 
nucleotide polymorphisms (SNPs), and three of these were responsible for visceral 
and cutaneous adiposity in Hispanic descendants (Sutton et al., 2005). Quite recently, 
a case report described mental retardation and ataxia alongside the triad due to a 
mutation in c.64delA of the POMC gene (Özen et al., 2015). Some of the other 
mutations affecting specific regions of the POMC gene were found to have milder 
affects due to compensatory mechanisms; for instance,  mutation in the ACTH coding 
region on POMC gene did not cause significant effects as it was found to be 
Pro-opiomelanocortin (POMC) gene 
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compensated through the first 13 ACTH residues within the α-MSH sequence (Krude 
and Grüters, 2000). 
The original functions of the melanocortins were thought to be limited to stimulating 
melanin synthesis in the epidermis of the skin and glucocorticoid production from the 
zona glomerulosa in the cortex of the adrenal glands (Abdel-Malek, 2001). However, 
other pathways, which are related to inflammation, energy homoeostasis, sexual 
behaviour, learning behaviour and memory, have now been described (De Wied, 
1999; Abdel-Malek, 2001; Gantz and Fong, 2003). 
2. 1. 2 The melanocortin peptides 
a-MSH is detected in various tissues: in the brain, it is synthesised in the arcuate 
nucleus where it behaves as an inhibitory neurotransmitter suppressing food intake 
and lowering body temperature (Xu et al., 2014). Peripherally, α-MSH analogues are 
thought to be useful therapeutic candidates for treatment of inflammatory and allergic 
conditions, as well as autoimmune diseases (Catania et al., 2004; Getting, 2006; 
Ahmed, 2014) because α-MSH inhibits the release of different cytokines (such as, IL-
1, TNFα and IFNγ) from monocytes and macrophages (Catania et al., 2004). a-MSH 
also counteracts inflammation by suppressing transcription factors (such as nuclear 
factor kappa B, NFƙB) in antigen presenting cells (Catania et al., 1998). a-MSH, β-
MSH, γ-MSH and ACTH contribute to anti-inflammatory responses (Muceniece et al., 
2004). The roles of ACTH were initially characterised as stimulating glucocorticoid 
synthesis in the adrenals and pigmentation in the skin (Ducrest et al., 2008). However, 
ACTH also mediates an anti-inflammatory response, and the ACTH synthetic 
analogue (ACTH (1-39)), Synacthen, has been used in the treatment of gouty arthritis 
(Getting, 2006). During the investigation of melanocortins in the central nervous 
system, studies also uncovered an indirect role for melanocortins in reproduction 
(Schiöth and Watanobe, 2002). The melanocortins were found to indirectly stimulate 
the release of GnRH through the interaction with estradiol, melanin concentrating 
hormone (MCH) and dopamine in the female rats (Wilson et al., 1991; Gonzalez et al., 
1997; Murray et al., 2000). GnRH stimulates the gonadotrophs of the pituitary gland, 
through activating different hypothalamic neurotransmitters such as leptin, prolactin, 
kisspeptin and orexin; thereby, enabling the hypothalamic-pituitary-gonadal (HPG) 
axis (Schiöth and Watanobe, 2002; Backholer et al., 2009). ACTH, through its activity 
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in the hypothalamic-pituitary-adrenal (HPA) pathway, is known to have an inhibitory 
effect on the hypothalamic-pituitary-gonadal (HPG) axis in various physiological and 
pathological conditions: such as stress, Cushing’s disease and pregnancy (Magiakou 
et al., 1997). The role of melanocortin peptides and their synthetic analogues will be 
discussed further in the following sections. 
2. 1. 3 Melanocortin receptors and their expression sites 
The melanocortin receptors (MC (1-5)) are five receptors belonging to the G-protein 
coupled receptor (GPCR) family. They have the same structure as the GPCRs 
belonging to the class A rhodopsin-like family; each receptor consists of a single 
polypeptide that is presented as seven short domains spanning the cell membrane 
with the amide end located at extracellular compartment and the carboxyl end located 
intracellularly (Figure 2. 2). 
The amide end contains N-glycosylation sites while the carboxyl end comprises 
palmitoylation sites; phosphorylation sites are in the transmembrane first and third 
domains (Yang, 2011). MC (1-5) share the same ligands which is not surprising given 
the homology between the receptors. There are sequence similarities of 45-60% 
between MC1 and MC3 and between MC4 and MC5 respectively; whilst MC2 and MC4 
share 38% sequence similarities making MC2 the most distinctive receptor of all the 
MCs (Yang, 2011). The most common signalling pathway activated by these receptors 
is the activation of adenylate cyclase and increased cAMP production through the Gs 
subunit of the G protein complex. However, other signalling pathways are also 
activated by the MCs, these include inositol triphosphate (IP3), which leads to a rise 
in Ca++ influx, and the phosphorylation cascade initiated by the Janus kinase 2 (JAK2) 
and signal transducers and activators of transcription (STAT1) tyrosine (Getting et al., 
2009). This is attributed to the differential binding affinity of the melanocortin peptides 
to the receptors and activating different G protein subunits. This could also explain the 
varied functions mediated by the same receptor binding to the same melanocortin 




Figure 2.2: The structure of class A G protein coupled receptor (GPCR). GPCR is made of transmembrane 
molecule those 7 spans across the membrane. The short carboxyl terminus is located intracellularly and attached 
to the G protein 3 subunits. The short amide terminus is located extracellularly and contains N-glycosylation sites.  
Cysteine residues in parts of the transmembrane domain and the extracellular loop are responsible for GPCR as 
well as MC dimerization. Image reprinted from Neumann et al.  (2014) (Permission to reuse image was granted by 
Nature Reviews Rheumatology). 
 
2. 3. 3. 1 Melanocortin 1 receptor (MC1) 
The first melanocortin 1 receptor (MC1), also known as an α-MSH receptor, was 
discovered in human melanoma cells (Chhajlani and Wikberg, 1992; Beleche et al., 
2012). The expression of MC1 was detected in the periaqueductal neurons, glial cells, 
neutrophils, macrophages, fibroblasts, Leydig cells, placenta and the corpus luteum 
(Xia et al., 1995; Wikberg et al., 2000). This receptor has an affinity to all the 
melanocortin peptides but has the highest affinity for α-MSH. Melanin synthesis was 
found to be mediated by MC1: following UV exposure the receptor and the 
melanocortin peptides are upregulated (Abdel-Malek, 2001). Additionally, MC1 
mediates an anti-inflammatory response through preventing neutrophil migration, 
stimulating the release of cytokines and inhibiting macrophage functions (Abdel-
Malek, 2001). While preliminary studies report that the receptor’s mRNA has been 
detected in all the tissues of the HPG axis, with higher levels in older male mice 
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(Dowejko, 2014), a role in the male and female reproductive axes remains to be 
characterised.  
 
2. 1. 3. 2 Melanocortin 2 receptor (MC2) 
The MC2 mRNA was first detected in the adrenal gland (Mountjoy et al., 1992; 
Chhajlani et al., 1993). The receptor is 100% selective for ACTH and when activated 
is responsible for glucocorticoid synthesis. The receptor is not exclusively expressed 
in the adrenal gland. The MC2 receptor is also found in mouse adipocytes where it is 
proposed to have lipolytic activity (Boston and Cone, 1996). In foetal mice, MC2 has 
been detected in the lungs, genital ridge, testes and ovaries. In the testis, MC2 was 
detected in Leydig cells while in the ovaries, the MC2 protein was localised within the 
oocyte hence a role for the receptor in oogenesis has been hypothesized (Nimura et 
al., 2006). MC2 is expressed in the corpus luteum of bovine ovaries and 
pseudopregnant rabbits and exposure to an ACTH agonist (ACTH1-24) in vitro led to 
an increase in the production of sex steroids in the cells of the corpus luteum (Amweg 
et al., 2011; Guelfi et al., 2011). Immuno-positive staining for MC2 has been found in 
the glands of the endometrium suggesting a role for stimulating uterine secretions 
(Lantang et al., 2015). 
 
2. 1. 3. 3 Melanocortin 3 receptor (MC3) 
The distribution of MC3 was found to be wider than MC2 as it was detected in the 
thalamus, hypothalamus, hippocampus, stomach, pancreas and the placenta (Gantz 
et al., 1993; Roselli-Rehfuss et al., 1993). Similar to MC1, MC3 has an affinity for all 
the melanocortin peptides with the highest affinity for γ-MSH. The primary functions of 
MC3 appear to be the control of feeding behaviour and energy expenditure in mice 
(Butler and Cone, 2002). The uterus expresses MC3 in the glandular epithelium of the 
endometrium of mice and natural killer cells of the uterus near the vasculature 
suggesting an indirect role for the receptor in controlling vascular stability through 
ACTH (Lantang et al., 2015). In male mice, MC3 was found to be expressed in all 
tissues of the HPG axis with lower amounts in the mouse testes (Dowejko, 2014). 
Dowejko’s studies showed higher expression in female pituitary than males, and this 
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expression is significantly higher in pregnancy, suggesting a potential role for the MC3 
in pregnancy. 
 
2. 1. 3. 4 Melanocortin 4 receptor (MC4) 
The expression of MC4 was detected in several areas of the brain, including the 
thalamus and hypothalamus (Gantz et al., 1993; Cerda-Reverter et al., 2003). In the 
limbic system (hippocampus and amygdala), MC4 was thought to have functions in 
memory and feeding behaviour (Wikberg et al., 2000). Based upon evidence that 
selective and non-selective MC4 antagonists (HS014 and SHU9119) reversed the 
inhibitory effect of leptin on food intake and that leptin treatment stimulated rat POMC 
expression, a role for MC4 in food intake and body weight was demonstrated (Schiöth 
and Watanobe, 2002). HS014 and SHU9119 intra-cerebroventricular administration 
also lowered LH and prolactin concentrations compared to leptin alone (Watanobe et 
al., 1999). These effects, however, were only noticed in female rodents as treatment 
of leptin-deficient male mice with the melanocortin peptides, agouti-related peptide 
(AgRP) or SHU9119 (non-selective MC3 and MC4 antagonists), showed no effects on 
LH, FSH or testosterone release which could suggest a role for the ovarian steroids in 
the leptin stimulatory pathway (Schiöth and Watanobe, 2002). Although these findings 
suggest a role for melanocortin in mediating the release of the gonadotropins from the 
pituitary; this may not be a reciprocal action, Sandrock and colleagues have shown 
that MC4 knockout obese mice had ovarian failure despite a regular estrous cycle and 
the group attributed this finding to possibly abnormal gonadotropin release (Sandrock 
et al., 2009). 
 
2. 1. 3. 5 Melanocortin 5 receptor (MC5) 
The last member of the melanocortin receptor family to be cloned was MC5 and it was 
found in skeletal muscles, spleen and the brain (Gantz et al., 1994; Cerdá-Reverter et 
al., 2003). It is also found in the lacrimal and sebaceous glands where it is suggested 
to have an excretory function; MC5 is also postulated to have a role in lipolysis and in 
mediating an anti-inflammatory response (Abdel-Malek, 2001). The expression of MC5 
protein was detected during the proliferative and secretory phases of the menstrual 
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cycle; it is found in the stromal cells and glandular epithelium of the uterus, where, in 
addition to stimulating the release of the uterine secretions, it may also affect vascular 
stability and hence menstrual flow (Lantang et al., 2015). 
2. 1. 4 Endogenous antagonists 
These include agouti, which is also known as agouti signalling protein (ASP), and 
agouti-related protein (AgRP). ASP antagonises the actions of both MC1 and MC4 
whereas AgRP competitively binds to MC3 and, again, MC4  (as reviewed by Yang, 
2011). AgRP is mainly found in the hypothalamus, but a shorter variant of AgRP is 
also found in the adrenals, the testis and the dorsal root ganglia (Ilnytska and 
Argyropoulos, 2008). The AgRP neurons, together with the neuropeptide Y, have an 
orexigenic role, initiating food intake, in the neuroendocrine circuit located in the 
arcuate nucleus of the hypothalamus (Bagnol et al., 1999). This role was thought to 
be mediated by suppressing the melanocortin peptides binding to the receptors that 
inhibit food intake.  
Humans with the Ala67Thr SNP in AgRP have a reduced  risk of type 2 diabetes and 
obesity later in life. AgRP-/- mice fed a high-fat diet when older were found to live longer 
than wild-type animals (Redmann and Argyropoulos, 2006). 
2. 1. 5 Melanocortin receptors accessory proteins (MRAPs) 
Two accessory proteins have been recognised: MC2 accessory protein 1 (MRAP1) 
and MRAP2 (Asai et al., 2013). They are required by MC2, and maybe the other MCs, 
to facilitate receptor trafficking, expression and intracellular signalling. The MRAP1 is 
predominantly expressed in the adrenal cortex transporting MC2 to the cell membrane 
thereby facilitating MC2’s response to ACTH (Asai et al., 2013). Deficiency of MRAP1 
causes familial glucocorticoid deficiency (FGD) type 2, and FGD type 2 is associated 
with mutations in a gene locus mapping to chromosome 21q22.1, which encodes for 
MRAP1: previously known as fat tissue-specific low molecular weight protein (Jackson 
et al., 2015). MRAP2, which is encoded by a gene located at chromosome 6q14.2, is 
expressed in the adrenal gland and in the brain, where it has a similar pattern of 
expression to MC4. MRAP2 may be involved in regulating metabolism: in contrast to 
wild-type mice, MRAP2 knock out mice were found to be obese, and this was not 
related to food intake (Asai et al., 2013). Unlike MRAP1 effects on MC2, reduced 
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signalling was noticed when both MRAP1 and MRAP2 were found co-expressed with 
the other MCs, and the two appear to inhibit dimer formation of the MCs (Webb and 
Clark, 2010). 
2. 1. 6 The melanocortin system and reproduction 
Most research characterising the roles of the melanocortin system in reproduction has 
focused on the central melanocortins (MC3 and MC4), although all MCs have been 
described in the reproductive axis (Amweg et al., 2011; Simamura et al., 2011; 
Dowejko, 2014; Lantang et al., 2015). The expression of MC1, MC2 and MC3 was 
detected in different compartments of the bovine ovaries and the melanocortin peptide, 
ACTH, is thought to be involved in the function of the ovaries (Amweg et al., 2011). 
Despite suggesting that the melanocortin system affects fertility, there has been little 
research into the effects of age or physiological condition on the expression of the 
MCs in females. 
The influence of age was investigated in the male reproductive axis of mice and, while 
all five melanocortin receptors were found to be expressed, the pattern varied. In the 
hypothalamus and pituitary gland, the expression of all MCs was found to be greater 
in 14 weeks old mice, but MC5 expression was more significant in the pituitary gland 
of younger age groups (8 weeks old). In the testes of mice MC3, MC4 and MC5 
expression were greatest in young adult mice (8 weeks) compared to an MC2 
expression which was doubled at 14 weeks. Preliminary findings indicate that all 
melanocortin receptors are expressed throughout the female reproductive system, but 





























3. 2 Materials 
Ethics approval for all the work described herein was granted by the University of 
Westminster (Ethics Approval VRE1415-0209). The animal tissues were provided by 
Dr Paul Le Tissier and Dr Joanne Murray from the University of Edinburgh. The 
animals were killed by a Schedule 1 method in accordance with the Home Office’s 
Animal Scientific Procedures Act (1986). The tissues were used in the reverse 
transcription quantitative polymerase chain reaction (RT-qPCR) and the chromogenic 
RNA in situ hybridisation (RNAscopeâ) studies. 
RNA extraction and cDNA synthesis: RNAlater® (ThermoScientific, UK) was 
purchased from Life Technologies, UK. RNA isolation reagents included TRI reagent® 
and molecular chloroform from Sigma Aldrich, UK, RNeasy micro kits and RNase-free 
DNase sets from Qiagen, UK, and SuperScript™ II reverse transcriptase cDNA 
synthesis kits from Invitrogen, ThermoScientific, UK.  
RT-qPCR expression analyses: Both the GeNorm kits with SYBRgreen and the 
PrecisionPLUS qPCR master mixes were obtained from Primer Design, UK. Primers 
for the gene expression studies were purchased from Qiagen, Primer Design and 
Eurofins. RNAscope® reagents used in the RNA in situ hybridisation included: 
RNAscope® 2.5 HD reagent kit-Brown; RNAscope® 2.5HD duplex reagent kit; 
RNAscope® 2-plex negative control probe; RNAscope® duplex positive control probe; 
RNAscope® probe- Mm-MC3r-C1and C2 (Catalogue number 412541,412541-2 
respectively); RNAscope® Probe Mm-Mrap2-C1 and C2 Catalogue number 474411 
and 474411-2); RNAscope® probe Mm-MC5r-C1 (Catalogue number 3000031); 
RNAscope® probe Mm-Gh-C2 (Catalogue number 320269-C2); and RNAscope® 
probe Mm-Lhb- C2 (Catalogue number 321584). All RNAscope® reagents were 
purchased from ACD Diagnostics.  Tissue sections were mounted on Superfrost® 
PLUS slides from FisherScientific, UK. 
The HTLA cells were kindly provided by Prof Wesley K Kroeze, (Kroeze et al. (2015), 
University of North Carolina, USA). The cell culture reagents included Dulbecco’s 
modified eagle’s medium (DMEM) (Catalogue number 41965-039 supplemented with 
10% foetal bovine serum (Catalogue number A9576), 100 IU/ml penicillin-
streptomycin 100 IU/ml and 2.5 µg/ml amphotericin B, (all reagents were from Gibco®, 
ThermoScientific, UK). Hygromycin B 100 µg/ml (Catalogue number ant-hg-1, 
 38 
Invivogen, UK) and puromycin dihydrochloride 2 µg/ml (Catalogue number 4089, 
Tocris, UK) were used for cell selection. For bacterial transformation, DH5a and SOC 
media were purchased from Invitrogenä (Catalogue number 18265017, UK); LB agar 
and broth were from Sigma Aldrich (Catalogue number L3147-1KG and L3522-1KG 
respectively, UK). Plasmid Qiaprep spin miniprep extraction kit was purchased from 
Qiagen (Catalogue number 27104, UK). The transfection reagent polyJet™ was 
purchased from SignaGen Laboratories (Catalogue number SL100688, USA). The cell 
transfection reagents included DMEM without phenol red (Catalogue number 21063-
029, Gibco®, UK); fluorescent plasmids [pCDNA3- enhanced- green fluorescent 
protein (pCDNA3.1-E-GFP) and/or pCHERRY10 (Addgene, catalogue numbers: 
13031 and 24664 respectively, USA)]. The pmCHERRY-N1 plasmid was a kind gift 
from Dr Sarah Coleman, University of Westminster. The PRESTO-TANGO assay 
plasmids MC3-TANGO and MRAP1-pCDNA3.1 were a generous gift from Dr Paul Le 
Tissier and Dr Joanne Murray, University of Edinburgh. MRAP2-pCDNA3.1-myc was 
a kind gift from Dr Li Chan, The William Harvey Research Institute, UK. Viability tests 
reagents included the MTT reagent A [MTT reagent (3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl -2H-tetrazolium bromide), Catalogue number M5655, Sigma Aldrich, UK). 
 
3. 2 Methods  
3. 2. 1 Tissue Collection 
The hypothalamus, pituitary gland, ovaries and uterus were removed from C57BL/6 
virgin mice aged 2, 6,10 and 14 weeks as well as  pregnant mice (9 weeks at mating 
and tissue taken at approximately day 13 day of gestation which is equivalent to mid-




Table 3-1: Mouse ages and their physiological status. 
 
3. 2. 2 RNA Extraction 
The tissues (no more than 3-5 mg) were disrupted in 800 µl of TRIreagent and 
homogenised for 5 minutes at 22°C. Chloroform (160 µl) was then added to the 
homogenate before being mixed using a vortex for 10 seconds and incubated on ice 
for 3 minutes. The homogenates were then centrifuged at 8,000 g at 4°C for 30 
minutes. Approximately 500-700 µl of the colourless aqueous phase of the 
supernatant were transferred to a new tube; an equal volume of 70% ethanol prepared 
in RNase-free water was added, and the samples were vortexed for 5 seconds. The 
sample: ethanol mixture (700 µl) was then transferred into spin column tubes 
(RNAeasy kit) placed in collecting tubes. Samples were centrifuged at ≥ 8,000 g for 
30 seconds and the flow-through discarded. RW1 (350 µl) buffer (RNeasy kit) was 
added to the spin columns; the samples were spun at ≥ 8,000 g for 30 seconds and 
the flow-through discarded. The samples were then incubated with DNase I (1500 
Kunitz units, 10 µl of the DNase stock to 70 µl of the DNase I Buffer RDD as described 
in the RNase-free DNase I protocol from Qiagen, UK) at 22°C for 15 minutes to remove 
any remaining genomic DNA (a necessary step when using the samples in the 
sensitive real-time PCR assays). Buffer RW1 was added to the spin column to stop 
the DNase treatment and to wash the sample. Washing and precipitating the DNA was 
done by adding 500 µl of Buffer RPE (RNeasy kit) to the spin columns, the samples 
were centrifuged and the flow-through discarded. To continue RNA precipitation, 500 
µl of 80% ethanol were added to the spin columns before the samples were 
centrifuged at ≥ 8,000 g for 2 minutes. To remove any carryover of ethanol, the lid of 
each tube with the sample was left open and the tubes re-centrifuged at maximum 
speed for 5 minutes. To elute the RNA, 14 µl of RNase-free water were added to each 
Mouse Age (in weeks) Physiological state 
Two weeks old Neonatal 
Six weeks old Peri-pubertal 
9-10 weeks old Sexually mature: young adult 
14 weeks old Mature adult 
Nine weeks old (13 days pregnant ±1 day) Pregnant: mid-gestation 
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sample, left on the bench for 1 minute and then the tubes were centrifuged at 
maximum speed for 2 minutes. The concentration of the purified total RNA was 
measured with a spectrophotometer at wavelengths of 260 and 280 nm (Nanodrop 
2000, ThermoScientificâ). An acceptable RNA yield was about 150-300 ng and 
accepted 260:280 and 260:230 ratios were approximately 2.00 and 2.0-2.2, 
respectively. The samples were either used directly to make complementary DNA 
(cDNA) or stored at -80°C. 
3. 2. 3 Complementary DNA (cDNA) synthesis 
The SuperScript II reverse transcriptase protocol for cDNA synthesis was followed 
(InvitrogenTM, UK). A 20 µl reaction volume contained: ~300 ng of RNA; 150 ng of 
random hexamer primers; dNTPs (10 µM each) (both from Sigma-Aldrich, UK). This 
reaction mixture was incubated at 65°C for 5 minutes to allow the primers to anneal. 
First strand buffer (1.0 M Tris-HCl, pH 8.3, 1.5 M KCl and 60 mM MgCl2), 0.2 M of 
dithiothreitol (DTT) and RNase-free water were added and left at room temperature 
for 2 minutes. The addition of 200 U/µl SuperScript II reverse transcriptase (RT) 
enzyme was followed by incubating the mixture at room temperature (22°C) for 10 
minutes to activate the enzyme. This was followed by incubating the reaction mixture 
at 42°C for 50 minutes for cDNA synthesis. Finally, the reaction was inactivated by 
incubating the mixture at 70°C for 15 minutes. Negative controls (NO-RT) were also 
included by adding RNase-free water instead of the RT enzyme. The cDNA was then 










3. 2. 4 Reverse transcription - quantitative polymerase chain reaction 
(RT-qPCR)  
3. 2. 4. 1 Reference gene stability analysis  
To determine the stability of reference genes for each tissue, the expression stabilities 
of twelve reference genes (GeNorm kit, Primer design, UK) were identified. Table 3.2 
lists the reference genes from the GeNorm kit with accession numbers and product 
length. The reference genes’ expression stabilities were examined in the cDNA 
samples (25 ng) of two biological replicates of the hypothalamus, the pituitary gland, 
the ovaries and the uterus of all age groups and nine weeks old pregnant (13 ±1 day 
post coitus, dpc). Each tissue was analysed separately. The samples were run in 
duplicates with RT-qPCR (total number was 24 samples). The threshold cycle (CT) 
values, (the number of cycles needed for the fluorescence to cross the threshold that 
was set above the background noise) were exported into Excel worksheets and 
analysed using GeNorm. To validate the results of GeNorm, three other different 
software packages (detailed below) were also used to analyse the same data to select 













Table 3-2: Reference genes names, function, accession numbers and product length. 
The reference genes used include 18S, β-actin, ATP5B, B2M, CANX, CYC1, EIF4A2, GAPDH, RPL13A, SDHA, 
UBC, YWHAZ (GeNorm kit, Primerdesign, UK). The reference genes’ stabilities were examined using RT-qPCR in 
technical duplicates of two hypothalami, two pituitary glands, two ovaries and two uteri (each tissue separately) of 
mice aged 2, 6, 10 and 14 weeks and nine weeks old pregnant (13 +1 DPC). Analyses were done using GeNorm 
(qBase+, Biogazelle, Belgium) and three other reference genes stability analyses software: BestKeeper, 






















NM_007393.3 90.2 84 
ATP5B ATP synthase ATP biosynthesis NM_016774.3 89.8 112 
B2M β-2-microglobulin Glycoprotein binding NM_009735.3 84.7 120 
CANX Calnexin Ca+ binding activity NM_007597.3 86.3 105 
CYC1 Cytochrome c isoform 1 Electron activity NM_025567.2 92.1 141 
EIF4A2 eukaryotic translation initiation factor 4A2 
ATPase and helicase 
activity 






NM_008084.2 90.8 127 
RPL13A ribosomal protein L13a RNA constituent NM_009438.5 91.0 130 
SDHA 
succinate dehydrogenase complex 
flavoprotein subunit A 
Mitochondrial electron 
transport 
NM_023281.1 87.1 133 
UBC ubiquitin C Protease binding NM_019639.4 96.8 129 
YWHAZ 
Tyrosine 3-Monooxygenase/Tryptophan 5-
Monooxygenase Activation Protein Zeta 
Involved in the 
signalling pathway 
NM_011740.3 87.8 141 
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3. 3. 4. 2 Reference gene selection software analyses 
a. GeNorm 
This software relies on calculating a normalisation factor based on multiple reference 
genes; GeNorm software hypothesises that two or more normalisers (reference 
genes) should have the same expression ratio across all samples and experimental 
conditions. A measure, “M”, which reflects the reference gene stability is established 
through the standard deviation of the logarithmically transformed expression CT ratios. 
The most stable genes will have the lowest “M” values. The normalisation factor is 
then calculated using the geometric mean from expression levels of the most stable 
reference genes. This software recommends the use of at least 2-3 of the most stable 
reference genes to calculate the normalisation factor; adding a fourth gene does not 
significantly contribute to the expression stability analysis (Vandesompele et al., 
2002). 
b. BestKeeper 
Pfaffl and colleagues developed a BestKeeper tool on the basis that the most stable 
reference genes show the least variability in their CT values across the samples 
examined. The software algorithm utilises the reference gene’s CT data calculating 
the geometric mean, the arithmetic mean, and standard deviation (St. Dev); 
represented as minimum CT, maximum CT and CT St. Dev. Reference genes with a 
St. Dev more than one are considered unstable. To be able to choose more than one 
stable gene, a pair-wise correlation analysis is done to estimate the inter-gene 
relations of all possible pairs: a BestKeeper index combines the most stably expressed 
reference genes. Then, the Pearson correlation coefficient, the coefficient of 
determination and the p-value statistically describe the correlation between this index 
and the reference genes (Pfaffl et al., 2004; Palombella et al., 2017). 
c. NormFinder 
NormFinder is a mathematical model describing the RT-qPCR log CT values, 
estimation of inter- and intra-group variations, sub-group analyses and, finally, the 
calculation of stability values of the reference genes examined. The reference genes 
are then ranked according to their stability value with the most stable gene having the 
lowest stability value (Andersen et al., 2004; Palombella et al., 2017). 
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d. Delta CT 
The process of exclusion is the basis of this method. The relative expression of a pair 
of genes is compared in different samples using the delta CT and St.Dev: stable genes 
would not show any variability in the different samples. This procedure is used with 
more than one pair and various conditions and pairs that show variable expression 
among samples, and hence have fluctuating expression stability, are excluded. 
In addition to these four software packages, a comprehensive ranking tool considers 
the data collected by the four software packages and provides a ranking order for the 
reference genes’ expression stabilities. 
 
3. 2. 4. 3 Primers for each of the genes of the MC system 
The primers for MC1, MC3-5, POMC- full-length gene and AgRP were purchased from 
Qiagen, UK. Primers for MC2 were purchased from Primer Design, UK. MRAP 2 
primers, as described by Asai and colleagues (2013), were obtained from Eurofins. 
Primers for the POMC-truncated gene were designed by the researcher and 
purchased from Eurofins, for sequences see table 3. 3. 
 
3. 2. 4. 3. A Determining primer pair amplification efficiency 
Before conducting the RT-qPCR expression analyses, the amplification efficiencies 
for all the primers were validated by generating RT-qPCR - standard curves. For each 
primer pair, cDNA from the most appropriate positive control tissue was used to 
prepare the standard curve. A 1:10 or 1:2 serial dilution [(100, 10, 1, 0.1 and 0.01 
ng/µl) or (100, 50, 25, 12.5 and 6.25 ng/µl)] was prepared from cDNA made from 
mouse testis (for MC1), adrenal gland (for MC2 and MRAP1), pituitary gland (for MC3 
and POMC), hypothalamus (for MC4 and MRAP2), preputial gland (for MC5) and skin 
(for AgRP). The serial diluted cDNA samples were used in a total reaction volume of 
20 µl: 12.5 µl of 2X Rotor-Gene SYBRgreen® master mix [HotStart Taq Plus DNA 
polymerase; Rotor-Gene SYBR Green RT-qPCR buffer (TrisCl, KCl, (NH4) 2SO4 and 
MgCl2) plus the 10 µM dNTPs mix  (dATP, dCTP, dGTP, and dTTP: Qiagen, UK); 300 
nM primers (primers were from Primer Design, Qiagen or Eurofins; the relevant 
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accession numbers, sequences and product size for each primer are listed in Table 
3.3); and RNase-free water. 
In addition to the reactions described above, each run contained a non-template 
control (cDNA volume replaced by RNase-free water, NTC) and a no reverse 
transcriptase control, NO-RT. The NTC control demonstrates that the reaction is not 
contaminated by a previously amplified product.  
Each RT-qPCR was carried out with an initial activation step at 95°C for 15 minutes, 
and this was then followed by 40 cycles of denaturation at 95°C for 15 seconds; 
annealing at 60°C for 30 seconds; and extension at 72°C for 30 seconds. A melt curve 
was also produced at the end of each run to check the specificity of the reaction. The 
wells were labelled as instructed by the thermal cycler software (Rotor-gene Q thermal 
cycler, Qiagen, UK). A standard curve, which includes information on the slope and 
efficiency, was generated by the cycler software (the graph in Figure 3.1 was produced 
using the log values of the concentration, X-axis, against the threshold crossing point 















Table 3-3: Primers used for determining primer pair amplification efficiency. 
 Column 2 indicates which mouse tissue was used as a positive control, here duplicates of the serial dilution cDNA 
were prepared from the positive control of different ages and used to determine primer efficiency starting with 100 
ng/µl. QG*: Qiagen (UK; primer pair sequences are unpublished); PD*: Primer Design (UK); ‡: obtained from (Asai 


















NM_008559 - 127 






MC3 Pituitary gland 
QG*-
QT00264404 




NM_016977 - 106 
MC5 Preputial gland 
QG*-
QT01166494 




































Figure 3.1: RT-qPCR melt curve and amplification curves. A: the RT-qPCR melt curve is a temperature dissociation 
curve to check for amplification specificity. The dissociation temperature is pre-set to 65º-90ºC by the Rotor-Gene 
Q thermal cycler. After the end of the amplification reaction, the sample temperature starts to increase while the 
cycler measures the fluorescence produced by SYBRgreen [the double strand (dsDNA) intercalating dye] until a 
peak is reached. The increased temperature denatures the amplified dsDNA into a single strand DNA leading to 
the fall in fluorescence. The fluorescence course is then plotted. 1: the reference gene; 2: the target gene; 3: primer 
dimer (non-specific binding of the primers) from the reverse transcription negative control (NO-RT); 4: non-template 
control (NTC). B: Amplification curve. a: low levels of amplification; b: a threshold that is set above the noise; c: 
exponential phase from the specific amplification reaction; d: plateau which is the end of the reaction due to the 
limitation of the RT-qPCR reaction. 
 
3. 2. 4. 3. B Determination of MC expression in female reproductive axis 
  
Duplicate reactions of 4-6 biological replicates (25 ng) of hypothalamus, pituitary 
gland, ovary and uterus from mice aged 2, 6, 9, 10 and 14 weeks and 9 weeks old 
pregnant (13 +1 dpc) samples were carried out using the correct pairs of primers for 
MC (1-5), POMC, MRAP1 and 2 and AgRP (see Table 3.4 for primers’ details) in 
RTqPCR assays to examine the expression of the melanocortin system in these 
tissues. Each tissue used different reference genes determined from the GeNorm 
assays (section 3. 2. 4. 1) to normalise the tissue expression data: CANX and YWHAZ 
(hypothalamus); CANX, YWHAZ and EIF4A2 (pituitary gland); EIF4A2, YWHAZ and 
GAPDH (ovary); and ATP5B, ACTB and YWHAZ (uterus). 
The 20 µl final volume RT-qPCR for each reaction consisted of 10 µl of 2x reaction 
buffer (0.025 U/µl Taq Polymerase, 5 mM MgCl2 and dNTP Mix [200 µM of dATP, 
dCTP, dGTP, and dTTP], Primer Design, UK), 300 nM primers and RNase-free water. 
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NTC and NO-RT controls were also included in the assays. The reaction conditions 
included activation of Taq polymerase for 2 minutes at 95ºC. This was followed by 40 
cycles of cDNA denaturation at 95ºC for 15 seconds; combined annealing and 
extension at 60ºC for 30 seconds and a melt curve was set at dissociation temperature 
65º-90ºC. 
3. 2. 3. 4. 3. C Determination of MC system expression workflow  
The relative expressions of members of the MC system in the female reproductive axis 
were calculated using the ΔΔCT method developed by Livak and Schmittgen 
(2001)The amplification threshold was set to 0.05. CT data were generated by the 
Rotor-Gene Q software and imported into an Excel analysis worksheet. Appendix 1 
shows an example of the analysis for one of the genes in the MC system. 
Calculating ΔCT (normalised raw data) by subtracting the geometric mean of the CT 
values of the reference genes:      
ΔCT= CT gene of interest – CT reference genes geometric mean 
As there are no control samples used, two-week samples were used as a reference 
sample or a calibrator; this was used to calculate ΔΔCT by subtracting ΔCT of the 
gene of interest from the calibrator: 
ΔΔCT= ΔCT gene of interest – ΔCT calibrator 
Converting the log-2 ΔΔCT to a linear scale was used to calculate the fold change 
which is the measure of the relative expression used to compare between the 
examined age groups and the pregnant samples. 
Fold change= 2-(ΔΔCt) 
To carry out statistical analyses for expression significance assessment, the log2 ΔCT 
of the replicates were converted to the linear scale; that is, equal to 2-ΔCT. 
One-way ANOVA (analysis of variance) was then conducted using GraphPad (Prism, 
USA) to determine the P-value. Post Tukey’s multiple comparison tests were also 





3. 2. 4. 3. D Gel electrophoresis of the RT-qPCR products 
The RT-qPCR amplification products were separated on 2% (W/V) agarose gel 
electrophoresis prepared in 1X 0.089 M Tris/ 0.089 M Borate/ 0.002 M EDTA (TBE) 
buffer. SYBRâsafe (1 µl/ 50 ml agarose), a DNA intercalating dye (ThermoFisher 
Scientific, UK), was then added to the melted gel and the gel was poured in the gel 
trays and left to set. The RT-qPCR products (including NTC samples) and 100 bp DNA 
ladder or Low range DNA ladder (0.5 µg/ µl) (ThermoFisher Scientific, UK) were run 
at 110 volts for 40 minutes and visualised at 300 nm using UVIPRO Silver 
transilluminator (Uvitec, UK). 
3. 2. 5 Chromogenic RNA in situ hybridisation, RNAscope® 
3. 2. 5. 1 Sample collection and paraffin embedding 
RNAscope® assays were performed in the laboratory of Dr Cynthia Andoniadou, 
King’s College London. The tissues (hypothalami, pituitaries, ovaries and uteri) of mice 
aged 2 and 10 weeks old and (14 ± 1 dpc) pregnant mice (10 weeks old) were kindly 
collected, fixed and embedded by Dr Joanne Murray at the University of Edinburgh. 
All the solutions used in the tissue preparation were RNase- free to prevent 
background noise from contaminants. 
On the first day, the tissues were dissected, washed in phosphate buffered saline 
(PBS) and placed in 25 ml of 10% neutral buffered formalin (NBF).  The tissues and 
formalin were placed on a roller and rotated at 4°C for 24 hours (samples from two 
weeks old) and 48 hours (samples from adult mice). 
After formalin fixation, the tissues were washed in PBS three times, one hour each, 
with rotation and  at room temperature. The tissues were then dehydrated in 25%, 
50% and 70% ethanol for two hours in each ethanol concentration. The tissues were  
stored in a fresh change of 70% ethanol at 4°C overnight. On the following day, tissue 
dehydration continued with 80%, 90%, 95% and 100% ethanol the tissues were left in 
fresh 100% ethanol rotating at 4°C overnight. 
On the final day, the tissues were immersed in fresh 100% ethanol and left at room 
temperature rotating for 30 minutes. The tissues were immersed in histoclear (pre-
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warmed at 60°C) for 10 minutes at room temperature. The tissues were then placed 
in watch glasses in pre-warmed histoclear and the oven at 60 °C for 10 minutes. The 
histoclear was replaced then with pre-warmed 50:50 histoclear: wax solution and 
incubated for 15 minutes at 60°C. This was then replaced with 100% wax solution, 
and the tissues were incubated at 60°C for one hour. The last step was repeated two 
times with fresh 100% wax solution. The wax solution was replaced a third time, and 
the tissue samples were oriented for the tissues to be cut in frontal sectioning and 
ensuring that the labels of the tissue sample are visible. The tissues samples were 
then left to set overnight at room temperature. The tissue blocks (3-4 tissues per block) 
trimmed and cut into 5 µm thick sections using a microtome. The cut ribbons were 
floated on water heated to 40-45°C and then mounted onto Superfrost® PLUS slides 
(FisherScientific, UK) 2-4 sections per slide.  The sections were dried in the oven at 
40°C overnight.   
 
3. 2. 5. 2 Pre-treatment of formalin-fixed paraffin-embedded (FFPE) tissue for 
RNAscope® 2.5 HD assay 
Slides were baked in the oven for 1 hour at 60°C. To remove the paraffin wax from the 
tissue sections, the slides were placed in two consecutive immersions of 100 % xylene 
(5 minutes each). The tissue sections were then dehydrated by placing the slides in 
two successive immersions of 100 % ethanol (3 minutes each). During these steps, 







Figure 3.2: The RNAscope® in situ hybridisation workflow. The sections were treated with H2O2, RNAscope® target 
retrieval and protease PLUS (step 1 and 2) to enhance probe hybridisation and block the background noise. The 
Sections were incubated with the RNA probes for 2 hours (step 2). The signal was then amplified through 
hybridising the sections with a series of amplification and label probe steps (step 3). Signal detection included the 
use of either 3-3’ diaminobenzidine (DAB) detection or the two-channel (green/red) detection system. The samples 
were then dried, mounted and visualised under a bright-field microscope (permission to use image was granted by 
ACD diagnostics). 
 
To prepare the tissue sections for the RNA probes hybridisation, the slides were 
treated with three reagents. To block the endogenous peroxidase activity, the slides 
were incubated with 1-2 drops of RNAscope® hydrogen peroxide® at room temperature 
for 10 minutes. The slides were then washed twice in dH2O and excess fluid tapped 
off. To improve probe detection in the fixed tissue sections, the slides were placed in 
a staining rack and a staining dish. They were then carefully placed in a beaker filled 
with boiling 1X RNAscope® target retrieval reagent for 15 minutes at 72ºC (this was 
prepared by diluting 70 ml RNAscope® 10X target retrieval with 630 ml distilled water 
in a beaker, covered with foil and left to boil 15 minutes before use) except for the 
hypothalami sections which were left in the boiling 1X RNAscope® target retrieval 
reagent for 17 minutes (see optimisation experiments in appendix 2). The staining dish 
containing the slides was then immediately placed in distilled water to wash the slides. 
The slides were then placed in the HybEZ slide rack in a humidity control tray, and a 
drop of RNAscope® Protease PLUS was added (one drop per slide) to permeabilize 
the cell membrane for better probe penetration. The tray was then covered with the lid 
and placed in the HybEZ oven, which was set to 40°C, for 30 minutes. The slide rack 
was removed from the oven: each slide was then tapped to remove excess fluid and 
washed once with distilled water. 
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After being warmed for 10 minutes before use, the target probes (MC3, MC5 and 
MRAP2, see table 3.5 for probes details) were applied to the sections, one drop per 
section. The slides were then placed in the covered HybEZ tray and the tray incubated 
in the HybEZ oven at 40°C for 2 hours: this incubation allowed hybridisation between 
the probes and the complementary RNA sequence in the tissue sections. In each run, 
two control slides were included: sections on one slide were exposed to a positive 
control probe, a housekeeping gene peptidylprolyl isomerase B (PPIB), to ensure the 
treatment conditions are optimised for each tissue. The sections on a second slide 
were exposed to a negative control probe, a bacterial protein called dihydro-
dipicolinate reductase B (DAPB), to check for background staining. The next part of 
the assay involved amplification and detection of the expression signals using either 
RNAscope® 2.5HD Brown or RNAscope® 2.5HD Duplex assays. 
 
 Table 3-4: RNAscope® probes used in the RNAscope® Brown assays.  
C1*: refers to the probes used for the RNAscope® Brown and channel 1 Duplex assays. N/A: not applicable as 
DAPB is a bacterial gene. #: gene unique to bacteria hence should not be expressed in mammalian 
















PPIB (peptidylprolyl isomerase 
B) 
19035 NM_011149.2 98 - 856 15 C1* 313911 
DAPB (dihydrodipicolinate 
reductase) 
# EF191515 414 - 862 10 C1 310043 
Mm-MC3-C1 17201 NM_008561.3 1627 - 2621 20 C1 412541 
Mm-MC5-C1 17203 NM_013596.2 2 - 1154 20 C1 478381 
Mm-MRAP2-C1 244958 NM_001177731.1 183 - 1387 20 C1 474411 
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3. 2. 5. 2. 1 RNAscope® 2.5 HD Brown detection assay 
After probe hybridisation, a series of amplifiers (that binds to the preamplifier attached 
to the target probes) were added to the tissue sections to amplify the target-specific 
signals. This is followed by detecting the signal using the DAB detection system which 
produces brown pigments due to oxidation by the RNAscope® hydrogen peroxide®.  
After probe hybridisation (see section 3. 2. 5. 2), the slide rack was then removed from 
the oven, excess fluid tapped off and washed with 1X RNAscope® wash buffer (200 
ml) twice (this was prepared by diluting 60 ml of 50X RNAscope® wash buffer with 
2.94 L distilled water). With the slide rack, still, in the HybEZ rack and tray, a series of 
six signal amplification steps were carried out for signal enhancement (see step 3, 
Figure 5). RNAscope® 2.5 AMP1® (one drop per section) was hybridised for 30 
minutes at 40°C in the HybEZ oven, this was followed by washing the slides with 200 
ml of 1X RNAscope® wash buffer twice for 2 min and tapping excess fluid off. The 
samples were washed twice for 2 minutes with 200 ml of 1X RNAscope® wash buffer 
after each subsequent amplification step. AMP2® was added, and the sections were 
incubated at 40°C for 15 minutes followed by washing the samples with 200 ml of 1X 
RNAscope® wash buffer twice for 2 min and tapping off excess fluid. AMP3® and 
AMP4® were also hybridised with the tissue sections using same incubation time, 
temperature and washes as AMP1® and AMP2® respectively. The next two 
amplification steps were conducted at 22ºC with the slide rack still in the HybEZ tray; 
AMP 5® was incubated for 30 minutes and AMP6® for 15 min.  
Signal detection and counter-staining 
The 3, 3’-diaminobenzidine (DAB) reagent (which is oxidised to a brown product in the 
presence of hydrogen ions produced from the reaction of hydrogen peroxide with the 
horseradish peroxidase) was used to detect the signal produced by the probe 
hybridisation with the RNA in the tissues. Equal volumes of the two-component liquid 
substrate system (DAB-A and DAB-B) were mixed in a 1.5 ml microcentrifuge tube. A 
total volume of 40 μl of substrate system DAB-A: DAB-B were added per section; the 
tray containing the slides with DAB was covered and incubated for 10 min at 22ºC. In 
the hood, the DAB from each slide was carefully disposed of (according to regulations) 
and then all the slides were washed three times with fresh distilled water. The tissue 
sections were counterstained with 50% haematoxylin (a basic dye that stains the 
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negatively charged structures of the cells such as the nucleic acids and the ribosomes) 
for 30 seconds and then immediately washed with distilled water until the sections 
were stained purple and the rest of the slide was clear. 
Slides dehydration and mounting the samples 
After washing in distilled water, the slides were then placed into a staining dish and, in 
the hood, the tissue sections were passed through a dehydration two 100% ethanol 
incubations (each for 2 minutes). This was followed by two immersion in xylene (each 
for 5 minutes) to remove lipid residues. From the xylene, one slide at a time, the excess 
fluid was tapped off the slides, and then three drops of Eco-mount (Biocare Medical, 
USA) were added on each coverslip which was then mounted on the slide. The slides 
were left to air-dry for 5 minutes. 
3. 2. 5. 2. 2 RNAscope® 2.5 HD Duplex detection assay 
 
The same FFPE pre-treatment (section 3. 2. 5. 2) was followed for both the brown and 
the duplex assays. The probes used were designed for 2 channels (C1 and C2) with 
the higher expressed probe in C1 which produces a green signal and the lower 
expressed probe at C2 which gives the red signal. Table 3.6 lists the probe names, 
accession and catalogue numbers, target region and channels designed and 









Table 3-5: RNAscope® probes used in the RNAscope® Duplex assays. 
C1*: refers to the probes used for the RNAscope® Brown and channel 1 Duplex assays. C2**: relates to probes 
used for channel 2 RNAscope® Duplex assay. #: gene unique to bacteria hence should not be expressed in 












Channel Catalogue no. 
PPIB (peptidylprolyl 
isomerase B)-Mm-PPIB 
19035 NM_011149.2 98 - 856 15 C1* 313911 
POLR2A (DNA-directed 








20 C2** 312471 
DAPB (dihydrodipicolinate 
reductase) 
# EF191515 414 - 862 10 C1 310043 
Mm-Mc3r-C1 17201 NM_008561.3 
1627 - 
2621 
20 C1 412541 
Mm-Mc3r-C2 17201 NM_008561.3 
1627 - 
2621 
20 C2** 412541-C2 
Mm-Mc5r-C1 17203 NM_013596.2 2 - 1154 20 C1 478381 
Mm-MRAP2-C1 244958 NM_001177731.1 
183 - 
1387 
20 C1 474411 
Mm-MRAP2-C2 244958 NM_001177731.1 
183 - 
1387 
20 C2 474411-C2 
GH-C2 (growth hormone) 14599 NM_008117.3 9 - 630 14 C2 445361-C2 
LHβ-C2 (Luteinising 
hormone –subunit beta) 
16866 NM_008497.2 26 - 503 12 C2 478401-C2 
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After probe hybridisation for two hours, the slides were washed twice in 1X RNAscope® 
wash buffer, and then transferred and kept at room temperature overnight in 200 ml 
of X5 Saline-Sodium-Citrate (SSC) buffer (0.15M NaCl, 0.015M sodium citrate). The 
X5 SSC was made by diluting 50 ml of X20 SSC buffer (0.75M NaCl, 0.075M sodium 
citrate) (pH 7.0) in 150 ml of dH2O. 
Amplification steps 1-6 
The slides were removed from 5XSSC and washed twice with the 1X RNAscope® 
wash buffer for 2 min. Excess liquid was tapped off, and the first 6 amplification steps 
were followed exactly as mentioned with the brown detection assay (section 3. 2. 5. 2. 
1).  
After brief spinning of the RED-B tube. The RED working solution was made by mixing 
RED-B to RED-A with a ratio of 1:60 and covered with aluminium foil until used. This 
was made 5 minutes before use as instructed in the protocol, 40 µl of the RED solution 
were added per section and then incubated covered in the HybEZ humidity control 
tray at 22ºC for 10 min. The slides were then washed twice in 1X RNAscope® wash 
buffer: each wash was for 2 minutes.  
Amplification steps 7-10 
After washing, excess liquid was tapped off, and one drop per slide of AMP7® was 
added and incubated in the HybEZ humidity control tray at 40°C for 15 min. The slides 
were then washed twice with 1X RNAscope® wash buffer each for 2 min. Excess liquid 
was removed and a drop of AMP8® was added to each section before being incubated 
in the HybEZ humidity control tray at 40°C for 30 min. AMP9® was added after washing 
the slides with 1X RNAscope® wash buffer as mentioned before (section 3. 2. 5. 2. 1) 
and the slides were then incubated at RT in the HybEZ humidity control tray for one 
hour. AMP10® was added after washing the slides twice in the 1X RNAscope® wash 
buffer each for 2 minutes. The slides were incubated in the HybEZ humidity control 
tray at RT for 15 min then the slides were washed twice with the 1X RNAscope® wash 




Green signal detection and counterstaining 
The GREEN working solution was prepared by mixing GREEN-B with GREEN-A with 
a ratio of 1:50. The GREEN solution (40 µl) was added to each section; the slides were 
then incubated covered in the HybEZ humidity control tray for 15 minutes at room 
temperature. The slides were immediately washed (less than 30 seconds) with dH2O. 
Haematoxylin (50%) was then used to counterstain the slides and left for no more than 
30 seconds. The slides were then rewashed with tap water for no more than 30 
seconds. 
Section mounting 
The slide rack was put in the oven (60°C) to dry for 30 minutes and then left at room 
temperature to cool down. Three drops of Vectamount mounting medium were added 
to coverslips, and those were then placed carefully over the sections avoiding air 
bubbles. The slides were left to dry for 5 minutes at 22ºC before visualisation.  
 
3. 2. 5. 2. 3 Pituitary gland RNAscope® 2.5 HD Duplex detection assay with 
channel swap 
 
For the pituitary gland sections, an additional method was used to detect the double 
expression of GH or LHβ at C1 and MRAP2 at C2 channels. The GH probe was used 
as a marker for the somatotrophs, and LHβ probe was used as a marker for 
gonadotrophs. Initially, the method above was followed. However, the expression 
signal intensity of GH and LHβ in the pituitary gland was masking the expression signal 
of the other channel probe. Therefore the signal detection was modified accordingly.  
Although the channels are as mentioned; the signal detection will be reversed. The 
signal detected for C1 will be red (instead of green) and for C2 will be green (instead 
of red). This is done by using the same protocol as in 3. 2. 5. 2. 2 but with swapping 
AMP4 and AMP8. With AMP8 (instead of AMP4) incubated for 40°C for 15 min and 
AMP4 (instead of AMP8) incubated at 40°C for 30 min. The RNAscope® C1 channels 
were found to generate expression signal intensity (GREEN) that is lower than that of 
C2 (RED). Therefore, the swap allows the cost-effective detection of the C2 designed 
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probes (in this case GH or LHβ) at C1 channel and vice versa without the need to 
design new probes for either GH or LHβ. 
Visualization of the RNAscopeâ probes (Brown or Duplex) 
The slides were visualised using a bright-field microscope. For a clear image 
resolution, the slides were also, visualised using the NanoZoomer-XR Digital slide 
scanner (Hamamatsu Photonics, Japan). Positive control slides (using the 
housekeeping gene peptidylprolyl isomerase B (PPIB) probe) were inspected for the 
signal strength. The negative control slides (bacterial gene DAPB probe) were 




Figure 3.3: RNAscope® HD 2.5 Brown assay in the uterus of 2 weeks old mouse. A: negative control probe (DAPB: 
dihydrodipicolinate reductase) was used to check for background staining. B: Positive brown punctate staining for 









3. 2. 5. 3 Interpretation of the RNAscope® assay 
The mRNA is detected as dots, and each dot represents one copy of mRNA. The 
intensity of the signal signifies the presence of more than one mRNA copy per one 
cell. The mRNA expression levels were determined using the scoring guideline 
provided by ACD Diagnostics (see Table 3.7 for interpretation of the expression 
signals). 
 
Table 3-6: Scoring guidelines for RNAscope® staining by ACD Diagnostics. 
Image Score Microscopic appearance or visualisation 
 
0 0-1 dots/10 cells (40X magnification) 
 
1 1-3 dots/cell (20X-40X magnification) 
 
2 4-10 dots/ cell (20X-40X magnification) + few clusters 
 
3 >10 dots/ cell. Less than 10% positive cells are with clusters 
 
4 >10 dots/ cell. More 10% positive cells are with clusters 
This scoring guideline enables manual semi-quantitative analysis of mRNA transcripts of the target gene. The 
staining is classified into five grades: 0, 1+, 2+, 3+, and 4+. Dots are representative of mRNA copies with the cells. 
Cluster refers to overlapping signals due to merged dots). The signal on positive signal sections should be detected 









3. 2. 5. 4 Quantification analysis of the RNAscope® 2.5HD brown and duplex 
assay 
In chapter 4, a single hypothalamic section of each target region was analysed to 
examine areas expression the target genes. To carry out quantitative analyses, 
consecutive sections of each of the target region would have been required to cover 
the whole region thickness of each region (rPOA, mPOA and the arcuate nucleus).  
In the current study, quantification analysis was conducted on pituitary sections to 
determine the expression level of MC3, MC5 and MRAP2. The quantitative studies 
were also conducted to compare between 2 and 10 weeks old mice and pregnant (14 
± 1 dpc) mice in each of the pituitary gland, the ovary and the uterus. The workflow 
protocol was as described below.  
At the magnification power of about 90X, a rectangle of about 6050 µm2 was randomly 
selected on each section of the anterior pituitary gland where the outline of the cells 
was visible on each slide from each age group. Artefacts such as air bubbles or black 
precipitates were identified and excluded from the selection. 
 
The rectangle is then divided into smaller squares to enable counting cells within each 







Figure 3.5: Dividing the area to be 
quantified for expression into small 
squares for cells expression counting. 
Figure 3.4: Selecting an area for 
quantification analysis in female mouse 
pituitary gland.   The black rectangle 




The percentage of the expression in each section is measured using the following 
equation:    Expression	Percentage = (2345266789	:8;6 ÷ ;8;=>	?2>>	?8@9;) × 100 
 
The last step was calculating the mean of all sections on one slide to measure the 
overall expression level within one age/pregnant group. E345266789	(E34)	F2=9 = (E34	(62?;789	1) + E34(62?;789	2) + E34(62?;789	3) ÷ 3 
 
The Percentage values were then plotted in GraphPad worksheets and analysed using 




















4  Molecular and cellular characterisation 











4. 1 Background 
The hypothalamus is the first component of the HPO axis. It contributes to the 
regulation of the HPO axis through the release of gonadotropin-releasing hormone 
(GnRH) which stimulates the secretion of the gonadotropins (FSH and LH) from the 
anterior lobe of the pituitary glands. This chapter describes the characterization of both 
molecular and cellular expression of components of the melanocortin system within 
areas of the hypothalamus associated with regulation of the reproductive axis. 
4. 1. 1 GnRH neurons distribution and axonal projections 
The GnRH neurons develop outside the hypothalamus in the olfactory placode and 
then migrate to their final location within the hypothalamus. In all mammals, the GnRH 
course is represented as an inverted Y shape starting from the medial septum and 
diverging at the third ventricle then meeting again at the anterior hypothalamic area 
(see Figure 4.1). However, there are differences as to where GnRH neurons 
predominate within that course in different species (Herbison, 2014). The soma of 
mouse and rat GnRH neurons are mainly found in the preoptic area; they are also 
found alongside the ventral aspect of the anterior hypothalamic area (AHA). The axons 
of these neurons project to the arcuate nucleus and median eminence (the latter two 
are collectively known as the mediobasal hypothalamus, MBH). These terminals 
release their GnRH content into the hypothalamic-hypophyseal circulation to be 
transferred to the gonadotropes in the anterior pituitary gland. Some GnRH neurons 
are found outside the hypothalamus in the periaqueductal area. In humans, in addition 








Figure 4.1:  GnRH neurons locations within the mouse hypothalamus. The drawings represent the coronal section 
of the GnRH neurons distribution within the hypothalamus. The neuron distribution takes an inverted Y shape 
pattern in mice and rats with the predominance within the medial septum (MS), rostral preoptic area (rPOA) and 
the more caudally anterior hypothalamic area (AHA). (Permission to reproduce this schematic drawing has been 
granted by Elsevier. (Taken from Herbison, 2014). 
 
4. 1. 2 Postnatal GnRH  
After reaching their final location, the unique GnRH soma starts forming the endocrine 
network by sending their long dendritic axons to the median eminence which connects 
it with the hypophyseal-portal circulation found in that area (Herbison, 2016). The 
formation of this dendritic network occurs during the first 2- 3 weeks after birth and is 
thought to be regulated through glutamatergic and γ-aminobutyric acid (GABA) 
interactions with those maturing dendrites (Cottrell et al., 2006). The biocytin cell-filling 
studies conducted in brain slices of postnatal (2 weeks old) and adult ( about 8 weeks 
old) mice by Cottrell and colleagues revealed the extensive branching of the rostral 
preoptic GnRH neuronal dendrites in postnatal mice compared to adult animals; while 
the dendritic spines responsible for receiving synaptic input were duplicated near the 
GnRH neuronal body and proximal dendrites in adult animals compared to postnatal 
animals (Cottrell et al., 2006). The postnatal development of the synaptic innervation 
and its interaction with different neuroendocrine input is thought to trigger the GnRH 
release that is responsible for the mechanism initiating puberty in mice (Cottrell et al., 
2006). However, the neuroendocrine factors that are thought to be interact with the 
GnRH dendritic network during the prepubertal period are yet to be identified. These 
factors were suggested to include kisspeptin and gonadal steroids. 
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Estradiol secreted by the growing ovarian follicles exert negative feedback on the 
release of GnRH. Recent kisspeptin cell specific estradiol receptor alpha mouse 
knockout (KERαKO) studies showed that the effect of estradiol during the juvenile 
period is exerted on the arcuate kisspeptin neurons (Dubois et al., 2016). Once the 
ovarian follicles gain full maturity, a final GnRH is activated through the positive 
feedback mechanism exerted on the kisspeptin neurons located in the anteroventral 
periventricular area (AVPV); the release of GnRH leads finally to commencement of 
puberty through the first ovulation (Prevot, 2014; Dubois et al., 2015). 
 
4. 1. 3 GnRH and puberty 
The onset of puberty in the female mouse is defined as the vaginal opening; this occurs 
as a culmination of a series of neuroendocrine and morphological events that occur at 
each level of the HPO axis leading to ovulation. At the hormonal level, the onset of 
puberty in girls preceded by a rise in the amplitude of LH pulsatile release during sleep 
in the hours between 2:00 am to 8:00 in the morning  (from about 5 mIU/ml to 12 
mIU/ml) (Griffin and Ojeda, 2004). Until now, the pathway that controls this event was 
not clearly defined, but it has been agreed that the rise in LH rise occurs as a result of 
an increase in the frequency and amplitude of GnRH pulsatile release (Herbison, 
2016). Some of the hypothalamic pathways were found to influence the timing of 
puberty. These include pathways controlling sexual receptivity and behaviour, energy 
homeostasis and food intake regulation. AgRP, neuropeptide Y (NPY) and leptin are 
good examples of peptides involved in the control of food intake. AgRP/NPY neurons 
are localised in the arcuate nucleus, near to GnRH projections. These peptide 
hormones are thought to be involved in the timing of puberty (Cardoso et al., 2014; 
Egan et al., 2017). Leptin, which is an adipocyte-derived peptide, regulates food intake 
through both NYP/AgRP and POMC neurons (Elias et al., 1999). Furthermore, 
synaptic communications between GnRH neurons and POMC neurons (through β-
endorphin) in mice (Ward et al., 2009) and rats (Chen et al., 1989) support theories 
regarding the participation of POMC and the MCs in the timing of the onset of puberty 
(Manfredi-Lozano et al., 2016). 
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4. 1. 4 GnRH pulsatile release 
In rodents, tip-tail blood sampling enabled the measurement of the LH secretions in 
different phases of the estrous cycle and this was suggested was to reflect the 
secretion of GnRH (Czieselsky et al., 2016).  During metestrus and diestrus and 
proestrus, LH was released about every hour, and this pulse frequency was reduced 
to less than half the time during estrus. Ovariectomy was found to increase the LH 
pulsatile release to about six pulses in 2 hours and also caused increased basal LH 
release (Czieselsky et al., 2016). The use of the mutant GNR23, that is characterised 
by an allele-dependent ephrin signalling mutation, with a resultant GnRH migratory 
failure had been shown to affect the LH pulsatile release, even though the frequency 
is retained at normal levels. These findings implicate the regulation of the LH pulsatile 
release by GnRH. The generation of the pulsatile pattern of GnRH release is thought 
to be regulated by both anteroventral periventricular nucleus  (AVPV) and arcuate 
nucleus kisspeptin (KissAVPV and KissARC respectively) neurons (Herbison, 2016), as 
recently demonstrated using optogenetics (Han et al., 2015). As with the timing of 
puberty, pulsatile GnRH secretion is also affected by different pathophysiological 
conditions, such as starvation, which might lead to infertility. Infertility caused by 
starvation is thought to be mediated by AgRP. The AgRP neurons project directly to 
and make inhibitory synapses with both KissAVPV and KissARC neurons while activation 
of the AgRP using clozapine has led to decreased fertility through delayed estrous 
cycles (Padilla et al., 2017).  
 
4. 1. 5 GnRH surge and the estrous cycle of mice 
The estrous/menstrual cycle is controlled by the feedback mechanism on the 
hypothalamus (GnRH) and pituitary gland (LH); this mechanism is mediated by 
estradiol (E2)  and progesterone. Different studies in rhesus monkeys have shown that 
E2 keeps the concentrations of gonadotropins, as well as GnRH, low during the entire 
ovulatory cycle except for the pre-ovulatory phase (Karsch et al., 1973, Spies and 
Norman, 1975). The increase in circulating concentrations of E2, (up to 360 pg/ml 
compared to of about 20 pg/m in other phases of the cycle)  from growing ovarian 
follicles, evokes a surge in GnRH followed by a LH surge (Xia et al., 1992). The same 
cycle of events also occurs in rats. Hypothalamic preparations collected from rats 
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showed constant frequency of GnRH pulses (with inter-pulse intervals of 40 minutes) 
throughout the estrous cycle. However, the amplitude was seen to rise in the afternoon 
of proestrus  (Parent et al., 2000). 
Unlike GnRH pulse generating neurons, the GnRH neurons involved in producing the 
GnRH surge are localised and found in areas that express c-fos, which is a marker of 
neuronal activity. The c-fos expression is found to be upregulated by the time of the 
LH surge during proestrus (Vastagh et al., 2016). In rodents, the GnRH surge 
generating neurons are located close to the organum vasculosum of lamina terminalis 
(OVLT) of the preoptic area (POA) (Herbison, 2016). The hypothalamic regions 
surrounding the OVLT are also reported to contain melanin-concentrating hormone 
(MCH) fibres (Murray et al., 2006). MCH is suggested to have a role in the regulation 
of the generation of GnRH release in female rats through the MCH receptor 1 (MCH1-
R) as well as MC5 (Murray et al., 2006). This might indicate that MC5 has an indirect 
role in inducing ovulation. 
Other melanocortin receptors are also thought to participate in controlling estrous 
cyclicity. This is supported by studies using MC4-knockout mice (MC4-/-). MC4-/- adult 
female mice are obese but appeared to have regular estrous cycles.  Their ovaries, 
however, contain many cystic large follicles and decreased numbers of the corpora 
lutea which might indicate previous anovulatory cycles (Sandrock et al., 2009). This 
had led the team to the assumption that these MC4-deficient mice would have 
inevitable ovarian failure due to abnormal gonadotropin stimulation or a failure at the 
hypothalamic-pituitary level (Sandrock et al., 2009). These observations were only 
made on adult females and did not include animals from different stages of the 
reproductive cycle.  
 
4. 1. 6 Hypothalamic control of pregnancy 
Pregnancy is one of the most extensively researched fields, yet due to the complexity 
of the interaction between the different molecular, cellular and hormonal cues, it still 
needs further investigation to understand the maternal adaptation to metabolic, 
hormonal and other demands of pregnancy. Therefore, this section focuses on some 
of the hypothalamic inputs and adjustments involved in maintaining pregnancy. 
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During pregnancy, there is a decreased concentration of GnRH due to the feedback 
inhibition exerted by the sex steroids produced by the corpus luteum.  In pregnant 
mare serum gonadotropin (PMSG) primed rats, the intra-arcuate and AVPV treatment 
with progesterone treatment was found to suppress the LH surge compared to vehicle-
treated rats (He et al., 2017). The inhibition of GnRH was found to persist after 
parturition but the inhibitory mechanism(s) at this stage were not well understood. 
Prolactin was thought to be responsible for suppressing GnRH during lactation. In 
2007, Grattan and colleagues suggested that prolactin inhibits LH secretion through 
regulation of GnRH secretion in the mouse arcuate nucleus. This study had also 
shown the prolactin receptor to be expressed in a subpopulation of GnRH neurons in 
the murine arcuate nucleus (Grattan et al., 2007). 
 
As a physiological condition, pregnancy causes an increased metabolic demand to 
meet the requirements of the growing embryo and to prepare the mother for lactation 
after giving birth. This is achieved by an alteration in the neural circuit controlling 
appetite and energy homeostasis. Many neuroendocrine peptides are involved in this 
neural circuit such as leptin, ghrelin and prolactin. All of these peptides interact with 
two distinct populations of neurons, POMC neurons and NPY/ AgRP neurons; both of 
which reside in the arcuate nucleus (Tong and Pelletier, 1992; Cowley et al., 2001; 
Cowley et al., 2003). As expected, AgRP is upregulated in pregnancy (Rocha et al., 
2003). This might explain the decreased sensitivity to a-MSH during pregnancy that 
has been recently reported (Ladyman et al., 2016). There are no reports on whether 
hypothalamic POMC or its derived products (and hence a-MSH) are differentially 
expressed and accordingly differentially regulated during pregnancy. However, one of 
the end products of POMC is b-endorphin, which was found to stimulate food intake 
in rats is also found to be upregulated in pregnancy (Grandison and Guidotti, 1977).  
Therefore, examining the manner of POMC processing during pregnancy could reveal 
whether POMC processing changes to meet the metabolic demands of pregnancy. 
 
 69 
4. 1. 7 The different approaches on hypothalamic organisation 
There are different theories describing how the hypothalamus is organised. This is 
attributed to various reasons; first, the exact course of the hypothalamic remodelling 
during its development is still a perplexing argument to most neurobiologists (Puelles 
and Rubenstein, 2015). Second, different fundamental survival functions are 
controlled by this small region of the forebrain; this was proved by finding neurons of 
various physiological functions overlapped in the same hypothalamic area (Loes et al., 
1991). The third reason was the method or the technique that was used to define the 
different regions of the hypothalamus such, MR imaging (Loes et al., 1991); 
histochemical studies (Pilgrim, 1974) and using the immunofluorescence techniques 
(Moga et al., 1990). In this research, we have adopted the following functional 
organisation of the mouse hypothalamus: the hypothalamus is divided into the preoptic 
region, the tuberal region (which is made of the arcuate nucleus, ventromedial and 
dorsomedial nuclei as well as the median eminence) and the posterior region. The 
areas of interest in this research are the preoptic and the tuberal hypothalamus, as 
both regions contain GnRH nuclei and projections that are involved in mouse 
reproduction, as explained earlier.  
The account of the hypothalamic role in reproduction highlighted above implies a role 
for the MC system at all stages of the reproductive cycle. Several research studies 
have focused on the indirect interaction of the central MC system with different 
components of the hypothalamus (Humphreys, 2004; Murray et al., 2006; Sandrock 
et al., 2009). This chapter aims to: 
1. Determine suitable reference genes in the mouse hypothalamus for 
normalisation using GeNorm expression stability analysis. 
2. Characterise MC (1-5), MRAP1 and MRAP2, POMC and AgRP expression in the 
hypothalamus of different aged mice (2, 6, 10 and 14 weeks old). 
3. Compare the expression of the melanocortin system members listed above in 
pregnant and non-pregnant mice. 
4. Determine cellular expression of MC3, MC5 and MRAP2 using chromogenic in 
situ hybridisation (RNAscope®). 
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4. 2 Methods  
 
For a detailed account of the materials and techniques used see chapter 3. 
4. 2. 1 Determining suitable reference genes in the hypothalamus 
The most stable reference genes in the hypothalamus were selected using the 
GeNorm analysis described in detail in section 3. 2. 3. 4. 1. Duplicates of cDNA 
samples from each age group were used in these analyses.  
 
4. 2. 2 Characterising the gene expression of the MC system 
The identified reference genes were used to normalise data obtained from the RT-
qPCR assays of the reverse transcribed RNA extracted from whole hypothalamic of 
female C57BL/6 mice aged 2, 6, 9, 10, 14 weeks and pregnant mice (14 ±1 day post 
coitus, dpc) (n=5; n=3 for 9 weeks and n=4 for 10 weeks). The efficiencies of the 
primers used in these assays were examined using standard curves with positive 
controls for each primer pair (see section 3. 2. 3. 4. 3 for details). The RT-qPCR 
amplification products were then separated on 2% agarose gel to check the size of the 
band and verify they were of the predicted size and to check for non-specific bands. 
The RT-qPCR data were analysed using the delta-delta CT method mentioned in 
section 3. 2. 3. 4. 3. C.  
4. 2. 3 RNAscope® 2.5HD protocol 
The hypothalamus sections were collected from female C57BL/6 mice aged 2 weeks, 
10 weeks and pregnant (14 ± 1 dpc). Slides were selected for the RNAscope® studies 
with sections observed with the regions of interest: rostral and medial preoptic (rPOA; 
mPOA) and arcuate nucleus of the hypothalamus (as in Figure 4.1). 
First studies included using RNAscope® 2.5HD single-plex (brown) staining kit with 
MC3, MC5 and MRAP2 as well as positive and negative controls.   
The second group of studies included using RNAscope® 2.5HD duplex (C1-green/C2-
red) staining kit with MRAP2 at C1 and MC3 at C2 channels as well as 2-plex positive 
and 2-plex negative controls. See section 3. 2. 5 for full details.  
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Figure 4.2: Hypothalamic sections showing the regions of interest studied with RNAscope®. rPOA: rostral preoptic 
area; mPOA: medial preoptic area and ARC: the arcuate nucleus of the hypothalamus. Drawings made by JF 





















4. 3 Results 
 
4. 3. 1.  A. Reference gene stability in the hypothalamus 
In the female C57BL/6 mouse hypothalamus, tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein zeta (YWHAZ), calnexin (CANX) and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were the most stable genes 
whereas Ubiquitin C (UBC), actin beta (ACTB) and 18S were the least stable genes 




Figure 4.3: GeNorm ranking order of reference genes’ stability in the female mouse hypothalamus. The ranking is 
based on calculating the geometric mean of the ranking values from Delta CT, BestKeeper, Normfinder and 
GeNorm reference gene analyses tools. The stability of 12 reference genes was examined using hypothalami of 
female mice aged 2, 6, 9, 10, 14 weeks and pregnant mice (14+1 dpc). The samples were run in duplicates. The 
reference genes are 18S, ACTB, ATP5B, B2M, CANX, CYC1, EIF4A2, GAPDH, RPL13A, SDHA, UBC and 




The Optimal number of housekeeping genes to be used in normalising the RT-qPCR 
data was two for the hypothalamus. This was obtained by calculating the pairwise 
variation (V-score) with the sequential addition of each reference gene one at a time. 
A V-score above 0.15 indicates the optimal number of most stable reference genes to 
be used (Figure 4. 4). The V-score was calculated using GeNorm analysis by qBase+ 
software (Biogazelle, Belgium). See Appendix 3. A for graphs of the BestKeeper, 
Normfinder, Delta CT and comprehensive reference genes stability analyses.  
 
 
Figure 4.4: Variation score (V- score) by GeNorm. An optimal number of stable genes used normalisation was 
calculated by pairwise variation with the addition of each reference gene one at a time. A V-score equal or below 
0.15 indicated the insignificance of using more reference genes. In this graph, 10 reference genes V-score results 
indicates the optimal number of most stable housekeeping genes (HKG) to be used in the hypothalamus are two 








 4. 3. 1. B. Amplification efficiencies of CANX and YWHAZ 
The amplification efficiency is defined as the doubling of the cDNA template for each 
RT-qPCR cycle. Table 4.1 lists the standard curve slope (M), the coefficient of 
determination (R2) and amplification efficiency (E) of CANX (80%) and YWHAZ (98%). 
These observations reflect the order of the stability of both reference genes as YWHAZ 
was most stable followed by CANX. See Figure 4. 5.  
 
Table 4-1: Amplification efficiency of CANX and YWHAZ in the hypothalamus. 
Gene R2 (Coefficient of Determination) 
M (Measurement of 
Efficiency) 
E (Efficiency) 
CANX 0.99 -3.90 80% 
YWHAZ 0.99 -3.62 98% 
Pooled cDNA from all samples used in MC system expression in the hypothalamus were used in generating 1:2 
standard curves. The efficiency was calculated automatically using the Rotor-Gene Q software (Qiagen, UK). 
 
4. 3. 2 MC system expression 
4. 3. 2. 1 Primers amplification efficiency 
 
Different optimisation steps were needed to validate the RT-qPCR assay used in 
examining MC (1-5), MRAP1, MRAP2, POMC and AgRP expression in the female 
reproductive axis. These included choosing the right annealing temperature for primer 
specific binding and evaluating the RT-qPCR efficiency. A 100% efficient RT-qPCR 
assay means that the cDNA amplification doubles each cycle. 
 
A low primer efficiency (<90%) could be due to poor optimisation, poorly designed 
primers or the presence of Taq polymerase inhibitors. Nonspecific products, such as 
primer dimers, could cause an efficiency higher than 110%. Determining the 
efficiencies is typically done by serial dilutions of the tissue of interest, as explained in 
chapter 3.  
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In Figure 4. 5. A, amplification curve 1 represents the most concentrated sample.  The 
the curves shift to the right as the samples are more diluted as seen with amplification 
curve 5. Table 4. 2 lists the primer pair amplification efficiencies for the MC (1-5), 
MRAP1, MRAP2, POMC and AgRP. 
 
 
Figure 4.5: A representative example of the data acquired for the calculation of primer pair efficiency (MC5 standard 
curve). A: an amplification curve produced by plotting the number of amplification cycle for a five-point serial dilution 
of cDNA against the normalised fluorescence units. The efficiency of the primer pair for MC5 was tested using 
cDNA from a preputial gland from a male mouse. The cDNA input range is from 30.61 ng to 0.0031 ng (10X fold 
dilutions). B: semi-log regression line plot of CT value vs log of nucleic acid concentration. CT: threshold crossing 




Table 4-2: Primer pair amplification efficiencies for the MC (1-5), MRAP1, MRAP2, POMC and AgRP. 
Different female mouse tissues were used for testing the each of the primer pairs’ efficiencies (whole mouse brain 
for MC1, adrenal gland for MC2 and MRAP1, pituitary gland for MC3 and POMC, hypothalamus for MC4 and MRAP2, 
preputial gland (male) for MC5 and skin for AgRP). R2: coefficient of determination, M: The graph slope and E: 
efficiency. The efficiency was automatically calculated using ThermoScientific qPCR Efficiency Calculator 
(ThermoScientific, 2015). See Table 1 for primer sequences and expected products sizes. 
 
 
4. 3. 2. 2  MC system expression 
 
All the MC system members (MC (1-5), MRAP1, MRAP2, POMC and AgRP) are 
expressed in the hypothalamus. The expression of the mRNA for these targets is not 
the same. At 2, 6, 9, 10 and 14 weeks old and pregnant (14 ±1 dpc), the hypothalamic 
expression of both MC1 and MC2 was very low (Figure 4. 6 A and B, respectively).  
 
Primer 
R2 (Coefficient of 
Determination) 
M (Measurement of 
Efficiency) 
E (Efficiency) 
MC1 0.96 -3.33 100% 
MC2 0.99 -2.68 136.20% 
MC3 0.98 -3.03 113.81% 
MC4 0.95 -3.28 101.78% 
MC5 0.99 -3.31 100.50% 
POMC 0.99 -3.27 102.21% 
MRAP 1 0.97 -3.11 109.67% 
MRAP 2 0.99 -3.16 107.04% 
AgRP 0.99 -3.31 100.00% 
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Figure 4.6: MC1 and MC2 expression in the female mouse hypothalamus. Hypothalamic cDNA duplicates from 
female C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (No. of animals =3-5) were used 
in the RT-qPCR studies. A: MC1; B: MC2. CT values of each assay were exported to an Excel worksheet, analysed using 
the delta CT Method developed by Pfaffl (2001). The skewed data seen in the graphs are due to animal sample variations 
(old vs. newly obtained samples). The 2-ΔCT values were imported to GraphPad and analyses using one-way analysis of 
variance (ANOVA). (Prism 7, USA). 
 
In Figure 4. 7. A, there appeared to be a decrease in hypothalamic MC3 expression 
between 2 and 6 weeks of age, however, as the animals got older the expression 
increased so that at 10 and 14 weeks of age the amount of MC3 expressed was similar 
to that at 2 weeks of age. Pregnancy appeared to not affect expression compared to 
9 weeks old non-pregnant mice. There were no significant differences in expression 
between any of the age groups or pregnant animals. 
The expression of MC4  appeared to be of a similar pattern of expression to MC3 in the 
2, 6, 9, 10 and 14 weeks old hypothalami. In the pregnant animal, MC4  expression 
was decreased compared to 14 weeks old animals. Age and pregnancy did not affect 
the pattern of MC4   expression in the mouse hypothalamus as seen in Figure 4. 7. B.  
Age had an effect on the expression of MC5 in the mouse hypothalamus. Neonatal 
animals had an increased MC5 (P = 0.0011) compared to 6, 9, 10 and 14 weeks old 
and pregnant (14 ± 1 dpc) animals which appeared to have the same level of MC5 
expression as shown in Figure 4. 7. C.  
MRAP1 expression appears to higher in older animals (10 and 14 weeks old mice) 
compared to the younger animals (2, 6 and 9 weeks old mice: Figure 4. 7. D). Pregnant 
animals showed a similar level of MRAP1 expression to a non-pregnant animal of the 
same age (9 weeks old mice). However, there were no significant changes in the 
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expression in relation to both age and pregnancy. MRAP2 expression appeared to be 
increased between 2 weeks and 6 weeks old mice and then the expression dropped 
to lower levels in 9 weeks old animals (Figure 4. 7. E). However, older mice (10 and 
14 weeks old mice) appeared to have higher MRAP2 expression than both 2 weeks 
and 6 weeks old mice. Pregnant animals appeared to have higher MRAP2 expression 
compared to non-pregnant animals of the same age (9 weeks old mice) but still lower 
than the expression seen in 10 and 14 weeks old mice. Nonetheless, both age and 
pregnancy did not affect MRAP2 expression significantly.  
 
Figure 4.7: MC3-5, MRAP1 and MRAP2 expression in the female mouse hypothalamus. Hypothalamic cDNA 
duplicates from female C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (13 +1 DPC) (No. of animals 
=3-5) were used in the RT-qPCR studies. A: MC3; B: MC4; C: MC5; D: MRAP1; E: MRAP2. **: P value= 0.0011.  CT 
values of each assay were exported to an Excel worksheet, analysed using the delta CT Method developed by Pfaffl 
(2001). The skewed data seen in the graphs are due to animal sample variations (old vs. newly obtained samples). The 
2-ΔCT values were imported to GraphPad and analyses using one-way analysis of variance (ANOVA). (Prism 7, USA). 
 
 




Both POMC and AgRP showed higher expression levels than other members of the 
MC system (MC1-5, MRAP1 and MRAP2). POMC expression increased between 2 
weeks old and 6 weeks old mice then showed a small decrease in expression in 9 
weeks old mice. The expression of POMC increased dramatically in older animals (14 
weeks old mice) (P = <0.0001) compared to 2 weeks old mice. Pregnant animals 
showed a small increase in expression compared to non-pregnant animals of the same 
age (9 weeks old mice: Figure 4. 8. A).  
AgRP expression appeared to be decreased between 2 weeks and 6 weeks old mice 
and got higher in 9 weeks old mice (Figure 4. 8. B).  Older mice (10 and 14 weeks old 
mice) had a similar expression that was lower than that seen in 9 weeks old mice. 
Pregnancy did not change the expression of AgRP as seen when compared to non-
pregnant animals of similar age (9 weeks old mice). A summary of the MC (1-5), MRAP1, 
MRAP2, POMC and AgRP expression in the female mouse hypothalamus is 
presented in Table 4.3. 
 
 Figure 4.8:  POMC and AgRP expression in the female mouse hypothalamus. Hypothalamic cDNA duplicates from 
female C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (No. of animals =3-5) were used 
in the RT-qPCR studies. A: POMC; B: AgRP.  CT values of each assay were exported to an Excel worksheet, analysed 
using the delta CT Method developed by Pfaffl (2001). The skewed data seen in the graphs are due to animal sample 
variations (old vs. newly obtained samples). The 2-ΔCT values were imported to GraphPad and analyses using one-way 







Table 4-3:  MC system expression in the female hypothalamus. 
The table represents each gene examined in hypothalamic cDNA from 3-5 female C57BL/6 mice. Age and 
pregnancy effects were examined by using animals aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1dpc). 
MC (1-5), MRAP1, MRAP2, POMC and AgRP were found in the hypothalamus. Age had an impact on the expression 
of MC5 (p-value 0.0011) and POMC (p-value <0.0001). There appeared to be no effect of pregnancy on the 
expression of any of the genes of interest when compared to non-pregnant mice of similar age (9 weeks old). (+) 
Indicate the presence of a gene or significant effect by age or pregnancy; (++) indicate moderate significance; 
(++++): indicate high significant were p <0.0001; (-):  indicates the absence of a gene or insignificant effect by age 
or pregnancy. N/A: not applicable. 
 
 
4. 3. 2. 3 Validation of the MC system expression 
 
The products of the RT-qPCR of MC (1-5), POMC, MRAP1, MRAP 2 and AgRP, as well 
as CANX and YWHAZ, were examined by electrophoresis on a 2% agarose gel 
(composition and method described in section 3. 2. 4. 3. 3: Figure 4. 9). Included were 
non-template controls for each of the target genes and the reference genes to check 
for genomic contamination.  
 
HYPOTHALAMUS (n= 3-5) 
Gene Expression P value Effect of Age Effect of Pregnancy 
MC1 + 0.80 - - 
MC2 + 0.35 - - 
MC3 + 0.33 - - 
MC4 + 0.36 - - 
MC5 + 0.0011 ++ - 
POMC + <0.0001 ++++ - 
AgRP + 0.18 - - 
MRAP1 + 0.20 - - 
MRAP2 + 0.27 - - 
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Figure 4.9: Gel electrophoresis of RT-qPCR of MC system in the hypothalamus. The RT-qPCR products were 
separated on 2% agarose gel at 110 volts for 40 minutes. Where L = ladder 100 bp to 5000 bp; (ThermoScientific, 
UK); CX = CANX, 105 bp; MC1 = 127 bp et cetera, MC2 = 86 bp, MC3 = 108 bp, MC4 = 106 bp, MC5 = 90 bp, yz = 
YWHAZ (141 bp), POMC = 99 bp, MRAP1 = 86 bp, MRAP2 = 150 bp, AgRP = 63 bp, -ve: non-template control for 
gene of interest in previous lane. Gel image was taken using UVIPRO (Uvitec, UK). 
 
4. 3. 3 Localisation of MC3, MC5 and MRAP2 mRNA transcripts in the female 
mouse hypothalamus 
In the RNAscope® 2.5HD single-plex (brown) assays, a single gene of interest was 
studied on each hypothalamic section.  Positive target probe signal is visible as 
punctate brown dots within cells. 
Before studying each of the genes of interest, it was necessary to optimise the 
RNAscope® pre-treatment conditions with the female mouse hypothalamic tissues. An 
incubation  in the RNAscope® target retrieval reagent of 15 minutes produced a very 
weak signal in the hypothalamic sections (data not shown). Therefore, the incubation 
time was increased to 17 minutes. This period was enough to produce a strong 
expression signal (Figure 4. 10. A) and did not show any background staining in the 
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negative control (Figure 4. 10. B). The negative control is a probe designed to hybridise 
with mRNA copies of bacterial protein 4-hydroxy-tetrahydrodipicolinate reductase, 
DAPB that should not be expressed in other species. No staining with the negative 
control indicates optimal treatment conditions that aimed to block non-specific binding 
of the mRNA probes. The intense staining signal seen with the positive control, 
Peptidylprolyl Isomerase B, PPIB mRNA probe indicates section treatment conditions 
enabled effective tissue permeability facilitating the hybridisation of the target probes 
with their target sequence within the tissue sections (Figure 4. 10. A).  
The difference of expression between 2, 10 weeks old and the pregnant could not be 
determined due to lack of time and resources as calculating the expression levels 
should be done in serial hypothalamic sections to cover the whole thickness of the of 




Figure 4.10: The RNAscope® 2.5HD Brown assay in the female mouse hypothalamus. A:  RNAscope® 2.5HD 
Brown assay of negative probe (DAPB). This was included to ensure there is no background staining indicating 
optimum treatment conditions. B: RNAscope® 2.5HD Brown using positive probe (PPIB). The expression signal 
represented with brown dots of mRNA copies with the tissue. 3V: third ventricle. Images were taken using a 






In the RNAscope® 2.5HD duplex assays, two different target probes were hybridised 
as two channels, channels 1 (C1) and channel 2 (C2). The signal detection of the 
RNAscopeâ duplex assay represented as green (C1) and/or red (C2) dots. The 
horseradish peroxidase detects the green signal while the red signal is detected 
through the activity of alkaline phosphatase as demonstrated in Figure 4. 11. A. The 
probes used in Figure 4. 11. A were PPIB at C1 (green) and RNA polymerase II subunit 





Figure 4.11: The RNAscope® 2.5HD Duplex assay in the female mouse hypothalamus. A: The RNAscope® 2.5HD 
Duplex 2-plex assay using positive probes. The double expression is seen as green dots for the expression of the 
PPIB at (C1) and the red dots for the expression of POLR2A (C2). B: The RNAscope® 2.5HD Duplex 2-plex 
negative probes (DAPB) which was included to ensure the absence of background staining and optimum 
conditions. Images were taken using a NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College 








4. 3. 3. 1. B RNAscopeâ 2.5HD detection of MC3, MC5 and MRAP2 in the rPOA 
1. RNAscopeâ 2.5HD-singleplex (Brown) assay 
Based on the RNAscopeâ results, MC3 expression was detected in the mouse rPOA 
of 2 weeks, 10 weeks and pregnant (14 ± 1 dpc) mice. The expression appeared to 
increase between 2 and 10 weeks old mice. Pregnant mice appeared to have a lower 
level of expression than both 2 weeks and 10 weeks old animals (Figure 4.12, A-F).  
MC5 was detected at lower levels than MC3 in the rPOA. The MC5 expression levels 
did not change between 2 weeks, 10 weeks old mice and in pregnant (14 ± 1 dpc) 
mice hypothalamic section (Figure 4.13, A-F). 
MRAP2 was detected in the rPOA of 2 weeks, 10 weeks and pregnant (14 ± 1 dpc) 
mice hypothalami at higher levels than MC3 and MC5. Pregnant animals appeared to 
have the highest level of expression compared to 2 weeks and 10 weeks old mice 
while the latter two ages seemed to have the same level of expression (Figure 4.14, 
A-F) 
The assay included both positive (PPIB) and negative (DAPB) probes to make sure 
that optimal hybridization conditions were maintained and that there was no 
background staining, respectively. Results of those sections were similar to those in 
Figure 4. 10. B and C, respectively. 
 
2. RNAscopeâ 2.5HD-duplex assay in rPOA of female mouse hypothalamus 
Double expression of MRAP2 (C1-green) and MC3 (C2-red) was observed in 
hypothalamic sections of 2 weeks, 10 weeks and pregnant (14 ± 1 dpc) (Figure 4. 15). 
In the current findings, there appeared to be more co-expression in 10 weeks old mice 
and the hypothalamic section of pregnant mice compared to 2 weeks old mouse 
hypothalamus (Figure 4.15, A - F). In addition to the double expression there were 




Figure 4.12: RNAscope® 2.5HD Brown assay of MC3 in rPOA of female mouse hypothalamus. The assay was carried in hypothalami of mice aged 2 weeks, 10 weeks and 
pregnant (14 ±1) mice. A: MC3 expression in 2 weeks hypothalamus; B: MC3 expression in 10 weeks hypothalamus; C: MC3 expression in pregnant (14  ±1 dpc) hypothalamus; 
D: Higher magnification of MC3 expression in 2 weeks hypothalamus E: Higher magnification MC3 expression in 10 weeks hypothalamus and F: Higher magnification MC3 
expression in pregnant (14  ±1 dpc). The black circles represent the rPOA which is medial to the anterior commissure (AC). Each age group was conducted as two slides with 




Figure 4.13: RNAscope® 2.5HD Brown assay of MC5 in rPOA of female mouse hypothalamus.  The assay was carried in hypothalami of mice aged 2 weeks, 10 weeks and 
pregnant (14 ±1) mice. A: MC5 expression in 2 weeks hypothalamus; B: MC5 expression in 10 weeks hypothalamus; C: MC5 expression in pregnant (14  ±1 dpc) hypothalamus; 
D: Higher magnification of MC5 expression in 2 weeks hypothalamus E: Higher magnification MC5 expression in 10 weeks hypothalamus and F: Higher magnification MC5 
expression in pregnant (14  ±1 dpc). The black circles represent the rPOA which is medial to the anterior commissure (AC). Each age group was conducted as two slides with 
two sections per slide. Images were taken using a NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London. 
 
 87 
Figure 4.14: RNAscope® 2.5HD Brown assay of MRAP2 in rPOA of female mouse hypothalamus.  The assay was carried in hypothalami of mice aged 2 weeks, 10 weeks and 
pregnant (14 ±1) mice. A: MRAP2 expression in 2 weeks hypothalamus; B: MRAP2 expression in 10 weeks hypothalamus; C: MRAP2 expression in pregnant (14  ±1 dpc) 
hypothalamus; D: Higher magnification of MRAP2 expression in 2 weeks hypothalamus E: Higher magnification MRAP2 expression in 10 weeks hypothalamus and F: Higher 
magnification MRAP2 expression in pregnant (14  ±1 dpc). The black circles represent the rPOA which is medial to the anterior commissure (AC). Each age group was conducted 




Figure 4.15: RNAscope® 2.5HD Duplex assay showing MRAP2 (C1-green)-MC3 (C2-red) expression in rPOA of female mouse hypothalamus. The assay was carried in 
hypothalami of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. The hypothalamic sections show expression and co-expression of MC3 (red arrow) or MRAP2 (blue 
arrow) or both (black arrow). A: 2 weeks hypothalamus; B: 10 weeks hypothalamus; C: pregnant (14  ±1 dpc) hypothalamus; D: Higher magnification of MRAP2-MC3 expression 
in 2 weeks hypothalamus, E: Higher magnification of MRAP2-MC3 expression in 10 weeks hypothalamus and F: Higher magnification of MRAP2-MC3 expression in pregnant (14  
±1 dpc). The black circles represent the rPOA which is medial to the anterior commissure (AC). The black rectangular demonstrate a zoomed in area of each section (80X). Each 
age group was conducted as two sections per slide and n=2. Images were taken by NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London. 
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4. 3. 3. 1. A. RNAscopeâ 2.5HD detection of MC3, MC5 and MRAP2 in the mPOA 
1. RNAscopeâ 2.5HD-singleplex (Brown) assay 
MC3 was detected in the mPOA area of 2 weeks, 10 weeks and pregnant (14 ± 1 dpc) 
mice. The expression appeared to be higher in 10 weeks old mice and pregnant mice 
compared to 2 weeks old mice (Figure 4. 16, A-F).  
By contrast, although MC5 was detectable in the mPOA, the level of expression was 
lower in 2 weeks, 10 weeks old mice and pregnant (14 ± 1 dpc) mice hypothalami than 
that of MC3. MC5 expression appeared to be increased in the 10 weeks old mice 
compared to both 2 weeks old and pregnant animals (Figure 4. 17, A-F).  
MRAP2 was highly expressed in the mPOA of 2, 10 weeks old mice and pregnant (14 
± 1 dpc) animals. Importantly, there was high MRAP2 expression throughout the 
hypothalamus at the level of the mPOA (Figure 4. 18, A-F). 
 
2. RNAscopeâ 2.5HD-duplex assay in mPOA of female mouse hypothalamus 
In the mPOA hypothalamic sections, the signal of MC3 (red) and MRAP2 (green) was 
detected in 2 weeks, 10 weeks old and pregnant (14 ± 1 dpc) mice. The double 
expression levels were higher in 2 weeks old mice and pregnant animals compared to 
the 10 weeks old mice (Figure 4. 19, A-F). In addition to the double expression, there 
were cells expressing either MC3 or MRAP2 with the latter been found more than that 







Figure 4.16: RNAscopeâ 2.5HD Brown assay of MC3 in mPOA of female mouse hypothalamus. The assay was carried in hypothalami of mice aged 2 weeks, 10 weeks and 
pregnant (14 ±1) mice. A: MC3 expression in 2 weeks hypothalamus; B: MC3 expression in 10 weeks hypothalamus; C: MC3 expression in pregnant (14  ±1 dpc) hypothalamus; 
D: Higher magnification of MC3 expression in 2 weeks hypothalamus E: Higher magnification MC3 expression in 10 weeks hypothalamus and F: Higher magnification MC3 
expression in pregnant (14  ±1 dpc). The black circles represent the mPOA which is lateral to the third ventricle (3V). The black rectangular demonstrate a zoomed in area of 
each section (80X). Each age group was conducted as two slides with two sections per slide. Images were taken using a NanoZoomer slide scanner (Hamamatsu Photonics) at 




Figure 4.17: RNAscope® 2.5HD Brown assay of MC5 in mPOA of female mouse hypothalamus. The assay was carried in hypothalami of mice aged 2 weeks, 10 weeks and 
pregnant (14 ±1) mice. A: MC5 expression in 2 weeks hypothalamus; B: MC5 expression in 10 weeks hypothalamus; C: MC5 expression in pregnant (14  ±1 dpc) hypothalamus; 
D: Higher magnification of MC5 expression in 2 weeks hypothalamus E: Higher magnification MC5 expression in 10 weeks hypothalamus and F: Higher magnification MC5 
expression in pregnant (14  ±1 dpc). The black circles represent the mPOA which is lateral to the third ventricle (3V). The black rectangular demonstrate a zoomed in area of 
each section (80X). Each age group was conducted as two slides with two sections per slide. Images were taken using a NanoZoomer slide scanner (Hamamatsu Photonics) at 
King’s College London.  
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Figure 4.18: RNAscope® 2.5HD Brown assay of MRAP2 in mPOA of female mouse hypothalamus. The assay was carried in hypothalami of mice aged 2 weeks, 10 weeks and 
pregnant (14 ±1) mice. A: MRAP2 expression in 2 weeks hypothalamus; B: MRAP2 expression in 10 weeks hypothalamus; C: MRAP2 expression in pregnant (14  ±1 dpc) 
hypothalamus; D: Higher magnification of MRAP2 expression in 2 weeks hypothalamus E: Higher magnification MRAP2 expression in 10 weeks hypothalamus and F: Higher 
magnification MRAP2 expression in pregnant (14  ±1 dpc). The black circles represent the mPOA which is lateral to the third ventricle (3V). The black rectangular demonstrate a 
zoomed in area of each section (80X). Each age group was conducted as two slides with two sections per slide. Images were taken using a NanoZoomer slide scanner 




Figure 4.19: RNAscope® 2.5HD Duplex assay showing MRAP2 (C1-green)-MC3 (C2-red) expression in mPOA of female mouse hypothalamus. The assay was carried in 
hypothalami of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. The hypothalamic sections show expression and co-expression of MC3 (red arrow) or MRAP2 (blue 
arrow) or both (black arrow). A: 2 weeks hypothalamus; B: 10 weeks hypothalamus; C: pregnant (14  ±1 dpc) hypothalamus; D: Higher magnification of MRAP2-MC3 expression 
in 2 weeks hypothalamus, E: Higher magnification of MRAP2-MC3 expression in 10 weeks hypothalamus and F: Higher magnification of MRAP2-MC3 expression in pregnant (14  
±1 dpc). The black circles represent the mPOA which lateral to the third ventricle (3V). Each age group was conducted as two sections per slide and n=2. Images were taken by 
NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London.
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4. 3. 3. 1. C RNAscope® 2.5HD detection of MC3, MC5 and MRAP2 in the Arcuate 
nucleus 
1. RNAscope® 2.5HD-singleplex (Brown) assay 
Expression of MC3 was detected in the arcuate nucleus of 2 and 10 weeks old mice 
as well as in the pregnant (14 ± 1 dpc) animals. The expression was higher in the 
arcuate nucleus of 10 weeks female mice and pregnant animals compared to 2 weeks 
old mice (Figure 4. 20, A-F).  
There were only low levels MC5 expressed in the arcuate nucleus of pregnant (14 ± 1) 
mice compared to MC3. The arcuate nucleus of 2 and 10 weeks old mice did not 
express MC5. (Figure 4. 21, A-F).  
The expression of MRAP2 in the arcuate nucleus was detected at 2 and 10 weeks old 
mice and pregnant (14 ± 1) mice hypothalamic sections. The expression levels were 
higher 2 week and 10 weeks old mice compared to pregnant animals (Figure 4. 22, A-
F). However, the expression of MRAP2 in 2 and 10 weeks old mice and pregnant 
animals was higher than that seen with MC3 and MC5. 
 
2. RNAscope® 2.5HD-duplex assay in the arcuate nucleus of the female mouse 
hypothalamus 
MRAP2-C1 (green)/MC3-C2 (red) expression was detected in the arcuate nucleus of 
2 weeks and 10 weeks old and pregnant (14 ± 1) mice (Figure 4. 23 A-F). In the current 
findings, MC3 was higher in both 10 weeks and pregnant mice compared to 2 weeks 
old mice (Figures 4. 23 A/D and B/E) and that of MRAP2 in the same hypothalamic 
sections. Also, there were less cells expressing both MC3 and MRAP2 in pregnant 





Figure 4.20:  RNAscope® 2.5HD single-plex (brown) assay showing MC3 expression in the arcuate nucleus of female mouse hypothalamus. The assay was carried in hypothalami 
of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. The hypothalamic sections show expression of MC3. A: 2 weeks hypothalamus (20X); B: 10 weeks hypothalamus 
(20X); C: pregnant (14  ±1 dpc) hypothalamus (20X); D: Higher magnification of MC3 expression in 2 weeks hypothalamus (40X); E: Higher magnification of MC3 expression in 
10 weeks hypothalamus (40X) and F: Higher magnification of MC3 expression in pregnant (14  ±1 dpc) (40X). The arcuate nucleus is found lateral to and the base of the third 
ventricle (3V). Each age group was conducted as two sections per slide and n=2. Images were taken using Leica bright-field DM, University of Westminster, London. 
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Figure 4.21:  RNAscope® 2.5HD single-plex (brown) assay showing MC5 expression in the arcuate nucleus of female mouse hypothalamus. The assay was carried in hypothalami 
of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. The hypothalamic sections show expression of MC5. A: 2 weeks hypothalamus; B: 10 weeks hypothalamus; C: 
pregnant (14  ±1 dpc) hypothalamus; D: Higher magnification of MC5 expression in 2 weeks hypothalamus; E: Higher magnification of MC5 expression in 10 weeks hypothalamus 
and F: Higher magnification of MC5 expression in pregnant (14  ±1 dpc). The arcuate nucleus is found lateral to and the base of the third ventricle e (3V). Each age group was 
conducted as two sections per slide and n=2. Images were taken by NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London. 
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Figure 4.22: RNAscope® 2.5HD single-plex (brown) assay showing MRAP2 expression in the arcuate nucleus of female mouse hypothalamus. The assay was carried in 
hypothalami of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. The hypothalamic sections show expression of MRAP2 (black arrow). A: 2 weeks hypothalamus (10X); 
B: 10 weeks hypothalamus (10X); C: pregnant (14  ±1 dpc) hypothalamus (10X); D: Higher magnification of MRAP2 expression in 2 weeks hypothalamus (20X); E: Higher 
magnification of MRAP2 expression in 10 weeks hypothalamus (20X) and F: Higher magnification of MRAP2 expression in pregnant (14  ±1 dpc) (20X). The arcuate nucleus is 
found lateral to and at the base of the third ventricle (3V). Each age group was conducted as two sections per slide and n=2. Images were taken by Leica-Bright-Field microscope 
DM, University of Westminster, London. 
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Figure 4.23: RNAscope® 2.5HD Duplex assay showing MRAP2 (C1)-MC3 (C2) expression in the arcuate nucleus of female mouse hypothalamus. The assay was carried in 
hypothalami of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. The hypothalamic sections show expression and co-expression of MC3 (red arrow) or MRAP2 (blue 
arrow) or both (black arrow). A: MRAP2- MC3 expression in 2 weeks hypothalamus; B: MRAP2- MC3 expression in 10 weeks hypothalamus; C: MRAP2- MC3 expression in 
pregnant (14  ±1 dpc) hypothalamus; D: Higher magnification of MRAP2- MC3 expression in 2 weeks hypothalamus; E: Higher magnification of MRAP2- MC3 expression in 10 
weeks hypothalamus and F: Higher magnification of MRAP2- MC3 expression in pregnant (14  ±1 dpc). The arcuate nucleus is found lateral to and at the base of the third ventricle 
(3V). Each age group was conducted as two sections per slide and n=2. Images were taken by NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London.
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4.4 Discussion: 
All of the findings in the current research study revealed the expression of MC3, MC5 
and MRAP2 in areas of the hypothalamus known to be involved in regulating the 
reproductive function. The RNAscopeâ in situ chromogenic study had revealed the 
cellular expression of MC3, MC5 and MRAP2 in rPOA at the level of OVLT and in the 
mPOA as well as the arcuate nucleus. The RNAscopeâ double expression had 
confirmed the singleplex findings and also showed the presence of cells expressing 
both MC3 and MRAP2 in the same areas of the singleplex expression studies. By RT-
qPCR it has been demonstrated that all of the MC system members (MC (1-5), MRAP1 
and 2, POMC and AgRP) are expressed in the female C57BL/6 mouse hypothalamus. 
Both POMC and AgRP were more highly expressed than MC3, MC4, MC5, MRAP1 
and MRAP2. Both MC1 and MC2 were expressed at very low levels. Age was found to 
influence the expression of MC5 and POMC with the former being higher in 2 weeks 
old female mice and the latter being higher in the older mice compare to all other age 
groups examined in this research. Pregnancy did not have any impact on the 
expression level of the MC system members in the female mouse hypothalamus in the 
RT-qPCR analyses. Nonetheless, the current chromogenic mRNA in situ hybridisation 
study findings had revealed more expression of MC3 and MRAP2 in pregnant animals 
in the mPOA area of the hypothalamus. This is the first report of MRAP1 expression 
in the hypothalamus of the female mouse. 
In the hypothalamus, all the members of the melanocortin system were detected. The 
central melanocortin members: MC3, MC4 and POMC are well characterised in the 
hypothalamus (Roselli-Rehfuss et al., 1993; Gantz et al., 1993; Iqbal et al., 2001). The 
central MC3, MC4 and POMC are involved in the neuroendocrine circuit that controls 
appetite and energy homoeostasis (Cone, 2005). Through RT-PCR and Southern blot 
analyses, MC4 was found in different areas of the goldfish hypothalamus including the 
preoptic area  (Cerdá-Reverter et al., 2003). The preoptic area is known to contain a 
large population of the GnRH neurones (Jennes et al., 1985). Dowejko (2014) 
managed to detect the rest of the receptors (MC1, MC2, MC5) and POMC in both the 
male and female hypothalamus and the data presented in this research study confirms 




Expression of MC1 in the central nervous system, in particularly in the periaqueductal 
grey matter, was previously reported by Chhajlani (1996). The present study detected 
MC1 at a low level in the female hypothalamus confirming preliminary observation by 
our research group in 2014 (Dowejko, 2014).  Age and pregnancy did not alter the 
expression pattern of MC1 expression. The anti-inflammatory role of MC1 might explain 
its presence in the hypothalamus as MC1 detected in the glial cells (Catania et al., 
2004) which are found in different parts of the brain including the hypothalamus. There 
was a very low expression signal detected for MC2 in the hypothalamus. Dowekjo’s 
findings also showed that the expression of MC2 is higher in male compared to female 
(Dowejko, 2014). Little is known about the role of MC2 in extra-adrenal tissues 
although it was thought to have a mediating  role in organogenesis in different tissues, 
including the brain, in mouse embryos (Nimura et al., 2006). However, further research 
is necessary to delineate the specific function of MC2 in the brain. 
 
The effect of age was also found to effect POMC RT-qPCR expression as POMC was 
found to be higher in adult mice (14 weeks old mice) compared to 2, 6, 9 and 10 weeks 
old mice. These findings contradict reports in rats which indicated a decline in POMC 
population in older female rats (Lloyd et al., 1991; Gruenewald and Matsumoto, 1991), 
Lloyd and colleagues used middle-aged and older rats, since both of these studies 
were conducted on rat brain it might indicate a species difference in the pattern of 
POMC expression. Nelson and colleagues also reported reduced hypothalamic 
POMC mRNA in about 30 months (2.5 years) old mice compared to younger (7-month-
old)  mice (Nelson et al., 1988); however, Nelson’s group had tested much older mice 
than those used in this research.  
As mentioned earlier, this is the first report of MRAP1 expression in the hypothalamus 
of the female mouse. The presence of MRAP1 in the brain could be to do with its role 
in assisting MC2 trafficking and signalling activity as in adrenal gland (Chan et al., 
2009; Asai et al., 2013) or could be regulating the expression of the other melanocortin 
receptors as reported by (Chan et al., 2009; Sebag and Hinkle, 2009).  
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In the RT-qPCR in the current research, a mid-gestational stage of pregnancy (14 ± 1 
dpc) did not seem to affect the expression pattern of the MC system in the 
hypothalamus. This was an unanticipated finding as in pregnancy, a down-regulation 
of the anorexigenic central melanocortin receptors would be expected to facilitate food 
intake and thus providing for foetal growth and maintain maternal health. However, the 
dilutional effect of RT-qPCR which might have masked MRAP2 differential expression 
in pregnancy, suggested in the RNAscope® assays and could explain the reason for 
the unchanged expression of the MC system during mid-pregnancy in mice. AgRP 
was detected in the hypothalamus as expected: the AgRP-expressing neurones of the 
arcuate nucleus of the hypothalamus are well characterized and have an important 
role in appetite and food intake regulation (Bagnol et al., 1999). However, although 
insignificant, there was fluctuation in expression in relation to age and pregnancy. 
The first series of studies aimed to select the most stable reference genes for 
normalising the RT-qPCR data in C57BL/6 female mouse hypothalamus using 
GeNorm expression stability analysis. The most suitable reference genes were CANX 
and YWHAZ. Both CANX and YWHAZ showed stable expression when examined in 
the 2, 6, 9, 10 and 14 weeks old mice and pregnant (14 ± 1 dpc) mice compared to 
more commonly used reference genes such as GAPDH. CANX is part of the 
endoplasmic reticulum membrane proteins and is known to be constantly expressed 
in high amount (Denzel et al., 2002). On the other hand, YWHAZ, is involved in signal 
transduction and is expressed at high levels in the brain. YWAHZ was a reference 
gene of choice in a study conducted on rat hypothalami (Li et al., 2014). 
 
In this research, two aspects were considered to choose the method by which MC3, 
MC5 and MRAP2 could be characterised at a cellular level. Firstly, the physiological 
organisation of the hypothalamic areas; this approach was adopted to characterise the 
mentioned genes and the functions of specific regions of the hypothalamus. Secondly, 
the method used to localise the target genes was considered. The chromogenic in situ 
hybridisation using RNA probes or in fewer words, “RNAscope®”, was decided as the 
method of choice because it would preserve the structural organisation of the 
hypothalamus using the haematoxylin counterstaining. The RNAscope® was used to 
characterise the target genes in the hypothalamic rPOA, mPOA and the arcuate 
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nucleus regions. GnRH neurons soma are known to be in the preoptic areas whilst 
their fibers reside in the arcuate nucleus (Herbison, 2014). Antibodies have been 
shown to be unreliable for detecting the melanocortin receptors due to their non-
specificity (Kathpalia et al., 2011), therefore, using the RNA probes would provide 
specificity. The RNAscope® was chosen to allow observations of subtle changes in 
specific cell types which are masked in the RT-qPCR, conducted using RNA from the 
entire hypothalamus.  The changes seen here with MC5  from the RT-qPCR analysis, 
the literature about MC3 (Roselli-Rehfuss et al., 1993; Nocetto et al., 2004; Rowland 
et al., 2010; Manfredi-Lozano et al., 2016) and evidence from knockout studies and 
the emerging role of the MRAP2 prompted the decision to investigate these targets at 
a cellular level using the RNAscope®. 
 
The expression of MC3 in the rostral preoptic area of the C57BL/6 female mouse could 
suggest a contribution in modulating the activity of LH surge through GnRH found in 
the rPOA. Herbison and colleagues located populations of GnRH neurons in the rPOA 
in GNR23 female mice (Herbison et al., 2008). The rPOA is found to be one of the 
main areas controlling ovulation in rodents (Wang et al., 2016). The melanocortin 
receptor contribution in ovulation might be through activating kisspeptin expression 
(Backholer et al., 2009). Kisspeptin was suggested to have a role in the generation of 
GnRH surge in POA (Wang et al., 2016). This study has found that the expression of 
MC3 was lowest in the pregnant animals (14 ± 1 dpc) compared to pre-weaned female 
animals (2 weeks old) and 10 weeks old mice. That both 2 weeks old mice and 
pregnant mice had higher expression of MRAP2 compared to 10 weeks old mice; the 
double MC3 / MRAP2 expression confirms these findings, as there was more double 
expression in the 2 weeks old mice and pregnant. This suggests that MRAP2 might 
be modulating MC3 surface expression, as well as the MC3 intracellular cascade. 
 
The RNAscope® expression of MC3 was detected in the mPOA and although the 
pattern of expression of MC3 was similar to the rPOA, higher levels of MC3 were 
detected in mPOA compared to the rPOA.  The localisation of MC3 in the mPOA 
emphasises its proposed role in mediating ovulation. The mPOA includes a population 
of GnRH neurons that are involved in generating the GnRH surge (Herbison, 2014). 
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This is augmented by surgical lesion studies conducted on rat mPOA hypothalamic 
regions which led to constant estrus (Freeman, 2006). The suggested role for the 
preoptic MC3  is also supported by reports of restored fertility and puberty in leptin 
knockout mice and stimulated GnRH neuron activity after MTII treatment, an MC3 and 
MC4 agonist (Israel et al., 2012). Israel et al. characterised the expression of MC4 in 
the mPOA area through single-cell RT-qPCR (scRT-qPCR) of green fluorescent 
plasmid (GPF) positive GnRH male and female mice brain slices (Israel et al., 2012). 
This study did not include a selective MC4 agonist and/or antagonist to confirm that 
the actions mediated by MTII were through activation of MC4. Therefore, MTII, as an 
agonist to both MC3 and MC4, might also have activated MC3 instead of MC4 or both, 
there is a possibility that this might be by forming heterodimers (Mandrika et al., 2005), 
restoring fertility in the leptin receptor-deficient mice. The RNAscope® expression of 
MRAP2 was also, significantly higher than that observed in the rPOA. The RNAscope® 
MRAP2 expression in the mPOA was also relatively higher than that of MC3. 
Furthermore, there was higher level of MC3/ MRAP2 double expression in the mPOA 
in contrast to the rPOA, which could be due to higher level of expression of both genes 
in the mPOA. 
The detection of MC3 in the arcuate nucleus using RNAscope® 2.5HD assay adds 
evidence to previous studies reporting MC3 expression in the arcuate nucleus. The 
highest level of MC3 expression was detected in arcuate nucleus of pregnant mice 
followed by the 10 weeks old mice and the lowest expression was observed in the 2 
weeks old mice. Compared to the other two areas, the expression of MRAP2 appeared 
to be higher in the 2 weeks and 10 weeks old mice compared to the pregnant animals. 
The MC3 role through the arcuate nucleus circuit controlling appetite has been 
extensively investigated (Cone, 1999; Hohmann et al., 2000; Cowley et al., 2001; Lee 
et al., 2006; Xu et al., 2011). The arcuate nucleus is known to contain GnRH axonal 
projections that are controlling GnRH pulsatile release (Yeo and Herbison, 2014). 
Gene profiling in the arcuate nucleus of C57BL/6 male and female mice revealed the 
expression of GHSR-1a, MCH receptors, ERs, dopamine receptors, prolactin 
releasing peptide receptor, kisspeptin receptors and γ-Aminobutyric acid (GABA) 
receptors (Rønnekleiv et al., 2014); all of these receptors were found to be linked to 
the  GnRH neural network (Kokay et al., 2011; Farkas et al., 2013).  The gene profiling 
studies had also identified MC1, MC3, MC4 and MC5 within the arcuate nucleus 
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(Rønnekleiv et al., 2014).  The receptors GHSR1-a, MCH receptors, ERs,  kisspeptin 
receptors and GABA were also reported to interact with the MCs (Schiöth and 
Watanobe, 2002; Murray et al., 2006; Schellekens et al., 2013; Bond and Smith, 2014). 
Roa and Herbison, 2012 have reported that α-MSH (Pan MCs agonist) as well as 
D(Trp8) -γ MSH (MC3 agonist) and other arcuate nucleus peptides such as AgRP and 
β-endorphin affect GnRH firing (with the melanocortins stimulating GnRH activity) 
using electrophysiological studies on female GnRH – GFP mice brain slices. A 
combination of these findings implies a role of MC3 in the neural reproductive circuit. 
The pattern of MC3 expression in the mPOA and rPOA in the RNAscope® singleplex 
and duplex expression studies are consistent with RT-qPCR findings. 
Extremely low levels of MC5 were found in the entire hypothalamic sections of all ages 
and pregnant animals. However, there was high expression of MC5 in the pia mater 
(the single layer of cells that is enveloping the brain). The expression of the MC5 in the 
two preoptic areas was very low. However, this could be further characterised by a 
greater quantification in all hypothalamic areas. The expression within both preoptic 
areas confirms reports by Murray et al. of an MC5 antagonist (FFMI-60) inhibiting LH 
release (via stimulating GnRH) through MCH in female rats (Murray et al., 2006). 
However, further studies are needed to investigate if the MC5 effect on MCH is imitated 
by the other central MCs such as MC3, that was also found expressed in the same 
areas as MC5. Other explanations of MC5 hypothalamic expression might be 
heterodimerisation or dimerization with either MC3 or MC5 detected in areas similar to 
those of MC3 in this research. Reports of MCs (MC1 and MC3) forming heterodimers 
(Mandrika et al., 2005) support this implication. 
The expression of MC5 in the arcuate nucleus was scarce, but a couple of reports of 
MC5 expression in the arcuate nucleus confirm this finding (Cerdá-Reverter et al., 
2003; Ronnekleiv et al., 2014). More studies are needed to determine MC5 function 
within this region of the hypothalamus. Surprisingly, the age difference reported here 
was not observed in data from the RNAscope®. However, the RNAscope® is detecting 
expression in specific regions (rPOA, mPOA and the arcuate nucleus) within the 
hypothalamus, unlike the RT-qPCR that is conducted on RNA from all cell types such 
as endothelial, epithelial and glial cells found in the hypothalamus.   
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High expression of MRAP2 was observed through most of the hypothalamic areas 
including ventromedial and dorsomedial nuclei and paraventricular nucleus not only 
the areas of interest to this research. This is consistent with the results from the RT-
qPCR as compared to the MCs. MRAP2 was found expressed in the hypothalamus 
(Chan et al., 2009) and the loss of its function was associated with lowered MC4 
expression, indicating a role in MC4 trafficking (Asai et al., 2013). In chicken, increased 
responsiveness to ACTH was recorded when either MC3 or MC4 was co-expressed 
with MRAP2 (Zhang et al., 2017). In vitro studies conducted in this and further 
discussed in chapter 8 recorded increased MC3 responses to ACTH (1-39) when co-
expressed with MRAP2 (see chapter 8 for data Figures). Based on the RNAscope® 
results, MRAP2 expression in the preoptic areas was higher in pregnancy than age-
matched virgin mice; in vitro studies conducted in this research had also showing 
decreased responsiveness to α-MSH when MC3 was co-expressed with MRAP2 (see 
chapter 8 for PRESTO-Tango cell study data Figures). These findings could explain 
reports of attenuated α-MSH response observed during rat pregnancy (Ladyman et 
al., 2016). In addition to the MC3 / MRAP2 double expression seen in the RNAscope® 
duplex assays, there were cells expressing MRAP2 alone in all of the three areas 
investigated. These findings indicate that MC3 could either be mediating its 
hypothalamic function without the MRAP co-expression or that it could be regulated 
by MRAP1 (not included in the current RNAscope® study). In addition to a possible 
role in regulating MC3 signalling and responsiveness, MRAP2 may also have a role 
interacting with other melanocortin receptors as described by (Chan et al., 2009) or 
with non-melanocortin receptors such as prokineticin receptor 1, orexin receptor and 
GHSR1-a (Chaly et al., 2016; Srisai et al., 2017; Rouault et al., 2017 respectively).   
 
To summarise, the characterisation of MC (1-5), POMC, MRAP1, MRAP2 and AgRP 
using RT-qPCR confirmed expression within the hypothalamus. The expression did 
not seem to be affected by age except for MC5 and POMC. Even though previous 
reports documented decreased anorexic effects exerted by the melanocortin receptors 
during pregnancy, the MC system expression was unchanged within the 
hypothalamus of pregnant mice. However, as there are changes in the hormonal 
profile during the different stages of pregnancy, other stages of pregnancy may need 
to be examined to explore if there would be any changes in the MC system expression 
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during early or later stages of pregnancy. The MC3, MC5 and MRAP2 cellular 
localisation displayed specific hypothalamic regions of expression; these included the 
preoptic area (both medial and rostral areas) and the arcuate nucleus. The areas of 
the hypothalamus expressing MC3, MC5 and MRAP2 suggest that they are in regions 
containing GnRH neurons, this could be confirmed in future studies using GnRH 
probes in RNAscopeâ however, due to high cost of the RNAscope® reagents and 
probe, using a GnRH probe the examined regions could not be carried out within this 
study. Therefore, a further study RNAscope® duplex assay combining GnRH/MC3, 
GnRH /MC5 would enhance the findings from this research. Other consideration for 
future work includes the addition of more hypothalamic samples from female mice of 
other physiological conditions such as the early and later stages of pregnancy, 
lactation, weaning stage of the reproductive cycle. Additionally, studying the RT-qPCR 
expression of POMC in older animal should also be considered to determine if there 
is a decline in POMC expression with age as seen in other studies. studies All of these 
stages are controlled by different neuroendocrine interactions within the hypothalamus 
that might be involving the melanocortin system. The current research study was set 
to characterise the expression and cellular localisation of the MC system members in 
the first level of the reproductive axis. The following chapters will analyse the MC 
expression in the pituitary gland, the ovary and the uterus in an attempt to explore the 













5  Molecular and cellular characterisation 














Hypothalamic GnRH stimulates gonadotrophs in the anterior pituitary gland to 
synthesise and release LH and FSH. Both hormones are involved in ovarian 
steroidogenesis. Additionally, the hormone LH induces ovulation and stimulates the 
formation of the corpus luteum while FSH stimulates folliculogenesis and estrogen 
secretion. The mouse pituitary gland is divided into three main lobes: anterior, 
intermediate and posterior lobes, also respectively known as pars distalis, pars 
intermedia and pars nervosa. This research will focus on the anterior pituitary gland. 
Reviewing the posterior lobe is beyond the scope of this research. This chapter will 
mainly discuss the endocrine, autocrine and the paracrine regulation of anterior 
pituitary gonadotrophs and their function in the female mice. 
 
5. 1. 1 Components of the anterior pituitary gland 
The anterior pituitary gland is made of three main components:  
1) Five types of hormone-secreting cells (ACTH-secreting corticotrophs; 
gonadotropin-secreting (LH and FSH) gonadotrophs; prolactin-secreting lactotrophs, 
growth hormone-secreting (GH) somatotrophs; and thyroid stimulating hormone 
secreting, TSH, thyrotrophs) (Griffin and Ojeda, 2004).   
2) Support cells known as folliculostellate cells (Le Tissier et al., 2012).  
3) A fenestrated capillary network in between the cells (Griffin and Ojeda, 2004).   
 
During development the cells of the anterior pituitary originate from Rathke’s pouch in 
a specific fashion of distribution within the gland. The percentage, spatial organisation 
and function of each of the 5 trophic cell types are summarised in table 5. The 
anatomical fate of these cells is controlled by specific transcription factors such as the 
pit-1 and prophet of Pit-1 (PROP1) for somatotrophs and gonadotrophs differentiation, 
respectively (Ward et al., 2006). A greater discussion about the different cell lineages 
and differentiation can be found in the review by Scully and Rosenfeld (2002). 
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Table 5-1: Anterior pituitary cells and their percentage, distribution, hormones and functions in mouse.  
POMC: proopiomelanocortin: ACTH; adrenocorticotropic hormone; LH: luteinising hormone; FSH: follicular 
stimulating hormone; GH: growth hormone and TSH: thyroid-stimulating hormone. The information in this table are 
adopted from Yeung et al., (2006); Mollard et al., (2012); Le Tissier et al., (2012). 
  
These hormone-producing cells are primarily controlled by the hypothalamic 
stimulatory and inhibitory regulators. Additionally, peripheral hormones regulate the 
release of the anterior pituitary hormones through feedback mechanisms. All of these 
regulators interact with receptors expressed on each of the anterior pituitary cells. 
Table 5. 2 summarises the receptors of the hypothalamic regulators and their main 
functions. From a reproductive point of view, this research will focus on the 
gonadotrophs and their regulation by different mechanisms including the intra-pituitary 
interactions. 
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Table 5-2: Hypothalamic regulators of the anterior pituitary hormone-producing cells in female mice. 
 ACTH: adrenocorticotropic hormone; CRH: corticotropin releasing hormone; CRF-R: corticotropin releasing factor 
receptor; D1/D2R: dopamine receptors 1 and 2; GH: growth hormone; GHRH/ GHRH-R: growth hormone releasing 
hormone and receptor; GnRH/GnRHR: gonadotropin releasing hormone and receptor; SST2R: somatostatin 2 
receptor; TRH/ TRH-R: thyroid releasing hormone and receptor and TSH: thyroid- stimulating hormone. The 




































































The gonadotropin-secreting gonadotrophs mediate the synthesis and release of LH 
and FSH primarily through the activation of the GnRH receptor (GnRHR). GnRHR 
expression is considered one of the critical steps in regulating the estrous cycle in 
rodents, with three-fold upregulation of GnRHR expression on the afternoon of 
proestrus compared to metestrus (Bauer-Danton et al., 1993). This rise persists until 
the evening of proestrus then drops to basal levels after 12 hours to reach levels 
similar to those reported in metestrus (Bauer-Danton et al., 1993). The period between 
the GnRH incubation and the pituitary cell response in this study correlates with the 
response observed after the GnRH surge as explained in section 4.1.5. The GnRHR 
is autoregulated through GnRH as continuous stimulation was found to cause receptor 
desensitisation and internalisation. This was shown by incubating female rat pituitary 
cells with GnRH, which resulted in increased GnRHR expression 6 hours after 
incubation followed by a downregulation of the receptor expression in the continuous 
presence of GnRH (Bjelobaba et al., 2016).  
 
5. 1. 2 Regulation of gonadotroph function 
The regulation of the GnRHR responsiveness and LH and FSH synthesis depends on 
different pathways. These pathways include endocrine pathways, autocrine 
autoregulation and paracrine intra-pituitary communication that is modulated by 
different factors. 
 
5. 1. 2. 1 The endocrine regulation of gonadotrophs 
The role of estrogen in exerting feedback on the pituitary, as well as  progesterone’s 
role, are well documented (Messinisi, 2006). Gonadectomy with estradiol and/or 
progesterone treatment has facilitated the understanding of the roles of the gonadal 
hormones in the regulation of the gonadotropin release and hence the induction of 
ovulation. Discussing the roles of both gonadotropins is beyond the scope of this 




5. 1. 2. 2 Intra-pituitary regulation of gonadotropin synthesis and release 
The cells of the anterior pituitary exist in well-defined networks and communicate with 
each other through autocrine, paracrine and endocrine pathways. Direct 
communication between the different hormone-producing cells of female rat pars 
distalis was revealed using high-density plating studies (Wilfinger et al., 1984). These 
findings might indicate a direct paracrine input between the different hormone-
producing cells in the gland or cell-cell communication through, for example, gap 
junction coupling (Tortonese, 2016). 
Prolactin secreted by the lactotrophs plays an essential role in the murine estrous 
cycle. Prolactin concentration has been found to be relatively similar to that of LH, with 
a basal concentration of about 20 ng/ml during the entire cycle but peaking on the 
afternoon of proestrus to about 300 ng/ml (Levine, 2014). This high concentration of 
prolactin is thought to have roles in luteolysis, receptivity to males, embryo 
implantation and/or mammary development (Grattan and Le Tissier, 2015). Prolactin 
was also found to stimulate LH production in LβT2 cells when used alone, an effect 
that was abolished after adding bromocriptine, a dopamine agonist (Henderson et al., 
2008). In support of these findings, Henderson and colleagues have also detected 
prolactin receptors in another gonadotroph cell line, the αT3-1 cell line, and 
demonstrated in vitro that treatment with prolactin reduced α-GSU expression, in αT3-
1 cells (Henderson et al., 2008).  
Although a direct somatotrophic effect on gonadotroph function is still under 
investigation, research examining the interaction between the two cell types has 
suggested somatotrophs could be influencing the gonadotropin release through 
follistatin. This was suggested after co-culturing LβT2 cells with the prolactin-secreting 
somatotrophic cell line GH3 (Kanasaki et al., 2011). Follistatin  produced by the GH3 
cells had no effect on prolactin synthesis but when GH3 cells were co-cultured with 
LβT2, follistatin suppressed FSHβ promotor activity;  this was attributed to its inhibitory 
effect on activin, which is known to stimulate FSHβ promotor activity (Kanasaki et al., 
2011). Another study has shown a less indirect interaction between gonadotrophs and 
somatotrophs, which is through the ghrelin receptor, which is expressed on 
somatotrophs, and was found to inhibit LH and FSH release in women (Kluge et al., 
2012). Co-localisation studies using GHSR1-a-eGFP mice have detected the 
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expression of the GHSR1-a in gonadotrophs, in addition to somatotrophs and the other 
pituitary cells (Reichenbach et al., 2012). These findings might indicate the 
gonadotroph stimulation could be mediated by either an autocrine or paracrine 
mechanism. 
Gonadotrophs have also been found to be in close association with corticotrophs 
(Mollard et al., 2012). Mollard and colleagues have described a group of LH-producing 
gonadotrophs that follow the corticotroph migration across the ventral surface, and 
later, parts of the anterior lobe, during development. Using tridimensional imaging 
studies, Budry and colleagues confirmed close anatomical proximity between 
gonadotropes and corticotropes and the knockout of Tpit, a transcriptional factor 
responsible for corticotroph differentiation, caused an expansion of the gonadotrophs 
network (Budry et al., 2011). In addition to this anatomical association, corticotrophs 
also contribute to the regulation of reproductive functions through activation of the 
hypothalamic-pituitary adrenal (HPA) axis. Pathophysiological conditions, such as 
stress, are known to activate the HPA axis; this axis suppresses the female 
reproductive axis at all levels through glucocorticoids that inhibit GnRH and LH 
release. At the pituitary level, the glucocorticoids that are produced from the adrenal 
gland in response to stress cause reduced LHb expression and responsiveness to 
GnRH. This was suggested to be a direct effect of the glucocorticoids on the 
gonadotrophs after detecting the glucocorticoid receptor in mouse gonadotrophs 
(Breen et al., 2012). CRH, from the hypothalamus, induces the corticotrophs to release 
ACTH that activate adrenal glucocorticoid synthesis via activating MC2. Earlier studies 
revealed that there was an increase in a-MSH content in the intermediate lobe of 
female rat pituitary gland and this was found to cause a partial inhibition in LH and 
prolactin plasma concentration (Khorram et al., 1985). Both MC3 and MC5 were found 
expressed in all levels of the HPA axis (Wachira et al., 2004). Based on these findings, 
the melanocortin sytem could be involved in the inhibitory effect of the stress axis on 
the LH and prolactin function. 
 
There is little known about the molecular pathways modulating the interactions 
between gonadotrophs and other pituitary cell types. Many candidates have been 
were suggested, such as the growth factors (reviewed by Childs and Unabia, 2001; 
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Denef, 2008; Luckenbach et al., 2010).  Other factors that may mediate paracrine 
pituitary interactions are ligands that activate melanocortin receptors. Recent 
unpublished findings by our group suggest that MC3 may be a target for these ligands. 
Ablating MC3 resulted in a significant reduction in the pituitary content of LH, FSH, GH 
and prolactin in adult male mice (see Figure 5. 1. A) compared to wild-type. In the 
adult female, ablating MC3 resulted in decreased pituitary content for GH only (see 
Figure 5.1.B) whilst LH, FSH and prolactin content tended to be lower but not 
significantly so (Dowejko et al., 2014). It should be noted that the study was conducted 
in female mice without determining the stage of the estrous cycle. 
 
Other anterior pituitary cell types have been found to be regulated by the 
melanocortins. Langouche and colleagues (2001) reported the increase of calcium 
influx in GH3 cells (a prolactin and growth hormone-producing cell line) after treatment 
with g3-MSH. Even though g3-MSH mediates its funtions mainly through MC3, the RT-
PCR analysis of these cells detected only MC5. These findings might indicate the 
involvement of MC5 in stimulating GH3 cells despite treatment with SHU9119, a known 
MC5 partial agonist, did not have any effect in this study. The same research group 
conducted similar experiments on primary pituitary cells prepared from neonatal rats, 
showing that g3-MSH and suprisingly an AgRP analogue (AgRP83−132), stimulated 
prolactin release and concluded, again, that the effect was not mediated by MC3 even 
though it was detected in those rat pituitary preparations, and the receptor involved is 
yet to be identified (Langouche et al., 2004). These studies show the involvement of 
the melanocortins in the function of different cells but there are different mechanisms 
that could underlie these effects. Given the interaction between the anterior pituitary 
cells described above, the melanocortins could be interacting with cells through either 




Figure 5.1: Hormonal pituitary content of MC3-/- and wild type male (A) and female (B) adult mice. 
Radioimmunoassay was used to measure the pituitary content of adrenocorticotropic hormone (ACTH), thyroid 
stimulating hormone (TSH), luteinising hormone (LH), follicular stimulating hormone (FSH), prolactin and growth 
hormone (GH). The data is presented as mean ± SEM. * p<0.05 vs. WT (t-test).  Figures are taken from (Dowejko, 
2014). 
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Thus, published studies have revealed different mechanisms regulating 
gonadotrophs; these included indirect effects of the melanocortin system in the 
regulation of the LH and FSH synthesis and release. The MC receptors have been 
detected in some of the pituitary cells such as the lactotrophs and corticotrophs. 
However, further characterisation might detect these receptors in other cell types 
including the gonadotrophs which would provide more evidence for a direct 
association of the MC system with reproduction via the pituitary gland. Therefore, the 
aims of the series of studies to be described in this chapter are to: 
 
1. Determine suitable reference genes in the mouse pituitary gland for 
normalisation using GeNorm expression stability analysis. 
2. Characterise MC (1-5), MRAP1 and MRAP2, POMC and AgRP in the pituitary 
gland of mice at different ages (2, 6, 10 and 14weeks old). 
3. Determine at the expression of the same melanocortin family members listed 
above in pregnant and non-pregnant mice. 
4. Determine, at the cellular level, MC3, MC5 and MRAP2 expression using 
chromogenic in situ hybridisation (RNAscope®). 
5. Determine if either MC3 or MRAP2 are specifically expressed in colocalising 
somatotrophs and/or gonadotrophs using GH and LH probes, respectively. 
 
5. 2 Methods  
For a detailed account of the materials and techniques used see chapter 3. 
5. 2. 1 Determining suitable reference genes for RT-qPCR analysis of the 
pituitary gland of C57BL/6 female mice 
 The most stable reference genes in the pituitary gland were selected using the 
GeNorm analysis described in detail in section 3. 2. 3. 4. 1. Technical duplicates of 
cDNA samples from 2, 6, 9, 10 and 14 weeks old mice and pregnant (14 ± 1) mice 




5. 2. 2 Characterising the gene expression of the MC system 
These reference genes were used to normalise data obtained from the RT-qPCR 
assays of the reverse transcribed RNA extracted from whole pituitary glands of female 
C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14  ± 1 dpc) (n=5 
for each group except n=3 for 9 weeks and n=4 for 10 weeks). The RT-qPCR 
amplification products were separated on a 2% agarose gel to check the size of the 
band and verify they were of the predicted size as well as to confirm that there were 
no non-specific bands. 
The RT-qPCR data collected were analysed using the delta-delta CT method 
described in section 3 .2. 3. 4. 3. C.  
 5. 2. 3 RNAscope® 2.5HD protocol 
The pituitary gland sections were collected from female C57BL/6 mice aged 2 weeks, 
10 weeks and pregnant (14-± 1 dpc) mice.  
First studies included using RNAscope® 2.5HD single-plex (brown) staining kit with 
MC3, MC5 and MRAP2 as well as positive and negative controls.   
The second group of studies included using RNAscope® 2.5HD duplex (C1-green/C2-
red) staining kit with MRAP2 at C1 and MC3 at C2 channels; GH (somatotrophs 
markers) at C1 and MC3 at C2 channels; LHβ (gonadotrophs marker) at C1 and MC3 
at C2 channels. Also, the RNAscope® 2.5HD duplex assays included the GH or LHβ 
at C1 and MRAP2 at C2; that is, a signal channel detection swap (see section 3. 2. 5. 
2. 3 for the protocol of channel swap) and 2-plex positive and 2-plex negative controls. 
See section 3. 2. 5 on methods for full details.  
The RNAscopeâ expression signals were quantified using the workflow described in 







5. 3 Results 
5. 3. 1.  A. Reference gene stability in the Pituitary gland 
Using the range of genes listed in Figure 5.2, we found that in the female C57BL/6 
mouse pituitary gland, calnexin (CANX) and Eukaryotic Translation Initiation Factor 4 
A 2 (EIF4A2) were the most stable genes, whereas Beta-2-Microglobulin (B2M) and 
Ribosomal Protein L13A (RPL13A) were the least stable genes (Figure 5. 2). As 
YWHAZ expression in the pituitary is within the first five most stable genes, it was also 
included in the normalisation of the pituitary RT-qPCR data to have a consistency of 
using the same reference genes with that of the hypothalamus. 
 
Figure 5.2: GeNorm ranking order of reference genes stability in the female mouse pituitary gland. The ranking is 
based on calculating the geometric mean of the ranking values from Delta CT, BestKeeper, Normfinder and 
GeNorm reference gene analyses tools. The stability of 12 reference genes was examined using the pituitary gland 
of female mice aged 2, 6, 9, 10, 14 weeks, and pregnant mice (14+1 dpc). The samples were run in duplicate. The 
reference genes are 18S, ACTB, ATP5B, B2M, CANX, CYC1, EIF4A2, GAPDH, RPL13A, SDHA, UBC and 
YWHAZ. CT values were imported to the qBase+ software and analysed using GeNorm (Biogazelle, Belgium). 
 
GeNorm analysis suggested the optimal number of housekeeping genes to be used 
in normalising the RT-qPCR data was two for the pituitary gland. This was obtained 
by calculating the pairwise variation (V-score) with the sequential addition of each 
reference gene one at a time. A V-score above 0.15 indicates the optimal number of 
most stable reference genes to be used (Figure 5. 3). The V-score was calculated 
using GeNorm analysis by qBase+ software (Biogazelle, Belgium). See appendix 3. B 
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for graphs of the BestKeeper, Normfinder, Delta CT and comprehensive reference 
genes stability analyses.  
 
Figure 5.3: Variation score (V- score) by GeNorm. An optimal number of stable genes used normalisation was 
calculated by pairwise variation with the addition of each reference gene one at a time. A V-score equal or below 
0.15 indicated the insignificance of using more reference genes. In this graph, 10 reference genes V-score results 
means the optimal number of most stable HKG to be used in the pituitary gland are two (GeNorm by qBase+, 
Biogazelle, Belgium). 
 
5. 3. 1. B. Amplification efficiencies of CANX and EIF4A2 
The amplification efficiency is defined as 100% if the signal from amplification of the 
cDNA template doubles for each RT-qPCR cycle. Table 4.1 lists the standard curve 
slope (M), the coefficient of determination (R2) and amplification efficiency (E) of CANX 
(100%) and YWHAZ (103%). EIF4A2 was expressed in a lower amount than that seen 
with the GeNorm analysis or when used in parallel with MC expression analyses which 
might indicate lower stability than that of CANX and YWHAZ. Therefore, it was 
excluded from the normalisation.  
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Table 5-3: Amplification efficiency of CANX and YWHAZ in the pituitary gland. 
Pooled cDNA from all samples used in MC system expression in the pituitary gland were used in generating 1:2 
standard curves. The efficiency was calculated automatically using the Rotor-Gene Q software (Qiagen, UK). 
 
5. 3. 2 MC system expression 
MC1 and MC2 were not detected in the pituitary of the C57BL/6 female mouse while 
MC (3-5), MRAP1, MRAP2, POMC and AgRP) expression could be detected. The 
expression of the mRNA for these targets is not the same. At 2, 6, 9, 10 and 14 weeks 
old and pregnant (14 ±1 dpc) mice, the pituitary expression of POMC was dramatically 
higher than all the other expressed MCs members (Figure 5. 4). This high level of 
expression remains relatively constant across 2, 6, 9, 10 and 14 weeks old mice and 




Figure 5.4: POMC expression in the female mouse pituitary gland. Pituitary cDNA duplicates from female C57BL/6 
mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-qPCR studies. CT 
values of each assay were exported to excel worksheet, analysed using the delta CT Method developed by Pfaffl (2001). 
The skewed data seen in the graphs are due to animal sample variations (old vs. newly obtained samples). The 2-ΔCT 
values were imported to GraphPad and analyses using one-way analysis of variance (ANOVA). (Prism 7, USA). 
Gene 
R2 (Coefficient of 
Determination) 
M (Measurement of Efficiency) E (Efficiency) 
CANX 0.99 -3.31 100% 
YWHAZ 0.99 -3.26 103% 
EIF4A2 0.52 -2.61 142% 
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The expression of both MC3 and AgRP was detected in the 2, 6, 10 and 14 weeks old 
mice and pregnant mice. There was a gradual increase in MC3 expression between 2 
weeks and 6 weeks and between 10 weeks and 14 weeks old mice and pregnant mice. 
Age and pregnancy did not have any significant effect on MC3 expression (Figure 
5.5.A). AgRP expression, on the other hand, remained constant across 2, 6, 9, 10 and 
14 weeks old mice and only appeared to increase in pregnant animals compared to 
non-pregnant 9 weeks old mice. There was however no significant AgRP expression 
variation in relation to age and pregnancy (Figure 5.5.B). 
 
Figure 5.5: MC3 and AgRP expression in the female mouse pituitary gland. Pituitary cDNA duplicates from female 
C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-qPCR studies. 
A: MC3 expression in female mouse pituitary gland. B: AgRP expression in female mouse pituitary gland. CT values of 
each assay were exported to excel worksheet, analysed using the delta CT Method developed by Pfaffl (2001). The 
skewed data seen in the graphs are due to animal sample variations (old vs. newly obtained samples). The 2-ΔCT values 
were imported to GraphPad and analyses using one-way analysis of variance (ANOVA). (Prism 7, USA). 
 
Age did not have any effect on the expression of MRAP1. However, MRAP1 
expression appeared to be slightly higher in 2 weeks compared to 6 and 9 weeks old 
mice and then it appeared to increase between 10 weeks and 14 weeks. Pregnant 
animals, although insignificant, appeared to have higher MRAP1 expression 
compared to non-pregnant 9 weeks old mice (Figure 5.6.A). MRAP2 expression 
appeared to increase gradually from 2 weeks old to 10 weeks old mice. MRAP2 
expression then was found to drop in 14 weeks old mice. This pattern of MRAP2 
expression was not significantly affected by age. Pregnant mice had lower expression 
than non-pregnant mice of the same age (9 weeks old mice). However, the pregnancy 




Figure 5.6: MRAP1 and MRAP2 expression in the female mouse pituitary gland. Pituitary cDNA duplicates from 
female C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-qPCR 
studies. A: MRAP1 expression in female mouse pituitary gland. B: MRAP2 expression in female mouse pituitary gland. 
CT values of each assay were exported to excel worksheet, analysed using the delta CT Method developed by Pfaffl 
(2001). The skewed data seen in the graphs are due to animal sample variations (old vs. newly obtained samples). The 
2-ΔCT values were imported to GraphPad and analyses using one-way analysis of variance (ANOVA). (Prism 7, USA). 
 
MC4 and MC5 had the lowest expression levels compared to the other MC system 
members in the female mouse pituitary gland. There were no significant variations due 
to either age or pregnancy. In 2 weeks old mice pituitary MC4 expression was higher 
than 6 weeks old mice. This expression rose again in the 9 weeks old mice. The 10 
weeks and the 14 weeks old mice, as well as the pregnant animals, had lower MC4 
expression than the younger animals (Figure 5.7.A). MC5 expression was higher in 
younger animals (2, 6 and 9 weeks old mice) compared to the older animals (10 and 
14 weeks old mice) and pregnant animals (Figure 5.7.B). It is worth mentioning  that 
MC4 was undetectable in 1 out 4 animals in most age groups and MC5 undetectable 
in 2 out of 5 of most age groups. A summary of MC (1-5), MRAP1, MRAP2, POMC and 




Figure 5.7: MC4 and MC5 expression in the female mouse pituitary gland. Pituitary cDNA duplicates from female 
C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-qPCR studies. 
A: MC4 expression in female mouse pituitary gland. B: MC5 expression in female mouse pituitary gland. CT values of 
each assay were exported to excel worksheet, analysed using the delta CT Method developed by Pfaffl (2001). The 
skewed data seen in the graphs are due to animal sample variations (old vs. newly obtained samples). The 2-ΔCT values 
were imported to GraphPad and analyses using one-way analysis of variance (ANOVA). (Prism 7, USA). 
Table 5-4:  MC system expression in the female pituitary gland. 
The table represents each gene examined in hypothalamic cDNA replicates of 3-5 female C57BL/6 mice. Age and 
pregnancy effects were studied by using animals aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1dpc). 
MC (3-5), MRAP1, MRAP2, POMC and AgRP were found in the pituitary gland. There appeared to be no effect of 
pregnancy or age on the expression of any of the genes of interest. (-):  indicates the absence of a gene or 
insignificant impact by age or pregnancy. N/A: not applicable. 
 
PITUITARY (n= 3-5) 
Gene Expression P value 
Significance of 
Age 
Significance of Pregnancy 
MC1 - N/A N/A N/A 
MC2 - N/A N/A N/A 
MC3 + 0.46 - - 
MC4 + 0.67 - - 
MC5 + 0.67 - - 
POMC + 0.68 - - 
AgRP + 0.15 - - 
MRAP1 + 0.60 - - 
MRAP2 + 0.64 - - 
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5. 3. 3 Validation of the MC system expression 
The products of the RT-qPCRs for MC (1-5), POMC, MRAP1, MRAP2 and AgRP, as 
well as CANX and YWHAZ, were separated by electrophoresis on a 2% agarose gel 
(composition and method described in section 3. 2. 4. 3. 3). The products also 
contained non-template control for each of the target and reference genes to check 
for genomic contamination (Figure 5. 8).  
 
Figure 5.8: Gel electrophoresis of RT-qPCR of MC system in the pituitary gland. The RT-qPCR products were 
separated on 2% agarose gel at 110 volts for 40 minutes. Where L = ladder 100 bp to 5000 bp; (ThermoScientific, 
UK); EF: EIF4A2 = 152; MC1, MC2 MC3 = 108 bp, MC4 = 106 bp, MC5 = 90 bp, CX: CANX = 105 bp, POMC = 99 
bp, MR1:  MRAP1 = 86 bp, MRAP2 = 150 bp, AgRP = 63 bp, yz = YWHAZ = 141 bp, -ve: non-template control for 








5. 3. 4 Localization of MC3, MC5 and MRAP2 mRNA transcripts in the female 
mouse Pituitary gland 
The RNAscopeâ expression signals of MC3, MC5 and MRAP2 were identified as brown 
dots. Figure 5. 9 included positive (PPIB) controls to ensure optimised conditions were 
achieved and negative (DAPB) control to ensure there are no background noise in the 
anterior pituitary cells. The expression in the pituitary gland sections was quantified 
and the data was presented in as a percentage. A 100% expression indicated the 
detected number of expression signals (in dots) of the target gene(s) is equivelant to 
the number of the cells. A percentage higher than 100% is due to more than one 





Figure 5.9: RNAscope® 2.5HD single-plex (brown) assay in the female mouse pituitary gland. The assay was show 
expression of positive (PPIB) control to illustrate how the expression signal as brown dots in cells, counterstained 
with Haematoxylin (Hx). B: negative (DAPB) control in the pituitary showing no background staining. Each group 
was conducted as 3 sections per slide (2 weeks were 4 sections per slide) and assay was carried out twice. Images 





5. 3. 4. A. RNAscope® 2.5HD brown detection of MC3, MC5 and MRAP2 in the 
pituitary gland 
 
The expression of MC3 was detected in the pituitary gland of 2 and 10 weeks old 
C57BL/6 female mice and pregnant (14 ± 1 dpc) mice.  The pregnant mice appeared 
to have higher expression ( 100.26%) than the 2 weeks and the 10 weeks old mice 
with expression percentages of 71.18% and 69.74% respectively (Figure 5. 10 A-C). 
However, neither age nor pregnancy had a signifcant impact on MC3 expression. 
Table 5. 5 shows MC3  mRNA expression levels in pituitary gland of 2 and 10 weeks 
and pregnant (14 ± 1 dpc) mice.
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Figure 5.10: RNAscope® 2.5HD Brown assay of MC3 in female mouse anterior pituitary gland. The assay was carried in pituitaries of mice aged 2, 10 weeks old mice and 
pregnant (14 ± 1 dpc) mice. A: MC3 expression in 2 weeks old mice; B: MC3 expression in 10 weeks old mice. C: MC3 expression in pregnant (14 ± 1 dpc) mice. The expression 
of MC3 was quantified manually within each section (within the black square) was calculated. The mean expression of all section on one slide representing an age group was 
measured. See quantification analyses workflow in methods section 3. 2. 5. 4. Each age group was conducted as two slides with two sections per slide. Images were taken using 
a NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London.
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Table 5-5: The percentage of MC3 expression in the RNAscope® brown assay in the mouse anterior pituitary gland. 
The RNAscopeâ brown expression in  2 and 10 weeks old C57BL/6 female mice and pregnant (14 ± 1 dpc) mice 
were quantified manually, and the percentage of expression within each section was calculated. The mean 
expression ± SEM of all sections on one slide representing an age group (4 sections per slide for 2 weeks old; 2 
sections per slide for 10 weeks old and 3 sections per slide for 14 ± 1 dpc pregnant) was measured. See 
quantification analyses workflow in methods section 3. 2. 5. 4. 
 
The expression of MC5 was detected in the pituitary gland of 2 and 10 weeks old mice 
and pregnant (14 ± 1 dpc) mice. The MC5 expression level (68.31%) in the 2 weeks 
animal is relatively similar to levels seen with MC3 in 2 and 10 weeks old mice. 
However, the expression was significantly higher in 2 weeks mice old (68.31%; p 
value= 0.0434) compared to 10 weeks old mice (43.92%). MC5 expression was greater 
in pregnant animals compared to similarly aged virgin mice reaching levels (60.13%), 
which is similar to that seen in 2 weeks old mice (Figures 5. 11 A-C). Table 5.4 shows 
















2 weeks 60.18 57.26 61.72 105.5 71.18±11.5 4 
10 weeks 62.5 86.54 60.19 N/A 69.74± 8.4 3 
(14 ± 1 
dpc) 





Figure 5.11: RNAscope® 2.5HD Brown assay of MC5 in female mouse anterior pituitary gland. The assay was carried in pituitaries of mice aged 2, 10 weeks old mice and 
pregnant (14 ± 1 dpc) mice.  A: MC5 expression in 2 weeks old mice; B: MC5 expression in10 weeks old mice; C: MC5 expression in pregnant (14 ± 1 dpc) mice. The expression 
of MC5 was quantified manually within each section (within the black squares) was calculated. The mean expression of all section on one slide representing an age group was 
measured. See quantification analyses workflow in methods section 3. 2. 5. 4. Each age group was conducted as two slides with two sections per slide. Images were taken using 
a NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London.
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Table 5-6: The percentage of MC5 expression in the RNAscope® brown assay in the mouse anterior pituitary gland. 
The RNAscopeâ brown expression in  2 and 10 weeks old C57BL/6 female mice and pregnant (14 ± 1 dpc) mice 
were quantified manually, and the percentage of expression within each section was calculated. The mean 
expression ± SEM of all sections on one slide representing an age group (4 sections per slide for 2 weeks old; 2 
sections per slide for 10 weeks old and 3 sections per slide for 14 ± 1 dpc pregnant) was measured. See 
quantification analyses workflow in methods section 3. 2. 5. 4. 
 
Similar to MC5, MRAP2 expression increased significantly between 2  weeks (p value= 
0.024) and 10 weeks old female mice and between 10 weeks old mice and pregnant 
animals (92.72%, 159.4% and 172.8% respectively) (Figure 5. 12 A-C). Table 5. 7 
shows MRAP2 expression levels in the pituitary gland of 2 and 10 weeks old mice and 














2 weeks 87.8 61.83 60.53 63.06 68.31± 6.5 4 
10 
weeks 
49.06 42.7 40 N/A 43.92± 2.7 3 
(14 ± 1 
dpc) 
50.55 68.04 61.8 N/A 60.13±5.1 3 
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Figure 5.12: RNAscope® 2.5HD Brown assay of MRAP2 in female mouse anterior pituitary gland. The assay was carried in pituitaries of mice aged 2  and 10 weeks old and 
pregnant (14 ± 1 dpc) mice . A: MRAP2 expression in 2 weeks old mice ; B: MRAP2 expression in 10 weeks old mice; C: MRAP2 expression in pregnant (14 ± 1 dpc) mice. The 
expression of MRAP2 was quantified manually within each section was calculated. The mean expression of all section (within black squares) on one slide representing an age 
group was measured. See quantification analyses workflow in methods section 3. 2. 5.4. Each age group was conducted as two slides with two sections per slide. Images were 
taken using a NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London.
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Table 5-7: The percentage of MRAP2 expression in the RNAscope® brown assay in the mouse anterior pituitary 
gland. 
The RNAscopeâ brown expression in  2 and 10 weeks old C57BL/6 female mice and pregnant (14 ± 1 dpc) mice 
were quantified manually, and the percentage of expression within each section was calculated. The mean 
expression ± SEM of all sections on one slide representing an age group (4 sections per slide for 2 weeks old; 2 
sections per slide for 10 weeks old and 3 sections per slide for 14 ± 1 dpc pregnant) was measured. See 





Differences between pituitary gland MC3, MC5 and MRAP2 expression were detected 
in the 10 weeks old mice and the pregnant animals. In the 10 weeks old mice, MRAP2 
expression was significantly higher than both MC3 and MC5. Pregnant animals had 
significantly lower MC5 expression compared to both MC3 and MRAP2. The younger 
animals did not show a difference in the expression between MC3, MC5 nor MRAP2. 
Figure 5. 13 A-C shows MC3, MC5 and MRAP2 expression comparison in 2 weeks, 10 
















2 weeks 77.5 80.88 122.5 90 92.72± 10.2 4 
10 
weeks 
135.9 215.1 127.3 N/A 159.43±28 3 
(14 ± 1 
dpc) 
148.2 180.8 189.4 N/A 172.82±12.5 3 
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Figure 5.13: Comparison between MC3, MC5 and MRAP2 expression in RNAscope® 2.5HD brown of the female 
mouse pituitary gland. The percentage values of each gene for each of the sections of 2 weeks, 10 weeks old or 
pregnant (14 ± 1 dpc) mice were plotted in GraphPad and analysed using non-parametric tests (Kruskal-Wallis 
test; Prism 7.04). A: MC3, MC5 and MRAP2 expression in 2 weeks old mice (p value= 0.16). B: MC3, MC5 and 
MRAP2 expression in 10 weeks old mice (p value= 0.002). C: MC3, MC5 and MRAP2 expression in pregnant (14 ± 
1 dpc) mice (p value= 0.002). 
 
5. 3. 4 RNAscope® 2.5HD Duplex detection in the pituitary gland 
The RNAscopeâ duplex assay was conducted with five different sets of target probes 
in the pituitary gland:  
MC3 (C1) / MRAP2 (C2). 
MC3 (C1) / GH (C2). 
MC3 (C1) / LHb (C2). 
MRAP2 (C1) / GH (C2) with channel swap. 
MRAP2 (C1) / LHb (C2) with channel swap. 
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The signal detection of the first three sets is green for C1 and red for C2. The channel 
swap conducted with latter two sets caused an exchange of C1 signal detection to red 
instead of green, and C2 was detected as green instead of red. 
 
1. Co-expression of MC3 and MRAP2 
 
The green / red double expression of MC3 / MRAP2 was detected in 2 and 10 weeks 
old mice and pregnant (14 ± 1 dpc) mice pituitary glands. The dual expression 
(represented in as a percentage) appeared to increase between 2 and 10 weeks old 
animals (69.32% and 75.53% respectively). The expression in pregnant animals than 
was found to decrease lower than the double expression seen in 2 weeks old animals 
(58.41%) (Figure 5. 15 A-C). However, there was no significant change observed in 
MC3 / MRAP2 co-expression in relation to age or pregnancy. In addition to the double 
expression, some cells had either MC3 or MRAP2 expressed alone. Table 5. 8 lists 
the percentages of MC3 / MRAP2 double expression, MC3, MRAP2 expression and 
cell that had no expression detected. Positive (PPIB / POL2A) and negative (DAPB 
2plex) duplex assay were included to ensure optimum conditions (see Figure 5. 14). 
 
 
Figure 5.14:  RNAscope® 2.5HD duplex assay in female mouse pituitary gland.  A: A pituitary gland section 
showing signal detection of the 2-plex positive control (PPIB-C1-green -blue arrow) and (POLR2A-C2-red-red 
arrow) (40X). There is also co-expression of both genes in the same cells (black arrow). B: A magnification power 
of 40 pituitary gland section with a 2-plex negative (DAPB) control to ensure there is now background staining. 





Figure 5.15: RNAscope® 2.5HD Duplex assay showing MC3 (C1)-MRAP2 (C2) expression in the female mouse pituitary gland. The assay was carried in pituitaries of mice aged 
2 and 10 weeks old mice and pregnant (14 ± 1 dpc) mice. The pituitary sections show expression and co-expression of MC3 (green arrow) or MRAP2 (red arrow) or both (black 
arrow). A: MC3 - MRAP2 expression in 2 weeks old mice; B: MC3 - MRAP2 expression in 10 weeks old mice: C: MC3 - MRAP2 expression in pregnant (14 ± 1 dpc) mice. The 
expression was quantified manually of each gene within each cell in each section (within the black squares) was calculated. The mean expression of all section on one slide 
representing an age group was measured. See quantification analyses workflow in methods section 3. 2. 5. 4. Each age group was conducted as two sections per slide and n=2. 
Images were taken by NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London.
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Table 5-8: The percentage of MC3 / MRAP2 expression in the RNAscope® Duplex assay in the mouse anterior 
pituitary gland. 
The RNAscopeâ duplex expression in  2 and 10 weeks old C57BL/6 female mice and pregnant (14 ± 1 dpc) mice 
were quantified manually, and the percentage of expression of each within each section was calculated in cells 
showing co-expression and single expression. The mean expression ± SEM of all section on one slide representing 
an age group was measured. See quantification analyses workflow in methods section 3. 2. 5. 4.  
 
 
2. Co-expression of MC3 and GH and LHb 
The RNAscopeÒ duplex assays with MC3 / GH and MC3 / LHb were qualitative assays 
to determine if MC3 expression is in the somatotrophs and/or gonadotrophs of the 
C57BL/6 female mouse.  
 
The intensity of the expression signal of GH was extremely high in most of the cells, 
which led to the masking of the MC3 expression signal within the same cells. GH signal 
was visible in these sections with the naked eye. Some MC3 expression could be 
detected in somatotrophs that had a lower GH expression signal (Figure 5.16 A-C). 
The double expression was detected in the anterior pituitary of 2 and 10 weeks old 
mice and pregnant (14 ± 1 dpc). The MC3 expression signal was also detected in some 



















2 weeks 69.32±5.9 10.96±3.7 13.11±3.3 6.74±1.8 4 
10 weeks 75.53±0.4 8.88±3.7 9.98±5.5 5.6±2.5 3 
(14 ± 1 dpc) 58.41±5.7 11.84±2.2 21.15±5.2 8.63±1.5 3 
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The expression signal of LHb, although lower than that of GH, was also of such a high 
intensity such that it masked the expression of MC3. Nonetheless, MC3 appeared to 
be expressed in the same cells expressing LHb, the gonadotrophs. The MC3 / LHb 
expression was seen in anterior pituitary of 2 and 10 weeks old mice and pregnant (14 
± 1 dpc) (Figure 5.17 A-C). Some of the other pituitary cells that do not express LHb 
were found to express MC3 (Figures 5.17 A-C).  
The current findings also reveal a reduction in the number of both GH and LHβ 
expressing cells during pregnancy (see Figures 5. 16, C and 5. 17, C respectively) 




Figure 5.16: RNAscope® 2.5HD Duplex assay showing MC3 (C1)-GH (C2) expression in the female mouse pituitary gland. The assay was carried in pituitaries of 2 and 10 weeks 
old mice and pregnant (14 ± 1 dpc) mice. The pituitary sections show expression and co-expression of MC3 (red arrow) or GH (green arrow) or both (black or white arrow). A: 
MC3 - GH expression in 2 weeks old mice; B: MC3 - GH expression in 10 weeks old mice; C: MC3 - GH expression in pregnant (14 ± 1 dpc) mice; The GH expression was of high 
intensity that masked the MC3 expression in most cells making quantification analyses difficult to achieve. Images were taken by NanoZoomer slide scanner (Hamamatsu 











Figure 5.17: RNAscope® 2.5HD Duplex assay showing MC3 (C1)-LHβ (C2) expression in the female mouse pituitary gland. The assay was carried in pituitaries of mice aged 2 
and 10 weeks and pregnant (14 ± 1 dpc) mice. The pituitary sections show expression and co-expression of MC3 (red arrow) or LHβ (green arrow) or both (black or white arrow). 
A: MC3 - LHβ expression in 2 weeks old mice; B: MC3 - LHβ expression in 10 weeks old mice; C: MC3 - LHβ expression in pregnant (14 ± 1 dpc) mice. The GH expression was 
of high intensity that masked the MC3 expression in most cells making quantification analyses difficult to achieve. Images were taken by NanoZoomer slide scanner (Hamamatsu 
Photonics) at King’s College London.
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3. Co-expression of MRAP2 and GH or LHb with a channel swap 
 
The RNAscopeÒ duplex assays were conducted to reduce the signal intensity of GH 
and LHb to enable better detection of MRAP2 expression. Although lowering the 
expression signal intensity was achieved, the signal was still masking MRAP2 co-
expression with  of GH or LHb.  
 
MRAP2 expression was detected in the somatotrophs of 2 and 10 weeks old mice and 
pregnant (14 ± 1 dpc) (Figure 5.18 A-C). MRAP2 expression could also be found in 
cells that do not express GH (Figures 5.18 A-C). 
 
The gonadotrophs were also found to express MRAP2. Co-expression MRAP2 and 
LHb was detected in gonadotrophs of 2 and 10 weeks old mice and pregnant (14- ± 1 
dpc) (Figure 5. 19 A-C).  
 
Figure 5. 18, C and 5. 19, C reveals a reduction in the number of GH and LHβ 











Figure 5.18: RNAscope® 2.5HD Duplex assay showing MRAP2 (C1)-GH (C2) expression after channel swap in the female mouse pituitary gland. The assay was carried in 
pituitaries of mice aged 2 and 10 weeks and pregnant (14 ± 1 dpc) mice. The pituitary sections show expression and co-expression of MRAP2 (red arrow) or GH (orange arrow) 
or both (white arrow). A: MRAP2 – GH expression in 2 weeks old mice; B: MRAP2 – GH expression in 10 weeks old mice; C: MRAP2 – GH expression in pregnant (14 ± 1 dpc) 
mice. The GH expression was of high intensity that masked the MRAP2 expression in most cells making quantification analyses difficult to achieve. Images were taken by 







Figure 5.19: RNAscope® 2.5HD Duplex assay showing MRAP2 (C1)- LHβ (C2) expression after channel swap in the female mouse pituitary gland. The assay was carried in 
pituitaries of mice aged 2 and 10 weeks and pregnant (14 ± 1 dpc) mice. The pituitary sections show expression and co-expression of MRAP2 (red arrow) or LHβ (orange arrow) 
or both (white arrow). A: MRAP2 – LHβ expression in 2 weeks old mice; B: MRAP2 – LHβ expression in 10 weeks old mice; C: MRAP2 – LHβ  expression in pregnant (14 ± 1 
dpc) mice. The LHβ expression was of high intensity that masked the MRAP2 expression in most cells making quantification analyses difficult to achieve. Images were taken by 
NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London. 
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5. 3 Discussion 
The current research study characterised the expression of MC3 and MRAP2 in 
gonadotrophs and somatotrophs of the anterior pituitary gland using RNAscope®. This 
RNA in situ technique had also shown, for the first time, MC5 to expressed in the 
pituitary gland of C57BL/6 female mouse. Both MC5 and MRAP2 were significantly 
upregulated with age. Pregnancy resulted in a dramatic rise in MRAP2 expression 
level. MRAP2 expression was also significantly higher than that of MC3 and MC5 in 
the anterior pituitary gland. The RT-qPCR data confirmed the expression of MC3, MC5 
and MRAP2 in the anterior pituitary, as well as MC4, MRAP1, POMC and AgRP, while 
MC1 and MC2 were not detected in the pituitary gland. POMC expression was 
substantially higher the other MC system members followed by AgRP and MC3, 
MRAP1 and then MRAP2, while MC4 and surprisingly MC5 had the lowest expression. 
Age and pregnancy did not influence the RT-qPCR expression levels of the MC 
system in the pituitary gland, which is contradicting the data obtained using the 
RNAscope®.  However, it is worth mentioning that the RT-qPCR data was conducted 
on RNA obtained from whole pituitaries including all three lobes of the pituitary gland. 
The first study of this chapter included selecting the most suitable reference genes for 
normalising the RT-qPCR data in the pituitary gland using GeNorm expression stability 
analysis. Those genes were CANX and EIF4A2. EIF4A2 is a eukaryotic translation 
initiation factor 4A2 and is needed in mRNA binding to ribosomes. CANX showed 
stable expression when examined in the 2, 6, 9, 10 and 14 weeks old mice and 
pregnant (14 ± 1 dpc) mice compared to other reference genes that are commonly 
used in research. When the same group of samples were examined with EIF4A2 and 
YWHAZ, YWHAZ was found to be stable; whereas EIF4A2 CT values were varied 
across the different age groups by 2- 3 cycles. YWHAZ was ranked first in the GeNorm 
expression stability for the hypothalamus and was fifth for the pituitary samples. 
Normalisation using CANX and YWHAZ showed similar data to that when 
normalisation was conducted with CANX, YWHAZ and EIF4A2. However, using the 
CANX and YWHAZ provided more reliable data regarding using stable reference 
genes as when compared to using EIF4A2. Therefore, EIF4A2 was excluded from 
normalising the pituitary gland RT-qPCR data.  
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The second series of studies conducted with the RT-qPCR data revealed the absence 
of MC1 and MC2 from the pituitary gland. Little is known about the expression (if any) 
of both genes in the pituitary gland.  
The current series of studies detected MC3 expression in the pituitary gland, by both 
RT-qPCR and RNAscopeâ. Although insignificant, the MC3 expression was gradually 
increased  with age. The RNAscopeâ had also detected the expression of MC3 in the 
intermediate lobe of the pituitary gland. In the RNAscopeâ, MC3 expression was not 
substantially affected by age. In pregnancy there was a 45% increase in expression 
of MC3, although this was not statistically significant. The RNAscope® duplex assays 
using either GH or LHβ with MC3 indicated that MC3 was localised in somatotrophs 
and gonadotrophs. However, observations on the effect of age and pregnancy on MC3 
in somatotrophs and gonadotrophs could not be made because the high intensity of 
GH and LHb expression masked much of the MC3 signal, making quantifying the 
expression within each cell difficult.  Finding MC3 in the somatotrophs and the 
gonadotrophs indicates that MC3 could be involved in mediating developmental and 
reproductive roles, respectively.  
These findings strengthen the proposed role of MC3 in regulating LHb and FSHb gene 
expression in the pituitary suggested by (Jiang et al., 2017). The present findings are 
also consistent with previous rat and mouse studies: in young rats  (14 day old), it has 
been shown that MC3 were detected in anterior and intermediate lobes of the pituitary 
gland (Lorsignol et al., 1999) and that in vitro stimulation of dissociated rat pituitary 
cells with γ3-MSH causes an increase Ca+2 influx. After the addition of SHU9119,Ca+2 
influx was seen only in half of the cell population (Lorsignol et al., 1999). Additionally, 
Regard and colleagues detected the expression of MC3 in the anterior pituitary gland 
of 12 weeks C57BL/6 male and female mice through GPCR anatomical profiling in 
different tissues (Regard et al., 2008).  
The expression of MC3 in somatotrophs could influence the response of these cells to 
ghrelin (which stimulates growth hormone release (Bouzo-Lorenzo et al., 2016)), since 
it has been shown that GHSR1-a and MC3 can heterodimerise and that this alters the 
responses of these GPCRs (Rediger et al., 2011); with a reduction in GHSR1-a 
response to stimulation, that may be due to receptor internalization (Schellekens et 
al., 2013). Based on these findings, MC3 detected on the somatotrophs could be 
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involved in the regulation of somatotrophs sensitivity to ghrelin and thus regulating GH 
secretion from the somatotrophs.  
The expression of MC3 in the gonadotrophs also supports the hypothesis of a direct 
effect of MC3 on gonadotropins synthesis and release from the gonadotrophs. This 
could also occur through the hetrodimerisation of MC3 with MC4. As mentioned earlier, 
MC4 was reported to stimulate LHb and FSHb synthesis after in vitro treatment with 
THIQ (MC4 selective agonist) and NDP-α-MSH respectivly (Jiang et al., 2017). 
Previous studies had reported the expression of MC3 in lactotrophs of mice 
(Matsumura et al., 2003) and in another study, the same research group had observed 
upregulation of MC3 in the anterior pituitary gland after estradiol treatment in 
ovariectomized mice (Matsumura et al., 2004). Although lactotrophs are known to 
express ERα (Mitchner et al., 1998), the estradiol effect could have been mediated 
through MC3 expression in either gonadotrophs or somatotrophs [which is also known 
to express ERα (Avtanski et al., 2014)]  As the RT-qPCR studies by Matsumura et al., 
2004 were carried out on RNA from the entire anterior pituitary gland, it was unclear 
which specific pituitary cell types expressed the gene. Matsumura and colleagues also 
reported that after 20 days of age female mouse had an increase in the levels of MC3 
expression, which is unlike the stable levels that were observed in male mice 
(Matsumura et al., 2004). These RT-qPCR data were consistent with the current 
research data. Despite the insignificant change in MC3 expression in relation to age, 
there was a moderate rise in the level of MC3 expression seen in our studies between 
prepubertal mice and adult mice, consistant with a rise observed between pre-pubertal 
and 45-day old female mice made by  Matsumura and colleagues findings (see Figure 
5.5. A) (Matsumura et al., 2004).  
The detection of MC3 in both somatotrophs and gonadotrophs could indicate another 
indirect role in both cells which is through forming heterodimers with other GPCRs. 
Previous reports had revealed the heterodimerisation of MC3 with GHSR1-a in the 
hypothalamus (Rediger et al., 2011). The GHSR1-a receptor was found expressed in 
adenomas of all pituitary cell types including both those of somatotroph and the 
gonadotroph origin (Korbonits et al., 2001). Furthermore, the use of double staining 
studies in GHSR1-a- (eGFP) reporter mouse had confirmed the GHSR1-a expression 
in all in each cell type with highest expression in the male and female mouse 
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somatotrophs (77%) followed by 21% and 9% of lactotrophs; 18% and 19% of 
gonadotrophs; 19%  and 12.6% of corticotrophs and the least was detected in 
thyrotrophs with 3% and 9% in males and females, respectively (Reichenbach et al., 
2012). Considering these findings, MC3 and the GHSR1-a could be regulating 
gonadotrophic and somatotrophic functions by forming heterodimers in both cell types. 
The same could also be investigated  for MC3 and the Kisspeptin receptor. Kisspeptin 
receptors where also found expressed in the pituitary gland and were found to 
stimulate LH release (Gutiérrez-pascual et al., 2007) and this might indicate that MC3 
is indirectly influencing LH release through interacting with kisspeptin in the 
gonadotrophs. 
The expression of MC3 in both gonadotrophs and somatotrophs adds further evidence 
to the interactions between the two cell types since it may act to coordinate the activity 
of these two cell types. A feedback circuit has been reported in fish by (Zhou et al., 
2004). In addition to being stimulated in an autocrine fashion, GH synthesis was found 
to be also mediated by LH or (HCG) in fish pituitary cells preparations; and the effect 
was dose-dependent. Growth hormone, in turn, was found to reduce the basal 
concentrations of LH even though GH was found to stimulate the β-subunit expression 
(Zhou et al., 2004). The feedback loop between the two cell types could be mediated 
by MC3 expressed in either or both cells. This is suggested because MC3 regulates 
gonadotropin release from the gonadotrophs and, through  GHSR1-a dimerisation, is 
likely to moderate GH secretion. 
The RNAscope® duplex results indicated the co-expression of MC3 and MRAP2 (the 
latter was also detected by RT-qPCR studies conducted in this research) in some cells 
of the anterior pituitary, and to a lower level in the intermediate lobe. The double 
expression was higher in older mice (10 weeks old) by about 6% compared to the pre-
weaned 2 weeks old mice. Even though the single RNAscope® studies indicated the 
upregulation of both genes in pregnancy, the co-expression of the MC3 and MRAP2 
was reduced in pregnancy by about 17% compared to 10 weeks old mice. However 
this reduction was not significant. The downregulation of the double expression during 
pregnancy could be attributed to the fact that MRAP2 is associated with regulating 
other melanocortin receptors, as well as, non-melanocortin receptors such as GHSR1-
a and prokineticin receptor-1 (Sebag and Hinkle, 2009; Srisai et al., 2017; Chaly et al., 
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2016 respectively). These findings might indicate MRAP2 role during pregnancy is in 
favour of other GPCR in the pituitary gland. 
The wide expression of MRAP2 seen in the pituitary is similar to that seen in the female 
mouse hypothalamus data from the previous chapter. These findings also agree with 
the emerging evidence of MRAP2 expression in the pituitary and the hypothalamus 
(Novoselova et al., 2016). MRAP2 was found to regulate MC3 and MC4 
responsiveness to the melanocortin peptides as reported in the in vitro studies with 
MC3 in the current research (see chapter 8 for data Figures) and also, in recent studies 
(Sebag et al., 2013; Zhang et al., 2017).   
MRAP2 expression increased with age as the 10 weeks old mice had significantly 
higher expression (p value= 0.024) than the pre-weaned 2 weeks old mice by about 
65%. Pregnancy caused only a 10% upregulation of MRAP2 compared to the 10 
weeks old virgin mice. The expression of MRAP2 was the highest in adult and 
pregnant animals when compared to both MC3. Similar to MC3 co-expression studies, 
the RNAscope® duplex assays using the GH and LHβ were also conducted with 
MRAP2, and had shown MRAP2 to be localised in somatotrophs and gonadotrophs.  
Although quantifying MC3 or MRAP2 co-expression with either LHβ or GH was not 
possible,  it was apparent that the number of both LHb and GH expressing cells in the 
RNAscopeâ data were reduced during pregnancy. These findings are consistent with 
previous studies which have reported a decrease of both gonadotrophs and 
somatotrophs in pregnancy (Molitch, 2000). The decrease in the somatotrophs could 
be attributed to their transdifferentiation to assist in producing prolactin which is 
significantly increased during pregnancy (Stefaneanu et al., 1992). The RNAscopeâ 
studies of the single gene expression of MC3 and MRAP2 had shown increased 
expression of both during pregnancy. Considering the RNAscopeâ single and duplex 
assays finding and findings by (Stefaneanu et al., 1992), MC3 and MRAP2 increased 
expression could be attributed to the increased lactotrophs in the pituitary during 
pregnancy. Using a prolactin marker for the in situ studies together with MC3 and 
MRAP2 would confirm this hypothesis.  
In the present research, we confirm characterisation of MC4 in the pituitary gland; 
although there was no difference in differential expression in relation to age or 
pregnancy. Previous studies have included a phenotypic examination of MC4-/- mice, 
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which have concluded that MC4, which was detected in the pituitary gland, could be 
affecting the LH release and pulse frequency. However, the underlying mechanism 
was unclear but could involve a direct action on the HPG axis (Chen et al., 2017). 
There are several different mechanisms which would lead to alteration of LH release 
and pulsatility by MC4, either at the level of the hypothalamus or the pituitary. 
Stimulation of LH release by activated MC4 could occur through the postsynaptic 
stimulation of GnRH, which in turn stimulates LH release, by α-MSH-activation MC4 in 
the hypothalamus. In the pituitary, MC4 could be modulating LH release through a 
paracrine mechanism, this is supported by the evidence of  α-MSH production by the  
intermediate lobe of the pituitary gland (Bicknell, 2008) which might be activating MC4 
expressed on the cell surface of anterior pituitary cells (Chen et al., 2017).  
Our finding that MC5 is expressed in the pituitary gland confirms the widespread 
expression of MC5 in the central and peripheral tissues (Labbé et al., 1994; Boston 
and Cone, 1996; Chhajlani, 1996). The RNAscope® single gene detection assays had 
shown that MC5 also to be expressed in C57BL/6 female mouse pituitary gland. The 
expression of MC5 was found significantly higher (p value= 0.0434) in pre-weaned 
animals (2 weeks old mice) compared to 10 weeks old mice and pregnancy was shown 
to upregulate MC5 expressions to levels similar to that seen in the pre-weaned 
animals. Our identification of MC5 expression in the pituitary gland increases the 
possibility of heterodimerization between the melanocortin receptors (Kobayashi et al., 
2016). MC5 were thought to be involved in stimulating the GH3 cells  as it was detected 
expressed in these cells (Langouche et al., 2001). However, this role could not be 
confirmed as using MC5 agonist (SHU9119) did not have any effect on the cells. 
Therefore, MC5 exact role in the pituitary gland is yet to be investigated. MC3, MC5 
and MRAP2 were also detected in lower levels in the intermediate lobe of the female 
mouse pituitary gland (see appendix 4 for Figures). 
POMC showed the highest expression of all the members of the melanocortin system 
in the pituitary gland and was found to have constant expression unaffected by age or 
pregnancy. Since both anterior and intermediate lobes of the pituitary were included 
in the samples used for RNA preparation, it is unclear whether reciprocal changes in 
corticotrophs and melanotrophs may mask any changes in these cell types.  In their 
study, Nelson et al. (1988) had shown a fluctuation in the expression of POMC in the 
mouse pituitary gland. There was a two-fold increase in the concentration of POMC 
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RNA in old mice (31 months old) compared to young (7 month) and middle aged (15 
month) mice. However, Nelson et al had attributed this increase as proportionate loss 
of prolactin and GH  mRNA  which was found to be reduced significantly in older 
animals (as reviewed by (Nelson et al., 1988).  
Also, the high expression of POMC in the current research study is expected due to a 
high demand for ACTH release from the pituitary, as well as the other peptides deriving 
from POMC with varying physiological functions such as modulating pain, stress, 
appetite and memory (Millington et al., 2001). 
We also found AgRP expression in the pituitary gland.  Takeuchi et al., 2000 found 
AgRP was widely distributed in chicken’s peripheral tissues (Takeuchi et al., 2000) 
and our studies extend these findings to the pituitary gland of the mouse. This 
suggests that AgRP may have a role in the regulation of the peripheral melanocortin 
receptors as previously suggested by (Takeuchi et al., 2000). However, AgRP 
analogue (AgRP83-132) was found to stimulate prolactin production by the GH3 cells 
(Langouche et al., 2004). AgRP83-132  was found to act as an inverse agonist on hMC3 
and hMC4 (Nijenhuis, 2001). Based on these findings, AgRP might be mediating a role 
in the pituitary gland through MC3.   
MRAP 1 was also detected in the pituitary suggesting that that they may have a  role 
as accessory proteins to the melanocortin receptors, similar to that described in the 
adrenal gland (Novoselova et al., 2013). Even though MC2 was not detected in the 
pituitary gland, MRAP1 is thought to have an inhibitory role on the other melanocortin 
receptors as shown by the studies of  (Chan et al., 2009). 
The expression of MC5 in the pituitary gland was found to be higher in pre-weaned 
mice which might indicate a developmental role for MC5 in these animals as suggested 
by (Nimura et al., 2006). MC5, is expressed in the pituitary gland of goldfish and it, was 
found to be responsive to MTII (pan MCs agonist) and HS014 (a selective MC4 
antagonist) (Cerda-Reverter et al., 2003). These findings might indicate that the MC3 
and MC4 roles in regulating LHb and FSHb gene expression could also be mediated 
by MC5. 
MC5 expression decreased from neonatal animals through to adults but was found to 
be high again in pregnancy, this pattern was also observed with MC3 and MRAP2. 
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This might indicate increased demand of the pituitary function(s) mediated by the 
melanocortin system during pregnancy that have yet to be identified. 
As mentioned in section 5.1, a range of paracrine activities have been described in the 
different pituitary cell types which may have important regualtory functions. Paracrine 
factors from gonadotrophs have been shown to stimulate prolactin release from 
lactotrophs following GnRH stimulation of male rat pituitary cells aggregates; whilst 
GnRH treatment in preparation from adult animals that did not have an affect on 
prolactin release (Denef and Andries, 1983). The GnRH by itself was not able to 
stimulate prolactin release, which indicates that other gonadotroph regulatory 
components are needed for the GnRH to stimulate the lactotrophs The expression of 
MC3 in both lactotrophs and gonadotrophs may mediate coordinated cell activity. 
Therefore, MC3 activity on prolactin release might be mediated through different 
mechanisms: 1) The autocrine mechanism as MC3 was detected on lactotrophs 
(Matsumura et al., 2004). 2) The paracrine mechanism through the activation of 
gonadotrophs and these cells, in turn, stimulate prolactin release by the lactotrophs 
(based on the current RNAscopeâ findings). 3) The heterodimerisation of MC3 with 
other GPCR such as kisspeptin which was found to stimulate prolactin release in cows 
pituitary cells (Kadokawa et al., 2008).  Other possible GPCR candidates for 
heterodimerisation with MC3 that need to be investigated are dopamine receptors.  
Dopamine is a known regulator of prolactin production and secretion (Shin et al., 2010) 
and dopamine 2 receptor (D2) was found expressed in the pituitary corticotrophs 
(Pivonello et al., 2004) and prolactin-secreting adenomas (De Camilli et al., 1979).  
The current research findings in the pituitary gland add more elements to the 
complexity of the intra- communications that are associated with the regulation of the 
anterior pituitary gland hormonal function. The involvement of the melanocortin system 
in regulation of the anterior pituitary gland has just started to be revealed. The current 
research managed to detect MC3 and MRAP2 in the gonadotrophs and the 
somatotrophs. Due to lack of resources, MC5 could not be included in the RNAscope® 
duplex assays although it might have provided insight into a potential role of MC5 in 
pituitary gland function.  
Additionally, members of the melanocortin system detected in the RT-qPCR studies 
of this research confirm previous reports of MC4 expression in the pituitary and might 
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have identified new roles for MC members in the pituitary gland. Furthermore, 
examining other anterior pituitary cell types for the expression of MC3 and MRAP2 with 
the RNAscope® duplex assays could have identified possible regulatory mechanisms 
through which both candidates might be mediating their anterior pituitary role. 
However, because of the time and financial limitations, these targets could not be 
included in the current research. 
The following chapters will analyse the MC expression in the ovary and the uterus in 




























6  Molecular and cellular characterisation 















The pituitary gland secretes the gonadotropins (LH and FSH) which are then 
transported via the circulation to their primary target in the female, the ovary. The main 
functions of the ovary are 1) oogenesis (oocyte growth and development), 2) 
folliculogenesis (follicular growth and development) and 3) steroidogenesis (steroid 
hormone synthesis). The development of mouse ovaries occurs at embryonic stages 
but is completed after birth. The developing ovary is made of female germ cells 
surrounded by somatic cells, both of which have different origins. The mouse 
ovariogenesis is composed of oogenesis accompanied by the growth of the somatic 
cells into follicular cells. This chapter will briefly describe the processes of mouse 
oogenesis and folliculogenesis. It will also briefly discuss the ovarian cycle and some 
of the regulatory - endocrine, paracrine and autocrine pathways of the ovarian cycle. 
Finally, a description of what is known to date about the roles of the melanocortin 
system in the mouse ovary will be given.   
6. 1. 1 Murine Oogenesis 
Oogenesis is the process of development and maturation of female germ cells (aka 
gametes). The primordial germ cells are first detected on embryonic day 7 and they 
migrate to the developing urogenital ridge by embryonic day 10. The oogonia undergo 
mitotic activity to make the primordial germ cells that last the entire reproductive life of 
the animal, and this mitotic activity is completed by embryonic day 15 (Peters, 1969). 
The primordial germ cells (primary oocytes) all enter meiosis I (starting on embryonic 
day 13.5) but become arrested in late prophase I until ovulation (Amleh and Dean, 
2002). The oocytes (diameter is about 20 µm) are found in clusters (forming germ cells 
nests) in the cortical tissue of the ovary with some oocytes surrounded by a single 
layer of epithelial cells called the pre-granulosa cells (primordial follicle), whereas other 
oocytes are freely touching. By the end of the 7th day after birth, all oocytes are 
surrounded by pre-granulosa cells (Peters, 1969). By the end of the postnatal period, 
the ovary is full of primordial follicles and growing follicles. Shortly before ovulation, 
which is also before the differentiation of the follicles to the mature antral (Graafian) 
follicles, the oocytes undergo maturation growing to mature morphology (reaching 70 
µm in diameter). The LH surge triggers meiosis in oocytes destined for ovulation. 
Meiosis is again arrested in the metaphase of meiosis II and will only be completed 
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when a spermatozoon enters the oocyte. Similar to the meiotic events, folliculogenesis 
is all but complete by ovulation (Wassarman and Josefowicz, 1978). 
The process of oogenesis is controlled by different molecular, hormonal autocrine and 
paracrine elements. Describing each element regulating the different stages of 
oogenesis is beyond the focus of the research; so for a detailed description see the 
review by Sánchez and Smitz, (2012). Oocyte maturation from oogonia to primary 
oocytes ready for ovulation is accompanied by differentiation of the follicular cell layers 
in a process called folliculogenesis. 
6. 1. 2 Folliculogenesis 
Folliculogenesis is the name of the process involving the growth and development of 
the ovarian follicle. There are different types of ovarian follicles based on their stage 
of development (Barnett et al., 2006): 
Primordial follicles: the oocyte is surrounded by 3 to 4 squamous epithelial pre-
granulosa cells. The oocyte is about 20 µm in diameter.  These follicles are considered 
quiescent. 
Primary follicles: when a primordial follicle starts to grow, the pre-granulosa cells 
become cuboidal in shape and increase in number to form a single layer surrounding 
the oocyte.  The oocyte also starts to increase in diameter.  Primary follicles start to 
appear by postnatal day (PND) 3. 
Pre-antral follicles: these are made of multiple layers of granulosa cells and the 
surrounding stromal cells differentiate to form the theca interna and theca externa cell 
layers. The oocyte reaches maximum growth (70 µm in diameter) with the surrounding 
cells producing interstitial follicular (antral) fluid.  
Antral follicles: at this stage, the follicles attain its greatest increase in diameter due to 
the accumulation of antral fluid. Once the follicle reaches maximal growth, it becomes 
responsive to FSH. These follicles can synthesise and release androgens, as a result 
of the action of LH on thecal cells, and estrogen, aromatisation of androgen to estrogen 
in granulosa cells influenced by FSH.  
The increased production of estrogen stimulates the hypothalamic-pituitary LH surge 
leading to ovulation of 10- 20  oocytes, whilst most of the other antral follicles 
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degenerate (Rajkovic et al., 2006). Although ovarian folliculogenesis is mainly 
mediated by FSH, there are other regulators of the different stages of folliculogenesis. 
One of these mechanisms includes the paracrine interaction between the growing 
oocytes and the follicular granulosa cells. This interaction was found to involve 
different elements such as the tyrosine kinase receptor, Kit and its ligand (KitL) which 
have been shown to be essential for follicular growth and oocyte maturation (Thomas 
and Vanderhyden, 2006). Other factors controlling follicular and oocyte maturation 
include regulatory genes, such as the factor in the germline alpha (FIGLA) and the 
newborn ovary Homeobox gene (Nobox). Both factors are oocyte-specific factors; 
hormones such anti-Mullerian hormone (which is thought to regulate primordial 
follicles numbers postnatally: (Durlinger et al., 1999); growth factors including insulin-
like growth factor-I (IGF-I) and transforming growth factor beta 1 (TGF-β1); and 
hormones such as estrogen and progesterone. The details of the functions of these 
elements are further reviewed by (Rajkovic et al., 2006; Sánchez and Smitz, 2012). 
6. 1. 3 Ovulation  
Ovulation is the process by which the mature oocyte is released from the ovary into 
the oviduct. Ovulation occurs approximately 10 hours after the beginning of estrus in 
rodents. This is preceded by an increased FSH concentration in the circulation during 
proestrus. The high FSH concentration stimulates the recruitment of some of the antral 
follicles which continue to undergo final maturation. The LH surge enables the oocytes 
to recommence meiosis whilst other antral follicles undergo atresia.  
The growing follicles secrete more estrogen, that influences the pituitary positively, 
leading to an LH surge (McGee and Hsueh, 2000). However, under an unknown 
mechanism, about 10- 20 follicles are selected for ovulation in mice, but one selected 
follicle produces a variety of factors which have an autocrine effect leading to 
increased sensitivity to FSH. This dominant follicle is also thought to produce 
degenerative factors acting in a paracrine fashion on the unselected follicles (McGee 
and Hsueh, 2000). The mural, granulosa and theca cells also contribute to the 
ovulatory process. This was proposed based on data reporting the expression of LH-
receptors in the mural granulosa cells of the preovulatory follicles while the cumulus 
granulosa cells require FSH to increase their sensitivity to LH (Russell and Robker, 
2007). Activation of the LH mediated signalling pathways in both groups of cells leads 
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to a reduction in the gap junctions between the two layers causing the separation of 
the cumulus-oocyte complex (COC) from the follicular mural layer making them float 
in the antral fluid, in addition there is upregulation of transcriptional genes regulating 
the oocyte meiosis, thus, enabling oocyte maturation (Russell and Robker, 2007). 
The ovulatory process includes mediating an acute local inflammatory response that 
consists of increased vascular permeability leading to follicular protein efflux and 
infiltration of leukocytes, mainly macrophages. The leukocytes secrete different 
cytokines, interleukins, proteolytic enzymes all of which are downstream of 
progesterone receptors (PR) and LH. These inflammatory elements contribute to the 
local disintegration of the ovarian surface epithelium through which the destined follicle 
will rupture (Kim et al., 2009). Some of these cytokine receptors were found expressed 
in the granulosa and theca cells of rat and mouse ovarian follicles. These include TNF-
a, interferons (INFs) and IL-1b  which were thought to participate in the remodelling of 
the follicle before ovulation through the production of proteolytic enzymes that assist 
in the follicular wall disintegration (Machelon and Emilie, 1997). 
6. 1. 4 Ovarian luteinisation and luteolysis 
After the release of the oocyte, luteinisation of the residual follicular tissues occurs 
through the differentiation of follicular cells, tissue remodelling and changes in the 
composition of the extracellular matrix: all these changes lead to the formation of the 
corpus luteum (Stocco et al., 2007). Vascular remodelling was also found to be part of 
the luteinisation process, and this is established through the production of angiogenic 
cytokines, such as vascular endothelial growth factor (VEGF) and TGF-β1 (Machelon 
and Emilie, 1997). The luteinisation process is regulated by different molecular factors 
which are involved also in the regulation of the expression of LH, FSH, P4 and prolactin 
receptors and the signalling pathways downstream of these receptors (Stocco et al., 
2007). Rodents have different types of corpora lutea (CL), these are: 
1. CL of the cycle: these are formed as a result of luteinisation of the ovulating 
follicles under the effect of the preovulatory LH surge. This type of corpora lutea 
lasts for about 14 days with the maximum size reached at estrus of the following 
cycle.  Within an ovary the CLs are therefore of 3 different  ages reflecting the 
ovulations of the previous 3 estrous cycles (Greenwald and Rothchild, 1968). 
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2. CL of pseudopregnancy: if cervical stimulation occurs at estrus, biphasic 
release of prolactin from the pituitary gland results and the prolactin acts on the 
CL to induce progesterone synthesis for up to 12 days.  
3. CL of pregnancy: this type of CL is a continuation of the CL of pseudopregnancy 
which increases in size reaching maximal growth on day 13 and progesterone 
production by this type of CL continues until day 16 (Greenwald and Rothchild, 
1968). 
4. CL of lactation: in other species the corpus luteum regresses after parturition. 
However, in rodents, prolactin, which increases as a result of pup suckling, is 
thought to regulates the maintenance of the corpus luteum which is now called 
the corpus luteum of lactation and it lasts up to 4 weeks in rodents.  
 
Granulosa and theca cells differentiate into large lutein and small lutein cells 
respectively; this is accompanied by the upregulation of enzymes involved in the 
synthesis of progesterone, such as cytochrome P-450 and 3b-hydroxysteroid 
hydrogenase (3b-HSD), and downregulation of enzymes associated with estrogen and 
androgen release (Niswender et al., 2000). The mechanisms involved in the formation 
of the corpora lutea, their maintenance and luteal steroidogenic activity are further 
reviewed by (Bachelot and Binart, 2005).  
At the end of the lifespan of the corpus luteum, the regression of the corpus luteum, 
luteolysis, occurs in two stages: functional luteolysis and structural luteolysis.   
Functional luteolysis occurs before structural luteolysis and is characterised by a 
decline in progesterone concentration. The lowered progesterone concentration is 
thought to be mediated mainly by prostaglandin F2a (PGF2a)  and the activation of 
the protein kinase C cascade (Bachelot and Binart, 2005). Apoptosis was found to be 
the main cause of structural luteolysis as reported by (Morales, 2000) in the human 
corpus luteum. Luteal apoptosis is mediated by different cytokines such as INFg and 
TNF-a,  Fas and Fas-ligand and caspase-3;  this was found to be mediated by the 
prolactin surge that occurs concomitantly with LH surge (Sugino and Okuda, 2007). 
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6. 1. 5 Implication of the MC system in the functions of the mouse ovary 
Although the melanocortin system is mediating different functions in different organs, 
little is known about its expression or function in the mouse ovary. The expression of 
melanocortin receptors in the ovaries of species other than mice have been reported 
(Amweg et al., 2011; Guelfi et al., 2011). The expression of the melanocortin receptors 
was thought to mediate the estradiol and testosterone concentrations via ACTH in 
follicles of different stages and also the corpora lutea and therefore suggested an 
ovarian steroidogenic and luteal role by melanocortin receptors. The melanocortin 
system could also be contributing to the different immunomodulatory events that are 
part of the follicular tissue remodelling during folliculogenesis, luteinisation and 
luteolysis. There are data, albeit in non-reproductive tissues, reporting a modulating 
action of the melanocortin peptides and receptors  on different cytokines; such as, 
TNF-a and IL-1b by (Catania et al., 2004; Getting, 2006; Kaneva et al., 2012). 
Therefore, the aims of studies described in this chapter are to: 
1. Determine suitable reference genes in the mouse ovary for normalisation using 
GeNorm expression stability analysis. 
2. Characterise MC (1-5), MRAP1 and MRAP2, POMC (full-length gene and the 
truncated gene) and AgRP in the ovary of different aged mice (2, 6, 10 and 14 
weeks old). 
3. Compare the expression of the genes listed above in pregnant and non-
pregnant mice. 
4. To evaluate the cellular expression of MC3, MC5 and MRAP2 expression using 
chromogenic in situ hybridisation (RNAscope®). 
 
 
6. 2 Methods  
For a detailed account of the materials and techniques used see chapter 3. 
6. 2. 1 Determining suitable reference genes in the uterus 
The most stable reference genes in the ovary were selected using the GeNorm 
analysis described in detail in section 3. 2. 3. 4. 1. Duplicates of cDNA samples from 
each age group were used in this analysis.  
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 6. 2. 2 Characterising the gene expression of the MC system 
These reference genes were used to normalise data obtained from the RT-qPCR 
assays of the reverse transcribed RNA extracted from whole ovaries of female 
C57BL/6 mice aged 2, 6, 9, 10, 14 weeks and pregnant mice (14 ± 1 day post-coitus, 
dpc) (all n=5; except n=3 for 9 weeks and n=4 for 10 weeks). The efficiencies of the 
primers used in these assays were examined using standard curves with positive 
controls for each primer pair (see section 3. 2. 3. 4. 3 in methods for details). The RT-
qPCR amplification products were then separated on 2% agarose gel to check the 
size of the band and verify they were of the predicted size, and to check for non-
specific bands. 
The RT-qPCR data collected were analysed using the delta-delta CT method 
mentioned in section 3. 2. 3. 4. 3. C in methods.  
 
6. 2. 3 RNAscope® 2.5HD protocol 
The ovarian sections were collected from female C57BL/6 mice aged 2 weeks, 10 
weeks and pregnant (14-± 1 dpc). The tissues were prepared and cut in cross-
sections. The studies included using RNAscope® 2.5HD single-plex (brown) staining 
kit with MC3, MC5 and MRAP2 as well as positive and negative controls.  Based on 




6. 3 Results 
6. 3. 1 Reference gene stability in the female mouse ovary 
In the female C57BL/6 mouse ovary, ATP synthase subunit beta (ATP5B) and 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were the most stable genes 
whereas Beta-2-Microglobulin (B2M) and Eukaryotic Translation Initiation Factor 4A2 
(EIF4A2) were the least stable genes (Figure 6.1). 
 
 
Figure 6.1:  GeNorm ranking order of reference genes stability in the female mouse ovary. The ranking is based 
on calculating the geometric mean of the ranking values from Delta CT, BestKeeper, Normfinder and GeNorm 
reference gene analyses tools. The stability of 12 reference genes was examined using the ovaries of female mice 
aged 2, 6, 9, 10, 14 weeks, and pregnant mice (14+1 dpc). The samples were run in duplicates. The reference 
genes are 18S, ACTB, ATP5B, B2M, CANX, CYC1, EIF4A2, GAPDH, RPL13A, SDHA, UBC and YWHAZ. CT 
values were imported to the qBase+ software and analysed using GeNorm (Biogazelle, Belgium). 
 
The Optimal number of housekeeping genes to be used in normalising the RT-qPCR 
data was two for the female mouse ovary. This was obtained by calculating the 
pairwise variation (V-score) with the sequential addition of each reference gene one 
at a time. A V-score above 0.15 indicates the optimal number of most stable reference 
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genes to be used (Figure 6.2). The V-score was calculated using GeNorm analysis by 
qBase+ software (Biogazelle, Belgium). See appendix 3. C for graphs of the 





Figure 6.2: Variation score (V- score) by GeNorm. An optimal number of stable genes used normalisation was 
calculated by pairwise variation with the addition of each reference gene one at a time. A V-score equal or below 
0.15 indicated the insignificance of using more reference genes. In this graph, 10 reference genes V-score results 









6. 3. 1. B Amplification efficiencies of ATP5B, GAPDH and YWHAZ 
The amplification efficiency is defined as the doubling of the cDNA template for each 
RT-qPCR cycle. Table 6.1 lists the standard curve slope (M), the coefficient of 
determination (R2) and amplification efficiency (E) of ATP5B (100%), GAPDH (97%) 
and YWHAZ (100%).  
Table 6-1: Amplification efficiency of ACTB, ATP5B and YWHAZ in the female ovary. 
Gene R2 (Coefficient of Determination) 
M (Measurement of 
Efficiency) 
E (Efficiency) 
ATP5B 0.99 -3.32 100% 
GAPDH 0.99 -3.38 97% 
YWHAZ 0.99 -3.32 100% 
Pooled cDNA from all samples used in MC system expression in the ovary was used in generating 1:2 standard 
curves. The efficiency was calculated automatically using the Rotor-Gene Q software (Qiagen, UK). 
 
6. 3. 2 MC system expression 
The RT-qPCR analysis of the C57BL/6 mouse ovary showed MC2, MC4, MC5, MRAP1, 
MRAP2, POMC (truncated gene) and AgRP were all detected. MC1, MC3 and full-
length POMC were not expressed in the female mouse ovary. The expression of the 
mRNA for these targets is not the same between the MC system members. Compared 
to the hypothalamus and the pituitary gland, the expression of all detected members 
was found at low levels.   
The expression of MC2 (Figure 6. 3. A), although low, appeared to be higher in pre-
weaned mice (2 weeks old) compared to 6 weeks old mice. Expression increased 
again at 9 weeks old before decreasing again in older mice (10 and 14 weeks old). 
However, age did not have a substantial effect on MC2 expression. Pregnancy caused 
a significant decrease in the expression of MC2 compared to the non-pregnant animals 
(p- value= 0.017) and non-pregnant animals of the same age. The expression of MC4 
was similar at all ages and there were no significant age influences on expression. 
Melanocortin 4 receptor was not detected in pregnant animals (Figure 6. 3. B). Apart 
from being higher in 2 weeks old mice, MC5 expression showed no change in 6, 9, 10, 
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14 weeks old mice and pregnant mice. There were no age or pregnancy effects on 
ovarian expression of MC5 (Figure 6. 3. C).  
 
Figure 6.3: MC2, MC4 and MC5 expression in the female mouse ovary. Ovarian cDNA duplicates from female 
C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-qPCR studies. 
A: MC2; B: MC4 and C: MC5.  The CT values of each assay were exported to excel worksheet, analysed using the delta 
CT Method developed by Pfaffl (2001). The skewed data seen in the graphs are due to animal sample variations (old vs. 
newly obtained samples). The 2-ΔCT values were imported to GraphPad and analyses using one-way analysis of variance 
(ANOVA). (Prism 7, USA). 
 
 
Even though age and pregnancy did not alter the expression significantly, MRAP1 
expression appeared to increase between the 6 weeks old mice and the pre-weaned 
animals (2 weeks old); and was lower in 9 weeks old compared to older animals (10 and 
14 weeks old). Pregnant animals had higher MRAP1 expression compared to the non-
pregnant animals of the same age. (Figure 6. 4. A).  Interestingly, the expression of 
MRAP2 followed a similar pattern of MC5 with a low MRAP2 expression in all ages and 
pregnant mice compared to 2 weeks old mice. Both age and pregnancy did not have any 
influence on MRAP2 expression (Figure 6. 4. B). 
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Figure 6.4: MRAP1 and MRAP2 expression in the female mouse ovary. Ovarian cDNA duplicates from female 
C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-qPCR studies. 
A: MRAP1 and B: MRAP2. The CT values of each assay were exported to excel worksheet, analysed using the delta CT 
Method developed by Pfaffl (2001). The skewed data seen in the graphs are due to animal sample variations (old vs. 
newly obtained samples). The 2-ΔCT values were imported to GraphPad and analyses using one-way analysis of variance 
(ANOVA). (Prism 7, USA). 
 
Although full-length POMC transcript was absent, 5’-truncated POMC gene transcript 
was detected in the ovary. The expression of POMC (5’-truncated gene transcript) 
appeared to decrease gradually. Younger animals (2 weeks old) mice had higher 
expression than older animals. Expression of POMC was not different between 
pregnant and non-pregnant animals of the same age (Figure 6. 5. A). AgRP 
expression did not show any alterations between the different ages and pregnant 
animals (Figure 6. 5. B). A summary of MC (1-5), MRAP1, MRAP2, POMC (5’- truncated 











Figure 6.5: POMC (truncated transcript) and AgRP expression in the female mouse ovary. Ovarian cDNA duplicates 
from female C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-
qPCR studies. A: POMC and B: AgRP.  The CT values of each assay were exported to excel worksheet, analysed using 
the delta CT Method developed by Pfaffl (2001). The skewed data seen in the graphs are due to animal sample variations 
(old vs. newly obtained samples). The 2-ΔCT values were imported to GraphPad and analyses using one-way analysis of 
variance (ANOVA). (Prism 7, USA). 
Table 6-2:  MC system expression in the mouse ovary. 
The table represents each gene examined in ovarian cDNA duplicates of 3-4 C57BL/6 mice. Age and pregnancy 
effects were examined by using animals aged 2, 6, 9, 10 and 14 weeks old mice and pregnant (14 +1DPC) mice. 
MC2, MC4, MC5, MRAP1, MRAP2, POMC (truncated transcript) and AgRP were found in the ovary. Pregnancy had 
a significant impact on the expression of MC2 (with a p-value of 0.02). Age did not affect the expression. (+) Indicate 
the presence of a gene or significant effect by age or pregnancy; (-): indicates the absence of a gene or insignificant 
effect by age or pregnancy. N/A: not applicable. 
Ovary (n:3-5) 
Gene Expression P value Significance of Age 
Significance of 
Pregnancy 
MC1 - N/A N/A N/A 
MC2 + 0.02 - + 
MC3 - N/A N/A N/A 
MC4 + 0.20 - - 
MC5 + 0.23 - - 
POMC 
(FULL) 
- N/A N/A NA 
POMC 
(Trunc.) 
+ 0.11 - - 
AgRP + 0.96 - - 
MRAP1 + 0.07 - - 
MRAP2 + 0.26 - - 
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6. 3. 3. Validation of the MC system expression 
The products of the RT-qPCR of MC (1-5), MRAP1, MRAP2, 5’-truncated POMC, and 
AgRP, as well as GAPDH, ATP5B and YWHAZ were seperated on 2% agarose gel 
(composition and method described in section 3. 2. 4. 3. 3). The products also 
contained non-template control for each of the target genes and the reference genes 




Figure 6.6: Gel electrophoresis of RT-qPCR of MC system in the female mouse ovary. The RT-qPCR products 
were separated on 2% agarose gel at 110 volts for 40 minutes. Where L = ladder 50 bp to 2000 bp; 
(ThermoScientific, UK); GD: GAPDH = 127 bp: MC1, MC2 = 86 bp, MC3, MC4 = 106 bp, MC5 = 90 bp, ATP: ATP5B= 
112 bp; MRAP1 = 86 bp, MRAP2 = 150 bp, AgRP = 63 bp, POMC (truncated gene) =77 bp, YZ: YWHAZ =141 bp. 






6. 3. 3 Localization of MC3, MC5 and MRAP2 mRNA transcripts in the female 
mouse Ovary 
RNAscopeâ brown expression signal is detected as brown dots which represent 
mRNA copies of the target gene. These assays included positive (PPIB) and negative 
(DAPB) controls to ensure optimised conditions were achieved. Figure 6.7 illustrates 
the expression and the absence of background staining in sections hybridized with the 
positive and negative control probes, respectively.  
 
 
Figure 6.7: RNAscope® 2.5HD single-plex (brown) assay in the female mouse ovary. The assay was carried out 
in the ovaries of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. A: The ovarian sections show 
expression of positive (PPIB) control to illustrate how the expression signal as brown dots in cells, counterstained 
with Haematoxylin (Hx). B: negative (DAPB) control in the uterus showing no background staining. Each group was 
conducted as 4 sections per slide. Images were taken by NanoZoomer slide scanner (Hamamatsu Photonics) at 
King’s College London. 
 
MC3 is expressed in both ovarian follicles and the interstitial tissues albeit very 
sparsely (Figure 6. 8. A). These findings contradict the RT-qPCR data.  The 
expression of MC5 is very similar to that of MC3 (Figure 6. 8. B). Compared to MC3 and 
MC5, MRAP2 expression was at a lower level but was detected in the same 





Figure 6.8: RNAscope® 2.5HD single-plex (brown) assay of MC3, MC5 and MRAP2 in the female mouse ovary. 
The assays were carried out in the ovaries of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. A: MC3 
expression in the female mouse ovary. B: MC5 expression in the female mouse ovary. C: MRAP2 expression in 
the female mouse ovary.  Each group was conducted as 4 sections per slide, and the assays were carried out 
twice. Images were taken by NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London. 
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6. 4 Discussion 
MC2, MC4, MC5, MRAP1, MRAP2, POMC (5’-truncated gene transcript) and AgRP 
were all detected in the mouse ovary. Even though MC3 was not detected in the ovary 
by RT-qPCR (as well as MC1 and full-length POMC gene transcript), MC3 expression 
was very sparsely expressed in both the ovarian follicles and the surrounding 
interstitial tissue as shown by the RNAscopeâ brown assay. The expression of both 
MC5 and MRAP2 in the mouse ovary was confirmed by the RNAscopeâ brown assay 
and, as for MC3, both MC5 and MRAP2 were expressed sparsely in both the ovarian 
follicles and the surrounding interstitial tissue. There appeared to be no effect of age 
on the expression of any of the expressed members of the melanocortin system 
however, both MC2 and MC4 ovarian expression were reduced during pregnancy by 
RT-qPCR. 
 
The GeNorm expression stability analysis found the most suitable reference genes for 
use in normalising the C57BL/6 female mouse ovary RT-qPCR data were ATP5B and 
GAPDH. These two reference genes showed stable expression when examined in the 
2, 6, 9, 10 and 14 weeks old mice and pregnant (14 ± 1 dpc) mice. The optimal number 
needed for normalising RT-qPCR data in the ovary was two. In the ovary, YWHAZ 
was also included in the RT-qPCR data to be consistent with normalisation of the 
hypothalamus, pituitary gland and uterus RT-qPCR data. The expression stability of 
YWHAZ was ranked fourth in the GeNorm stability analysis of the reference genes in 
the ovary. 
 
MC2 was found in the ovary with higher expression in the non-pregnant sexually 
mature adult mice (9 weeks old) compared to pregnant animals. MC2 might directly 
influence ovarian action through ACTH as the current research findings were 
comparable with findings reported by (Guelfi et al., 2011) using a rabbit model. Guelfi 
and colleagues reported a dual action of ACTH on P4 release from the CL with higher 
P4 release in the earlier days of pseudopregnancy (day 4) compared to decreased 
production at the later stages (day 9). The effect of ACTH was consistent with the 
pattern of immunostaining for MC2 in CL (Guelfi et al., 2011). However, the current 
research had only examined MC2 expression in mid-pregnancy. Examining earlier 
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stages of pregnancy are, therefore, necessary to determine if MC2 expression levels 
during early pregnancy in mice agree with those observed in pseudopregnant rabbits.  
 
The absence of MC1 and MC3 from the ovaries contradicts findings by Amweg et al., 
2011; this research team had localised both receptors in the bovine corpus luteum of 
the ovary. However, the use of anti-MC1 and anti-MC3 antibodies, as well as anti-MC5, 
were reported to produce non-specific binding in many different studies (Kathpalia et 
al., 2011; Ahmed, 2014; Dowejko, 2014).  The absence of MC3 could also be due to 
species differences or due to dilutional effects that resulted from using mRNA 
extracted from a whole tissue especially since the levels of the other detected 
receptors are at low levels. The latter explanation is supported by the RNAscopeâ 
findings in which MC3 was shown to be expressed in both ovarian follicles and the 
surrounding interstitial tissues. MC3 modulates inflammation by regulating the 
expression of some cytokines, such as IL-1b and TNF-a, by increasing the expression 
of the anti-inflammatory cytokine, IL-10 (Patel et al., 2010; Henagan et al., 2011). 
According to these findings, MC3 could be contributing to keeping the normal 
inflammatory process in check and the findings that report the regulation of MC3 
promoter expression by estradiol (Okutsu et al., 2015) support this proposed function. 
 
The ACTH luteal effect mediated by MC2 could also be mediated by MC4 which was 
also found expressed in the ovary in the current research. Although there was no 
mention of MC4 expression in the ovary, the study conducted by Sandrock et al., 2009 
reported reduced CL numbers in MC4-/- 6- month old obese mice compared to wild 
type mice. Although Sandrock and colleagues implied an indirect MC4 role in the ovary 
based on the present research findings, the luteal effect could be directly mediated by 
MC4 on the CL. 
MC5 was suggested to suppress inflammation in the eye through stimulating the 
production of different cytokines; an action mediated by a-MSH (Clemson et al., 2017) 
based on these findings, MC5 might be involved in regulating the proinflammatory 
events that are accompanying ovulation, luteinisation and luteolysis.  The RNAscopeâ 
data of the current research study had shown MC5 to be expressed in the ovarian 
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follicles and interstitial tissue, a distribution similar to that of MC3 which might indicate 
mediating the proposed anti-inflammatory role through forming heterodimers.  
 
Although not significant, MRAP1 was found to be higher in the pregnant mice 
compared to the non-pregnant control group. In contrast the pattern of MC2 expression 
was found to be higher in non-pregnant animals; MRAP1 is known to regulate MC2 
trafficking and surface expression (Chan et al., 2009). However, a recent study has 
shown MRAP1 is not required in the trafficking of elephant shark MC2 (Reinick et al., 
2012); also MRAP1 could be regulating the expression and signalling of the other 
expressed MCs as reported by (Chan et al., 2009; Kay et al., 2013). MRAP2 detection 
in the ovary agrees with its role as an accessory protein for MCs, and this is 
augmented by the RNAscopeâ data that showed a similar distribution of MRAP2 to 
that of MC3 and MC5 in the ovary. Additionally to MCs, MRAP2 is reported to regulate 
non-melanocortin GPCRs in the hypothalamus (Chaly et al., 2016; Srisai et al., 2017; 
Liang et al., 2018) and co-localisation studies of MRAP2 with GPCRs expressed in the 
ovary might elucidate more regulatory functions by MRAP2.  
 
The next step after characterising the expression of the melanocortin receptors in the 
ovary is to examine whether their functions would be mediated by locally derived 
melanocortin peptides or those peptides that reach the ovary from the circulation. The 
AgRP expression had shown it to be expressed in the ovary. Previous studies reported 
the expression of the IL-1 receptor in the hypothalamic AgRP neurons and the receptor 
expression was upregulated during inflammation (Scarlett et al., 2008). According to 
these findings, AgRP could also be involved in the acute inflammatory status during 
the different ovarian functions. Examining the expression of POMC revealed the 
absence of the full-length gene transcript from the ovary, but the truncated gene 
transcript was detected at low levels in the ovary. The 5’-truncated POMC gene is a 
shorter sequence that is devoid of both exon 1 and exon 2 and the latter sequence 
contains the sequence necessary to transport the POMC mRNA transcript to the 
endoplasmic reticulum (ER) to be translated to protein (Ivell, 1994). Therefore, the 
expressed truncated POMC gene cannot be transported to the ER for protein 
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synthesis. However, why the shorter transcript of POMC is expressed needs further 
investigation.  
 
This research study has identified the expression of MC2, MC4, MC5, MRAP1, MRAP2, 
POMC (5’-truncated gene transcript) and AgRP in C57BL/6 mouse ovary. It has also 
shown that MC5, MRAP2 and MC3 are distributed in both ovarian follicles and ovarian 
interstitial tissue. If the resources and time were sufficient, the RNAscopeâ  assay 
would have included more ages and other stages of pregnancy to examine the effect 
of both on the expression and the distribution of the MCs and MRAP2 at a cellular 
level. Also, RNAscopeâ  duplex assays could have been conducted to determine if 
there is co-localization of either MC3 and MC5 or if MRAP2 is co-localised with these 
receptors. The double expression study could also have been used to detect the 
specific cells expressing the receptors found expressed in the ovary. This could be 
achieved using cell markers of granulosa (B4galt2 encoding type II membrane-bound 
glycoprotein that synthesises N-acetyllactosamine in glycolipids and glycoproteins); 
macrophages (CD56++) and endothelial cells (CD31 or CD34). This research study 
had shown that most of the MCs are expressed at all levels of the hypothalamic-
pituitary-ovarian axis which further strengthen the proposed reproductive role of the 
melanocortin system. The following chapter will be aimed at determining whether the 

















7  Molecular and cellular characterisation 













7. 1 Background 
The function of the uterus is to provide support in the establishment of pregnancy, 
provide nutritional, hormonal and immunological support to the developing fetus and 
through the actions of its muscular contractions that enable birth. 
Unlike humans, the mouse uterus is a Y-shaped duplex organ made of two elongated 
uterine horns that join caudally at the short uterine corpus (uterine body) and a dual 
cervix. The uterus is made of three compartments:  
1. The endometrial luminal columnar epithelium and the glandular cuboidal 
epithelium. 
2. The endometrial stroma which is a supportive connective tissue that surrounds 
the endometrial glands and contains the spiral arteries. 
3. The myometrium which is made of inner circular and outer longitudinal smooth 
muscle layers.  
7. 1. 1 Postnatal uterine development 
The uterus develops from the Mullerian duct (paramesonephric duct) in the absence 
of the sex determinant factors which include the transcription factor SRY, testosterone 
and anti-Mullerian hormone (Spencer et al., 2012). At birth, the mouse uterus is made 
of undifferentiated mesenchyme surrounding the simple epithelial tubules. Around 
postnatal day (PND) 5, the luminal epithelium invaginates forming the endometrial 
gland; the mesenchyme differentiates into the endometrial stroma, the inner circular 
and outer longitudinal smooth muscle layers of the myometrium (Spencer et al., 2012). 
The extension of the endometrial glands into the surrounding endometrial stroma is 
completed around postnatal day 10. The development of the adult uterus morphology 
is completed by PND 15 (Spencer et al., 2012).  
Previous studies had reported that the differentiation of endometrial epithelium could 
be regulated locally through the biochemical alteration in the extracellular matrix and 
composition of glycosaminoglycans (GAGs). These alterations influence the cell cycle 
and the pattern of branching of developing cells in both the epithelium and the stroma 
(Gray et al., 2001).  Epithelial cellular proliferation was found to be mediated by 
fibroblast growth factors (FGF) such as FGF-7, FGF-10 and insulin-like growth factors 
(IGF- I and II) produced by the endometrial (mesenchymal) stroma (Gray et al., 2001). 
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FGF receptor (FGFR) deletion resulted in eventual infertility due to impaired postnatal 
development of the luminal epithelium leading to abnormalities in implantation sites 
(Filant et al., 2014). Activated FGFR signalling pathways include the activation of the 
Pi3K/ERK phosphorylation pathway (Winterhoff and Konecny, 2017) that stimulates 
transcriptional factors mediating expression of genes involved in cellular proliferation 
and function (Zhang et al., 2007). The same signalling pathway was found to be 
activated by MC4 and MC5 (Ramírez et al., 2015; Rodrigues et al., 2009 respectively) 
which might indicate a proliferative role mediated by MC4 and MC5: both of which have 
been reported to be expressed in human uterine endometrium using 
immunohistochemistry (Lantang et al., 2015). 
Other uterine growth factors include the transcriptional factors coding the Homeobox, 
or Hox, genes and the wingless-type-MMTV integration site genes, or Wnts family (19 
genes which are known regulators of cellular proliferation). Out of the 19 known Wnt 
genes, three have been detected in the mouse uterus: Wnt4, Wnt5 and Wnt7.  The 
regulatory functions of the Hox genes and Wnts in the uterus are beyond the scope of 
this research; however, a full description of their roles in the uterus was reviewed by  
Hayashi et al. (2011) and Du and Taylor (2016).  
Estradiol (E2) was found to be non-essential in postnatal uterine development and  
estrogen receptor a knockout (ERaKO) mice have comparable uterine proliferative 
patterns to wild type mice (Cooke et al., 2015). Progesterone had a paradoxical effect 
on uterine development, as it was found to both inhibit the growth of endometrial gland 
and prompt proliferation of the endometrial stroma in neonatal mice (Filant et al., 
2012). The neonatal maturation of the uterus is completed by the end of the third week 
after birth. The effect of the ovarian steroids on the uterus was found to be essential 
after puberty in mice to regulate the uterine remodelling that occurs in every estrous 
cycle. 
7. 1. 2 Uterine changes during the estrous cycle 
During the different stages of the mouse estrous cycle, there are specific changes 
observed in the luminal and the glandular epithelia and the endometrial stroma of the 
uterus.  
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Many studies have suggested that the fluctuations in E2 and P4 concentrations are the 
leading causes of the uterine changes. Wood et al. examined this hypothesis in mice 
by measuring the circulating concentrations of E2 and P4 in relation to each stage of 
the estrous cycle and the uterine morphological changes (Wood et al., 2007). The 
changes observed in the mouse uterus during the estrous cycle in relation to the 
concentrations of both E2 and P4 are summarized in Table 7.1. 
 
Table 7-1: Circulating E2 and P4 concentrations in relation to morphological changes in the mouse uterus during 
the estrous cycle. 









highest rate of stromal proliferation 
Low luminal cell death rate accompanied by a continued normal luminal 
proliferation 
Loss of glandular collagen type-IV and profound increase in collagen type-I 
Neutrophils infiltrating endometrial stroma 











A significant increase in glandular proliferation 
A significant increase in luminal and stromal cells death which is more 
profound in luminal epithelium (LE) 
A profound increase in collagen type-I 
Neutrophil infiltrating LE 








highest rate of stromal cell death 
Loss of luminal collagen type-IV 
Neutrophils infiltrating endometrial stroma 










A significant increase in glandular proliferation 
Neutrophils infiltrating endometrial stroma 
Macrophages mainly in myometrium and deep in endometrial stroma and 
near LE 




The regulation of the mouse uterine remodelling by E2 and P4 is mediated through 
their respective receptors ERa and ERb,  and PR-A and PR-B. A detailed account of 
the regulatory role in the mouse uterus during the estrous cycle by these receptors 
can be found in the following reviews (Wang et al., 2000; Binder et al., 2014; Wood et 
al., 2007). 
In the absence of copulation and pregnancy, the uterus undergoes remodelling 
through an immunomodulatory process which is under hormonal control. Estradiol 
treatment in ovariectomized mice was found to increase the influx of leukocytes 
(mainly neutrophils) into the endometrial stroma and myometrium. The treatment of 8 
weeks old wild-type and progesterone receptor knockout (PRKO) mice with estrogen 
was found to increase the number of macrophages and neutrophils in the uterine 
stroma (Tibbetts et al., 1999). These proinflammatory effects by estradiol  were 
significantly lowered by concurrent progesterone treatment in the wild-type animals 
but had no effect in the PRKO mice (Tibbetts et al., 1999). Therefore, the drop in 
progesterone concentrations during the follicular phase, or proestrus, leads to the 
increase of the expression of genes coding proinflammatory cytokines, and the 
leukocyte infiltration of the endometrial epithelium continues. The inflammatory 
process causes cell death and vascular necrosis and micro-bleeding (Gellersen et al., 
2009). A particular type of natural killer cells (NK) are found in the uterus which were 
referred to as the uterine natural killer (uNK) cells. The uNK population was found to 
be greatest during the late secretory phase in human (Gong et al., 2017). Both 
macrophages and uNK were found to have a unique regulatory role in the mouse, and 
human, uterus; these uNK cells were the first cells to undergo apoptosis at the end of 
the luteal phase (before the beginning of the next cycle) in women which might indicate 
an essential role in the uterine remodelling (Yang et al., 2011).  
7. 1. 3 Uterine preparation for implantation, decidualisation and 
maintenance of pregnancy 
7. 1. 3. 1 Early pregnancy 
After successful fertilisation, an interaction between the growing blastocyst and the 
maternal uterus leads to implantation of the blastocyst. There is a specific window 
between fertilisation and implantation called the receptivity window which lasts up to 
4 days in rodents (day of the appearance of the murine vaginal plug is day 1) (Wang 
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et al., 2017). The attachment of the blastocyst to the uterine epithelium causes uterine 
changes, or decidualisation at the implantation site of the endometrial stroma and 
henceforth the implantation of the growing embryo into the decidua (stromal 
implantation site). The changes required to make the uterus receptive for implantation 
include increased permeability of the epithelial cells and eventually dissolvement, the 
proliferation of the endometrial stroma into decidual secretory cells and uterine 
vascular angiogenesis. The implantation process involves a variety of molecular, 
hormonal and cellular regulators such as growth factors (VEGF, EGF and transforming 
growth factor, TGF-α), ovarian steroids, prolactin and immunomodulatory factors. 
Estrogen and progesterone have different roles during the implantation process; while 
E2 was found to be essential in determining the receptivity window, progesterone was 
reported to be required in the process of implantation itself. This is supported by 
detecting the ERa in the endometrial epithelium on the first and second days of 
conception  (Tan et al., 1999). Progesterone was also found to be essential during 
implantation as the progesterone receptor (PR) was detected in the endometrial 
epithelium and subluminal stromal layer on day 3-5 of pregnancy (Tan et al., 1999). 
Progesterone functions involve the regulation of genes that are essential during 
implantation. These genes include bone morphogenetic protein 2 (BMP2) and 
Hoxa10. Detailed description on the ovarian steroids and the regulatory genes 
affecting implantation is beyond the scope of this research, but they are thoroughly 
described in the following reviews (Ramathal et al., 2010; Cha et al., 2014; Bhurke et 
al., 2016).  
Another hormone found to have a role during the implantation period is prolactin. Apart 
from prolactin’s leading role in the formation of the corpus luteum of pregnancy 
(discussed in section 6. 1. 4), it was also found to be expressed in the decidual cells 
where it is thought to have an adverse regulatory effect on implantation  (Eyal et al., 
2007). 
The implantation process also involves immunomodulatory components including 
cytokines such as: macrophage colony-stimulating factor, leukaemia inhibitory factor 
(LIF) and IL-11.  LIF is found in high concentrations in the mammalian uterine glands 
on the fourth day of pregnancy and falls on day 6-7 of pregnancy, which might indicate 
its requirement during implantation (Kimber, 2005). This cytokine is suggested to be 
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regulated by Hoxa3, Hoxa11 and estrogen, as the lack of any of these three was 
reported to down-regulate LIF protein (Kimber, 2005). LIF mediates its function 
through activating LIF receptor beta (LIF-Rb). This receptor activates different 
signalling pathways such as JAK/STAT and PI3K/Akt pathways.  
 
7. 1. 3. 2 Mid-pregnancy 
After successful implantation of the embryo, formation of the placenta is required for 
the maintenance of pregnancy. The placenta is an embryonic-maternal vascular unit 
that is required for physical support, and the exchange of gas, nutrients and waste 
products between the growing foetus and the maternal circulation. It also behaves as 
an endocrine organ in providing pregnancy-associated hormones. Unlike human, 
mouse placentation is completed in mid-pregnancy (around day 13.5 of gestation) 
(Furukawa et al., 2014). The mouse placenta is discoid in shape and is made by the 
differentiation of the embryonic trophectoderm cells into trophoblast giant cells; two 
types of diploid cells adjacent to the embryonic cell mass arise from the polar 
trophectoderm. These are the outer extraembryonic ectoderm which is differentiated 
finally into the labyrinth which is supported inwards by the second type of cells, the 
ectoplacental cone which differentiates into the spongiotrophoblast (Watson, 2005).   
Around mid-pregnancy, the uterus is rapidly increasing in size to accommodate the 
growing foetus, the foeto-maternal unit and the accumulating amniotic fluid. This 
growth increment is made possible by the myometrium, which experiences 
hyperplasia, then hypertrophy and finally remodelling of the smooth muscle cells. The 
smooth muscle hyperplasia was reported to be under the control of estrogen which 
activates different signalling pathways including the IGF-I and the 
PI3K/Akt/mammalian target of rapamycin (mTOR) pathways (Jaffer et al., 2009). 
Myometrial cell hypertrophy was found to be activated by the acute stretching in rats 
which causes transient myometrial hypoxia, which in turn activates hypoxia-induced 
transcription factors (HIF-1a). The latter stimulates intrinsic apoptotic CASP3 cascade 
(Shynlova et al., 2010). The activation of the CASP3 pathways was suggested to block 
further myocyte proliferation by lowering the expression of the mTOR pathways 
thereby causing a switch from myometrial hyperplasia to hypertrophy (Shynlova et al., 
2010).  
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Contractility of the expanding myometrial wall could end pregnancy abruptly. 
Therefore, the myometrium is quiescent until labour, this is achieved mainly through 
the effect of progesterone. In humans, progesterone stimulates myometrial relaxation 
through maintaining a resting membrane potential through Ca++ activated K+-gated 
channels and regulates the expression of genes coding receptors that either stimulate 
or inhibit myometrial contractility such as oxytocin and atrial natriuretic peptide, 
respectively (Soloff et al., 2011). 
  
7. 1. 3. 3 Parturition and uterine involution 
At term (which is around day 20-21 of gestation in mice), the uterus undergoes 
dramatic changes to expel the fully grown foetus in a process called parturition. It is 
impossible to include all mechanisms involved in parturition in this chapter fully. 
Therefore a summary of the parturition events is included in this chapter, but the 
parturition mechanisms and events are best reviewed in (Ratajczak and Muglia, 2008). 
In summary, murine parturition includes a series of events starting with a fall in 
progesterone due to the degradation of the corpus luteum of pregnancy initiated by 
prostaglandins (PGs) (Piekorz et al., 2005). There is also an increase in the 
concentrations of hormones that are essential for: uterine contractions (oxytocin); 
cervical ripening (relaxin) and CRH which activates the HPA axis and glucocorticoid 
release, thus, leading to more PGs production. The HPA axis also activates nitric oxide 
synthase which leads to the vasodilatation of uterine and foetal blood vessels 
(Snegovskikh et al., 2006). During pregnancy, progesterone antagonises the pro-
inflammatory processes that could have been mediated by estrogen. Lack of 
progesterone causes localised leukocyte infiltration that digest the extracellular matrix 
proteins in the cervical stroma leading to remodelling and ripening of the cervix; 
decidual and myometrial infiltration by neutrophils and macrophages initiate the 
release of potent cytokines such as IL-1b, TNF-a and also prostaglandins which 
stimulate myometrial contractility (Shynlova et al., 2013).  
Postpartum, the uterus utilises different mechanisms to recover the estrous cyclical 
properties of each compartment, including the remodelling of the myometrium to 
reduce to the non-pregnant size and the regeneration of the endometrial luminal and 
glandular epithelia. The main compartment that is dramatically increased in size during 
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pregnancy is the myometrium. After birth, uterine remodelling occurs through a 
process of lysosomal degradation of the cytoplasmic component (autophagy) of the 
myometrial smooth muscle cells without signs of significant apoptosis (Hsu et al., 
2014). The recovery from the profound changes in the endometrium that occurred 
during pregnancy was suggested to be mediated by the endometrial stroma. The 
transition of the proliferating stromal mesenchymal cells to the luminal and glandular 
epithelia was reported to be the mechanism by which the  endometrial epithelium 
regenerates. Huang et al (2012) reported that a population of progenitor cells 
differentiates into glandular epithelial cells and those progenitor cells are localised in 
the endometrial stroma after parturition (Huang et al., 2012). 
7. 1. 4 The possible role of the melanocortin system in the mouse uterus 
Uterine remodelling during the estrous cycle, pregnancy, parturition and the 
postpartum involution is known to involve different pathways and mechanisms 
regulating these changes. These pathways, regulated by different aspects within the 
uterus can be summarised as follows:  1) the proliferation and differentiation of the 
uterus and 2) the modulation of the inflammatory response accompanying different 
events. A recent study reported the expression of the melanocortin receptors in all 
compartments of the uterus, but mainly in the endometrium; some of the receptors 
were located in the uNK cells (MC3 and MC5) (Lantang et al., 2015). Identification of 
these receptors in uNK might indicate the implication of the MCs in the 
immunomodulation pathways. The uNK cells express a group of cell surface markers 
including CD65+. In rheumatoid arthritis, CD65+ expressing NK were also found to 
express all of the melanocortin receptors and were suggested to regulate the uNK 
cytokines, including TNFa and INFg (Andersen et al., 2017), although this has not 
been confirmed in uNK. Based on Andersen et al.’s findings, MCs could be mediating 
an inflammatory response which is essential during uterine remodelling throughout the 
estrous cycle, pregnancy, parturition and uterine involution after birth. Little is 
published about either the expression of the MC system in the uterus or any possible 




Therefore, the aims this chapter are to: 
1. Determine suitable reference genes in the mouse uterus for normalisation using 
GeNorm expression stability analysis. 
2. Characterise MC (1-5), MRAP1, MRAP2, POMC (full-length gene and truncated 
gene) and AgRP in the uterus of different aged mice (2, 6, 10 and 14 weeks 
old). 
3. Compare the expression of the genes listed above in pregnant and non-
pregnant mice. 
4. To evaluate the cellular expression of MC3, MC5 and MRAP2 expression using 
chromogenic in situ hybridisation (RNAscope®). 
 
7. 2 Methods  
 
For a detailed account of the materials and techniques used see chapter 3. 
7. 2. 1 Determining suitable reference genes in the uterus 
The most stable reference genes in the uterus were selected using the GeNorm 
analysis described in detail in section 3. 2. 3. 4. 1 in methods. Duplicates of cDNA 
samples from each age group were used in this analysis.  
 7. 2. 2 Characterising the gene expression of the MC system 
These reference genes were used to normalise data obtained from the RT-qPCR 
assays of the reverse transcribed RNA extracted from whole uteri of female C57BL/6 
mice aged 2, 6, 9, 10, 14 weeks and pregnant mice (14 ± 1day post-coitus, dpc) (all 
n=5 except n=3 for 9 weeks and n=4 for 10 weeks). The efficiencies of the primers 
used in these assays were examined using standard curves with positive controls for 
each primer pair (see section 3. 2. 3. 4. 3 in methods for details). The RT-qPCR 
amplification products were then separated on 2% agarose gel to check the size of the 
bands and verify they were of the predicted size, and to check for non-specific bands. 
The RT-qPCR data collected were analysed using the delta-delta CT method 
mentioned in section 3. 2. 3. 4. 3. C in methods.  
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7. 2. 3 RNAscope® 2.5HD protocol 
The uterine sections were collected from female C57BL/6 mice aged 2 weeks and 10 
weeks as well as pregnant mice (14± 1 dpc). The tissues were prepared and cut in 
longitudinal sections. The studies included using RNAscope® 2.5HD single-plex 
(brown) staining kit with MC3, MC5 and MRAP2 as well as positive and negative 
controls.  Based on the results from the single-plex studies, duplex studies were not 
included for the uterus. 
 
7. 3 Results 
7. 3. 1. A Reference gene stability in the female mouse uterus 
In the female C57BL/6 mouse uterus, tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein zeta (YWHAZ), actin-beta (ACTB) and ATP 
synthase subunit beta (ATP5B) were the most stable genes whereas Beta-2-
Microglobulin (B2M) and 18S ribosomal RNA (18S) were the least stable genes 
(Figure 7. 1). 
 
The Optimal number of housekeeping genes to be used in normalising the RT-qPCR 
data was three for the female mouse uterus. This was obtained by calculating the 
pairwise variation (V-score) with the sequential addition of each reference gene one 
at a time. A V-score above 0.15 indicates the optimal number of most stable reference 
genes to be used (Figure 7. 2). The V-score was calculated using GeNorm analysis 
by qBase+ software (Biogazelle, Belgium). See appendix 3. D for graphs of the 







Figure 7.1:  GeNorm ranking order of reference genes stability in the female mouse uterus. The ranking is based 
on calculating the geometric mean of the ranking values from Delta CT, BestKeeper, Normfinder and GeNorm 
reference gene analyses tools. The stability of 12 reference genes was examined using uteri of female mice aged 
2, 6, 9, 10, 14 weeks, and pregnant mice (14+1 dpc). The samples were run in duplicates. The reference genes 
are 18S, ACTB, ATP5B, B2M, CANX, CYC1, EIF4A2, GAPDH, RPL13A, SDHA, UBC and YWHAZ. CT values 
were imported to the qBase+ software and analysed using GeNorm (Biogazelle, Belgium). 
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Figure 7.2: Variation score (V- score) by GeNorm. An optimal number of stable genes used normalisation was 
calculated by pairwise variation with the addition of each reference gene one at a time. A V-score equal or below 
0.15 indicated the insignificance of using more reference genes. In this graph, 10 reference genes V-score results 
indicates the optimal number of most stable HKG to be used in the uterus are three (GeNorm by qBase+, 
Biogazelle, Belgium). 
7. 3. 1. B Amplification efficiencies of YWHAZ, ACTB and ATP5B 
The amplification efficiency is defined as the doubling of the cDNA template for each 
RT-qPCR cycle. Table 7.1 lists the standard curve slope (M), the coefficient of 
determination (R2) and amplification efficiency (E) of ACTB (79%), ATP5B (95%) and 
YWHAZ (94%).  
Table 7-2: Amplification efficiency of ACTB, ATP5B and YWHAZ in the female uterus. 
Gene 
R2 (Coefficient of 
Determination) 
M (Measurement of 
Efficiency) 
E (Efficiency) 
ACTB 0.99 -3.94 79% 
ATP5B 0.99 -3.44 95% 
YWHAZ 0.97 -3.48 94% 
Pooled cDNA from all samples used in MC system expression in the uterus was used in generating 1:2 standard 
curves. The efficiency was calculated automatically using the Rotor-Gene Q software (Qiagen, UK). 
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7. 3. 2 MC system expression 
The RT-qPCR analysis of the C57BL/6 mouse uterus showed only MC2, MC4, MC5, 
POMC (truncated gene) and AgRP were detected in the uterus. MC1, MC3، full-length 
POMC, MRAP1 and MRAP2 were not expressed in the female mouse uterus. 
Compared to the hypothalamus and the pituitary gland, the expression of all detected 
members was found at low levels.  
 
The expression of MC2 appeared to be increased between pre-pubertal (6 weeks old) 
and pre-weaned female mice (2 weeks old). The expression falls again in older mice 
(9 and 10 weeks old mice) to be increased mildly again in 14 weeks old mice. 
Pregnancy showed lower expression than that seen in non-pregnant mice of the same 
age (9 weeks old mice) (see Figure 7. 3, A for graph). Age and pregnancy did not 
cause any significant change in expression.  
The expression pattern was similar for MC4 and MC5. The expression was higher in 
pre-weaned mice (2 weeks old) compared to 6 and 9 weeks old mice (the expression 
change was significant for MC5). The expression levels appeared to increase again in 
10 weeks old mice and dropped mildly in 14 weeks old mice. Neither MC4 nor MC5 




Figure 7.3: MC2, MC4 and MC5 expression in the female mouse uterus. Uterine cDNA duplicates from female 
C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-qPCR studies. 
A: MC2; B: MC4 and C: MC5. (**): Significant MC5 expression change (p value= 0.0087).  CT values of each assay were 
exported to excel worksheet, analysed using the delta CT Method developed by Pfaffl (2001). The skewed data seen in 
the graphs are due to animal sample variations (old vs. newly obtained samples). The 2-ΔCT values were imported to 
GraphPad and analyses using one-way analysis of variance (ANOVA). (Prism 7, USA). 
 
The expression of POMC and AgRP followed a relatively similar pattern as the expression 
of both genes appeared to be constant in younger mice (2, 6 and 9 weeks old mice). The 
expression then increased in 10 weeks old mice and dropped in 14 weeks old mice 
(POMC had lower expression than AgRP). Pregnancy had similar expression level seen 
in non-pregnant mice of the same age (9 weeks old mice) (see Figures 7.4, A and B for 
graphs). Table 7. 2 summarises the MC (1-5), MRAP1, MRAP2, POMC and AgRP 
expression in the female mouse uterus. 
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Figure 7.4: POMC (truncated transcript) and AgRP expression in the female mouse uterus. Uterine cDNA duplicates 
from female C57BL/6 mice aged 2, 6, 9, 10 and 14 weeks and pregnant mice (14 +1 DPC) (n=3-5) were used in the RT-
qPCR studies. A: MC2; B: MC4 and C: MC5.  CT values of each assay were exported to excel worksheet, analysed using 
the delta CT Method developed by Pfaffl (2001). The skewed data seen in the graphs are due to animal sample variations 
(old vs. newly obtained samples). The 2-ΔCT values were imported to GraphPad and analyses using one-way analysis of 
variance (ANOVA). (Prism 7, USA). 
 













The table represents each gene examined in uterine cDNA duplicates of 3-4 C57BL/6 mice. Age and pregnancy 
effects were examined by using animals aged 2, 6, 9, 10 and 14 weeks old mice and pregnant (14 +1DPC) mice. 
MC2, MC4, MC5 and AgRP were found in the uterus. Age had a significant impact on the expression of MC5 (with 
a p-value of 0.01). Pregnancy did not affect the expression. (+) Indicate the presence of a gene or significant effect 
by age or pregnancy; (-): indicates the absence of a gene or non-significant effect by age or pregnancy. N/A: not 
detectable. 
Uterus (n: 4) 
Gene Expression P value Significance of Age Significance of Pregnancy 
MC1 (-) N/A N/A N/A 
MC2 (+) 0.61 (-) (-) 
MC3 (-) N/A N/A N/A 
MC4 (+) 0.15 (-) (-) 
MC5 (+) 0.01 (++) (-) 
POMC (full) (-) N/A N/A N/A 
POMC (trunc.) (+) 0.06 (-) (-) 
AgRP (+) 0.08 (-) (-) 
MRAP1 (-) N/A N/A N/A 
MRAP2 (-) N/A N/A N/A 
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7. 3. 3 Validation of the MC system expression 
The products of the RT-qPCR of MC (1-5), POMC, MRAP1, MRAP2 and AgRP, as well 
as β-actin, ATP5B and YWHAZ were seperated on 2% agarose gel (composition and 
method described in section 3. 2. 4. 3. 3). The products also contained non-template 
control for each of the target genes and the reference genes to check for genomic 




Figure 7.5: Gel electrophoresis of RT-qPCR of MC system in the female mouse uterus. The RT-qPCR products 
were separated on 2% agarose gel at 110 volts for 40 minutes. Where L = ladder 50 bp to 2000 bp; 
(ThermoScientific, UK); Actb: β-Actin=84 bp, 105 bp; MC1 = 127 bp, MC2 = 86 bp, MC3 = 108 bp, MC4 = 106 bp, 
MC5 = 90 bp, ATP: ATP5B= 112 bp POMC (truncated)= 70 bp, MRAP1 = 86 bp, MRAP2 = 150 bp, AgRP = 63 bp, 
yz = YWHAZ (141 bp -ve: non-template control for gene of interest in previous lane. Gel image was taken using 




7. 3. 3 Localization of MC3, MC5 and MRAP2 mRNA transcripts in the female 
mouse uterus 
RNAscopeâ brown expression signal is detected as brown dots and all sections have 
been counterstained with haematoxylin (purple) to visualize the tissue architecture. 
The assays included positive (PPIB) and negative (DAPB) controls to ensure 




Figure 7.6: RNAscope® 2.5HD single-plex (brown) assay in the female mouse uterus. The assay was carried in 
uteri of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. A: The uterine sections show expression of 
positive (PPIB) control to illustrate how the expression signal as brown dots in cells, counterstained with 
Haematoxylin (Hx). B: negative (DAPB) control in the uterus showing no background staining. Each group was 
conducted as 3 sections per slide and the assays was carried out twice. Images were taken by NanoZoomer slide 
scanner (Hamamatsu Photonics) at King’s College London. 
 
MC3 was detected at low levels in the uteri of 2 weeks old mice but MRAP2 was not 
detected in the uteri of animals of any age or in pregnancy (Figure 7. 7 A and B). 
Based on the current findings, the expression of MC3, although low, was observed in 
the luminal and glandular epithelia, endometrial stroma and lower levels in the 




Figure 7.7: RNAscope® 2.5HD single-plex (brown) assay of MC3 and MRAP2 in the female mouse uterus. The 
assay was carried in uteri of mice aged 2 weeks, 10 weeks and pregnant (14 ± 1) mice. A: MC3 expression in 
female mouse uterus (20X). B: MRAP2 expression in female mouse uterus (20X). Each group was conducted as 
3 sections per slide and the assays was carried out twice. Images were taken by NanoZoomer slide scanner 
(Hamamatsu Photonics) at King’s College London. 
 
 
Compared to MC3 and MRAP2, MC5 expression was higher in the female mouse 
uterus. Based on the current observations, the expression of MC5 appeared to be 
higher in the pre-weaned (2 weeks old) and pregnant mice compared 10 weeks old 
mice. The expression of MC5 was distributed in all compartments of the mouse uterus 




Figure 7.8: RNAscope® 2.5HD single-plex (brown) assay of MC5 in the female mouse uterus. The assay was carried in uteri of mice aged 2 weeks, 10 weeks and pregnant (14- 
± 1) mice. A: MC5 expression in 2 weeks old female mouse uterus. B: MC5 expression in 10 weeks old female mouse uterus. C: MC5 expression in pregnant (14 ± 1) female 
mouse uterus. D: a higher magnification of MC5 expression in 2 weeks old female mouse uterus. E: A higher magnification of MC5 expression in 10 weeks old female mouse 
uterus. F:  A higher magnification of MC5 expression in pregnant (14 ± 1) mice uterus. Each group was conducted as 3 sections per slide and the assays was carried out twice. 
Images were taken by NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College, London.
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7. 4 Discussion 
These studies revealed a signicant expression of MC5 in the pre-weaned C57BL/6 
mice compared to older age groups.  At a cellular level,  MC5  was detected in all three 
compartments of the uterus (luminal and glandular endometrial epithelia, endometrial 
stroma and the myometrium) of 2 weeks and 10 weeks old mice. Even though MC5 
could not be detected in the pregnant mouse uterus using the whole tissue RT-qPCR, 
MC5 was detected in all compartments of the uterus of pregnant mice at a cellular level 
with RNAscopeâ. This was also true for MC3 and MRAP2, as both were absent as 
determined by the RT-qPCR expression studies but detected in pre-weaned mice with 
a similar localisation to that of MC5 using the RNA in situ chromogenic studies. In 
addition to MC5; MC4, AgRP and truncated POMC gene were also expressed in the 
C57BL/6 female mouse uterus. All the genes detected in the uterus had lower 
expression levels compared to those observed in the female mouse hypothalamus 
and pituitary gland.  Other melanocortin system members (MC1, MRAP1, MRAP2 and 
the full-length POMC gene) were not detected in the female mouse uterus.  
 
GeNorm expression stability analysis found the most suitable reference genes for use 
in normalising the C57BL/6 female mouse uterus RT-qPCR data were ATP5B, ACTB 
and YWHAZ. These three reference genes showed stable expression when examined 
in the 2, 6, 9, 10 and 14 weeks old mice and pregnant (14 ± 1 dpc) mice.  Unlike in the 
other three tissues examined, the optimal number needed for normalising RT-qPCR 
data in the uterus was three  whereas  the optimal number of reference genes in the 
hypothalamus, the pituitary gland and the ovary was two. This could indicate that using 
less than three reference genes could cause inaccuracy of the data analysis as 
explained by (Morley, 2014). The reference gene ATP5B is encoding a mitochondrial 
ATP synthase subunit beta that catalyses ATP synthesis while ACTB is coding β-actin 
which is essential for cell motility. 
 
The RT-qPCR data of the uterus is consistent with GPCR anatomical profiling data 
conducted by (Regard et al., 2008), which included the profiling of MC3, MC4 and MC5. 
The latter two were detected at low levels in the mouse uterus whereas MC3 was 
absent. However, the absence of MC3 in mouse uterus in the current research and the 
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gene profiling study contradicts findings in the human uterus. Lantang and colleagues 
found MC3 expressed in human endometrial glandular and luminal epithelia using 
immunohistochemistry and most of the MC3 immune-positive cells were uterine natural 
killer cells (Lantang et al., 2015). This could be attributed to species differences. Also, 
it is worth mentioning that the antibodies against the MC3 were found to produce non-
specific interactions as detected by (Kathpalia et al., 2011; Dowejko, 2014).  
 
The study conducted by Lantang and colleagues showed MC5 immuno-positive cells 
were extending from the endometrial glandular epithelium to the endometrial stroma; 
MC5 was also detected in the endothelial cells and the smooth muscle cells of the 
endometrial vasculature with less staining in the natural killer cells of the uterus. These 
MC5 findings are consistent with the wide distribution of the MC5 expression using the 
RNAscopeâ observed in the current research. Uterine natural killer (uNK) cells are 
thought to be involved in the remodelling of the spiral arteries in both human and mice; 
uNK were found to secrete angiogenic factors such as vascular endothelial growth 
factor (VEGF) and placental VEGF making them essential during implantation during 
early pregnancy (Gaynor and Colucci, 2017). Taking the uNK role and findings by 
Lantang et al. (2015), in this present study MC5 findings raise the possibility that MC5, 
and possibly MC3, might be involved in the vascular remodelling of murine uterine 
arteries. 
 
MC5 was found to be expressed in different exocrine glands, such as sebaceous and 
preputial gland (Zhang et al., 2006; Morgan and Cone, 2006). It was also suggested 
that MC5, together with MC1 were needed for the differentiation of the sebaceous 
glands as MC5 (and MC1) antagonist, JNJ-10229570 caused a decrease in the 
sebaceous gland differentiation marker epithelial-membrane antigen when used in 
primary human sebaceous cells and skin grafts (Eisinger et al., 2011). It is possible to 
hypothesise that the proliferative effects of MC5 on the sebaceous glands is more likely 
to occur in the endometrial glandular epithelium remodelling in the estrous cycle (or 
menstrual cycle) and in preparing for pregnancy. 
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Both MC4 and MC5 had a relatively similar patterns of expression in the RT-qPCR data 
(except in pregnancy) indicating that both could be mediating the same role in the 
mouse uterine tissue either separately or through forming heterodimers. As mentioned 
for MC5, the expression of both was higher in neonatal mice strengthening the 
association of MC4 and MC5 with the endometrial maturation and formation of the 
gland that occurs postnatally. This is supported by reports of the interaction of 
phosphatidylinositol 3-kinase (Pi3Ks) signalling pathways with the melanocortin 
system. The Pi3K signalling pathway was recently suggested to control the 
endometrial gland proliferation through protein kinase-dependent and independent 
pathways based on mice Pi3K deficient studies. Mice deficient in Pi3K were found to 
have reduced uterine gland number around postnatal day 20 indicating impaired 
postnatal uterine development (Chang et al., 2018). Estradiol and progesterone 
treatment of the Pi3K deficient mice caused an increased endometrial epithelial mass 
and decreased endometrial stroma compared to the wild type animals indicating an 
essential role for Pi3K in regulating the endometrial cell proliferation (Chang et al., 
2018). Two independent studies have shown that the treatment of cells transfected 
with either MC4 or MC5 with NDP-a-MSH caused an increased c-AMP production, an 
effect that was abolished by the Pi3K inhibitors, wortmannin and LY294002 (Vongs et 
al., 2004; Chang et al., 2018). Based on the findings from these studies, both MC4 and 
MC5 might be associated with endometrial proliferation during development and 
throughout the estrous cycle. Chang and colleagues had also suggested that the Pi3K 
gene was highly expressed at the time of implantation (Chang et al., 2018). Although 
the RNAscopeâ studies were conducted on uteri from mid-pregnant animals, MC5 
expression in the uterus could be related to findings by Chang and colleagues. 
Therefore, an MC5 / Pi3K in situ localisation study in a different stage of mouse 
pregnancy could provide a direct link between the MC5 and its function in fertility at the 
level of the uterus.  
 
As discussed earlier in section 7.1.3, the proliferation of the uterine epithelium is also 
regulated by the preovulatory ovarian estrogen with estrogen receptors expressed in 
the glandular epithelium. Both estrogen and progesterone are expressed in the 
stroma, regulating the stromal proliferation which is necessary for the implantation 
during early pregnancy (Tan et al., 1999). Estradiol treatment was found to up-regulate 
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the expression of MC5 in chicken liver (Ren et al., 2017). In the rat hypothalamus, MC4 
expression was up-regulated by estradiol treatment (Silva et al., 2010). Based on 
these findings the ovarian steroid mediating the mouse uterine proliferative function 
through activating MC4, and possibly MC5, estradiol, was also found to activate the 
Pi3K/ERK pathway in the rat uterus (Kazi et al., 2009). 
 
The detection of MC2, MC4 and MC5 in the current research led to the assumption of 
the expression of either of the MRAPs in the uterus to aid in the expression and 
signalling of MCs, specifically MC2, as reported by previous studies (Chan et al., 2009). 
However, neither of the MRAPs were detected in the uterus.  
 
Although the MC2, MC4 and MC5 could be mediating their function in the uterus through 
melanocortin peptides which reach the uterus from the circulation, the expression of 
POMC, the 5’-truncated gene, indicates that the melanocortin peptides might be 
produced locally. The POMC 5’- truncated was also found expressed in other tissues 
such as the human skin cells and rat cardiomyocytes (Millington et al., 1999; Zapletal 
et al., 2013). The 5’- truncated gene is a shorter transcript with exon 1 and 2 missing 
in this transcript (Ivell, 1994). However, 5’-truncated POMC transcript is missing the 
signal sequence in exon 2 that enables the POMC polypeptide to be transferred to the 
ribosomes and endoplasmic reticulum to be translated. Therefore the 5’-truncated 
POMC transcript is unable to be processed in the uterus, bringing back the suggestion 
that the MC receptors expressed in the uterus mediate their function through the 
circulatory melanocortin peptides. 
 
The present studies have detected the expression of MC2, MC4, MC5, 5’-truncated 
POMC and AgRP in the uterus. Whereas MC1, MC3, full-length POMC transcript gene, 
MRAP1 and MRAP2 were absent. The distribution of MC5 in the uterus was in the 
endometrial glandular and luminal epithelia, the stroma and myometrial layers. The 
expression was more pronounced in the neonatal animals which might indicate a 
developmental role for MC5 and maybe MC4 which had a similar RT-qPCR expression 
to that of MC5. It is unfortunate that the RNAscopeâ assays did not include co-
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localising MC5 with uterine markers such as Pi3K, CD56+ (for uNK cells), CD10 (for 
the endometrium) and VEGF (for the uterine endothelial cells); these genes would 
identify the specific cells expressing MC5 and would help to elucidate the functions 
mediated by the melanocortin system in the mouse uterus. Further studies should also 
include the different stages of the mouse estrous cycle, as well as, earlier and later 
stages of pregnancy to understand the role of the MC system, particularly MC5, in the 
uterine remodelling and the events that occur in preparing the uterus for conception.  
The studies in this chapter and the previous three chapters have characterised the 
expression of the melanocortin system family at each level of the female mouse 
reproductive system. These included identifying the expression of MC (1-5), MRAP1, 
MRAP2, POMC and AgRP in the C57BL/6 mouse hypothalamus, the pituitary gland, 
the ovary and the uterus. These groups of studies also determined the specific cells 
or areas that expressed the MC members. The next part of this thesis includes in vitro 
studies that were designed to determine the responsiveness of MC3 to different 























8   Melanocortin 3 receptor (MC3) 









8. 1 Background 
As previously mentioned, the five melanocortin receptors are part of a GPCR family. 
The MCs are involved in mediating a variety of biological functions, and this is due to 
interactions with naturally occurring melanocortin agonists and antagonists 
distinguishing them from other GPCR. Table 8. 1 lists the MCs and their affinities to 
different melanocortin peptides and selective analogues.  
 
Table 8-1: The melanocortin receptors and their melanocortin natural and synthetic analogues. 
Receptor 








α-MSH > β-MSH 
> ACTH and !-
MSH 1 
MS05 and BMS-470539 2  1, 2 







!-MSH > β-MSH 
> ACTH > α-MSH 
1 
[D-Trp8]-!-MSH PG-106 1 
MC4 
β-MSH > α-MSH 







α-MSH > β-MSH 
> ACTH > !-MSH 
1 
PG-901 2 PG20N 2 1, 2 
The information in this table was collected from 1: Guide to Pharmacology database. 2:(Rossi et al., 2016). 
 
Through their ligands, the MCs activate a variety of G-protein dependent and 
independent signalling pathways. The expression of the  receptors and sensitivity to 
their ligands were found to be regulated by two accessory proteins, MRAP1 and 
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MRAP2 (Chan et al., 2009). This introduction will illustrate some of the characterised 
signalling pathways of the MCs focussing specifically on MC3, as well as discussing 
the role of the MRAPs in regulating the expression of MCs and their responses to the 
melanocortin peptides. Finally, this introduction will include a list of some of the 
methods by which the GPCR interactions and functions are investigated and describe 
why the PRESTO-Tango assay was chosen as the method of choice to study MC3. 
8. 1. 1 Melanocortin receptors signalling pathways 
Melanocortin receptors mediate different functions in the body, and this is attributed to 
the receptors’ abilities to bind to different melanocortin peptides and activate various 
signalling pathways. Most of these pathways depend on activating intracellular second 
messenger signalling cascades. The most commonly adopted signalling pathway 
consists of the guanine (G) protein complex that is made of three heterotrimeric 
subunits (a, b and g). The stimulation of the MCs by their ligands leads to an exchange 
of GDP (bound to the α-subunit) for GTP which causes a conformational change of 
the heterotrimeric subunit and initiates dissociation of the α-subunit from the dimeric 
non-dissociable βγ-subunit of the G-complex.  This in turn leads to the dissociation of 
the G-complex from the receptor and activation of an intracellular cascade. The 
specific intracellular cascade that is stimulated depends on the type of the Gα-subunit 
interacting with the receptor. There are four main subtypes of Ga: Gas, Gaq, Gai, and 
Ga12 (Syrovatkina et al., 2016). The most common cascade activated by the MCs is 
the Gas-dependent pathway. This pathway activates adenylyl cyclase, leading to an 
increase in cAMP production which ultimately activates the protein kinase A (PKA) 
pathway in response to both ACTH and a-MSH (Wikberg et al., 2000).  
However, MC3, and also MC5, were found to activate other GPCR-dependent 
pathways such as the Gaq/11 and PKC–dependent pathway (Konda et al., 1994; 
Rodrigues et al., 2009). The binding of NDP-MSH (Melanotan I) to MC3 was found to 
stimulate cellular proliferation through the Gai/o-phosphoinositide 3-kinase (Pi3K) 
and extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) pathway (Chai 
et al., 2007). 
In addition to the G-protein dependent pathways, the MCs are also able to activate 
G-protein independent pathways such as anti-inflammatory cytokine activation by 
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the JAK/STAT pathway that is mediated by a-MSH activated MC5 (Buggy, 1998). 
The aforementioned Pi3K/ERK1/2 is also known to be activated through different 
mechanisms including growth factors and non-GPCRs. The Pi3K/ERK1/2 was also 
found to be activated by MC1 but, through direct activation of the tyrosine kinase 
dependent pathway (Herraiz et al., 2011).  
Another essential G-protein-independent pathway is that of b-arrestin recruitment. 
Ligand binding to a GPCR activates b-arrestin 1 or 2 which in turn stimulates GPCR 
kinases, leading to phosphorylation of serine and tyrosine residues on the receptors 
and causing endocytic internalisation of the receptor into a clathrin-coated vesicle 
(Lohse and Hoffmann, 2014). The MCs utilise the b-arrestin recruitment mechanism, 
since AgRP (in addition to  antagonising melanocortin binding to the melanocortin 
receptors) binding causes internalisation of both MC3 and MC4 as a result of b-
arrestin recruitment (Breit et al., 2006). Other melanocortin peptides are also 
involved in the recruitment of b-arrestin. The internalisation of MC1 was reported to 
occur through GPCR dependent kinase 6 (GRK6) after binding with a-MSH (Wolf 
Horrell et al., 2016). 
8. 1. 2 The regulation of MCs by the MRAPs 
The regulatory role of the melanocortin receptors by accessory proteins was first 
suggested after discovering the role of MRAP1 in the transport of MC2 to the cell 
surface which facilitated the activation of the receptor by ACTH (Metherell et al., 
2005). The existence of a second MRAP1 related protein was confirmed four years 
later by (Chan et al., 2009). At first, both of the MRAPs were thought to regulate MC2 
trafficking and signalling in the adrenal gland exclusively. The expression of the 
MRAPs in extra-adrenal tissues suggested that the MRAPs could be regulating other 
melanocortin receptors. Expression of MRAP1 was reported in adipose tissue and 
the gonads while MRAP2 was found to be expressed mainly in the brain (Chan et 
al., 2009).  
Mutational studies suggested MRAP1 was affecting MC2 expression and signalling 
as it was found to be acting as a chaperone to MC2, facilitating its movement from 
the endoplasmic reticulum to the cell membrane and facilitating the binding of ACTH 
(Sebag and Hinkle, 2009). Binding to ACTH requires the anti-parallel 
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homodimerisation of MRAP1 (Malik et al., 2015). The same MRAP1 mechanism of 
action on the other MCs could not be concluded as different studies suggested an 
opposite role for the MRAP1 with the other four receptors. Chan et al., 2009 reported 
a reduced sensitivity of MC1, MC3, MC4 and MC5 to NDP-MSH in CHO cells in the 
presence of MRAP1. However, in chicken, Zhang and colleagues reported the 
presence of MRAP1 increased the constitutive activity of both MC3 and MC4 in 
response to ACTH (Zhang et al., 2017). The contradiction between the two studies 
could be attributed to either species differences or that the MRAP1 acts differently 
with the other melanocortin analogues and the same could be extrapolated for the 
MRAP2 from the same two studies. However, another explanation was provided by 
Asai et al. (2013) regarding the effect of MRAP2. Through their research study, MC4 
responsiveness to a-MSH increases after the co-expression of MC4 with MRAP2 but 
this was after the use of higher doses of the MRAP2 plasmid in the transfection 
procedure.  
The role of MRAP2 was found to extend beyond the melanocortin receptors. Within 
the neuroendocrine circuit that is controlling feeding behaviour, MRAP2 was found 
to downregulate the prokineticin 1 and 2 receptors, orexin receptor (Rouault et al., 
2017) and stimulate GHSR-1 and AgRP signalling (Srisai et al., 2017). 
The different characteristics of the melanocortin signalling and regulation discussed 
above reveals the complexity of the mechanisms by which the melanocortin receptor 
signalling pathways are affected by different factors. Moreover, a further level of 
complexity results from the possible dimerisation of the melanocortin receptors with 
each other and with other GPCRs as reported by (Mandrika et al., 2005; Rediger et 
al., 2011; Kobayashi et al., 2016) and finally the sequence similarities shared 
between the melanocortin receptors mentioned in chapter 1. All of these factors 
complicate identifying the exact mechanism by which each biological activity is 





8. 1. 3 The design of the PRESTO-Tango assay 
A difficulty in studying all GPCRs is finding an appropriate method to investigate the 
responsiveness of the GPCRs to their ligand. Recently, a screening platform was 
developed to investigate different aspects related to the GPCRs, identifying ligands, 
characterising homo- and heterodimerisation interactions and also investigating their 
regulatory mechanisms. All of these targets are established by bypassing the 
different G-protein-dependent signalling pathways activated by the GPCRs. The 
platform is called PRESTO-Tango which is an abbreviation for Parallel Receptor-
some Expression and Screening via Transcriptional Output - transcriptional 
activation following arrestin translocation. Half of this assay (Tango assay) was 
developed initially by (Barnea et al., 2008) and its modification allows monitoring of 
b-arrestin recruitment to a specific GPCR. Briefly, the assay design is based on 
binding of a ligand to a GPCR this leads to the recruitment of the b-arrestin which is 
fused to an endoprotease that is in turn activated to cause the cleavage of an 
activator of luciferase gene expression.  
 
The addition of the reporter substrate (luciferin) leads to the degradation of the 
luciferin and bioluminescence activity (Barnea et al., 2008).  This assay was later 
adopted by (Kroeze et al., 2015) and was modified into the following design (see 
Figure 8. 1 for a schematic drawing of the PRESTO-Tango assay design): 
The codon optimised Tango construct: which is made of: 
1. A signal sequence to facilitate the localisation of the receptor on the cell 
membrane and a FLAG epitope tag both of which located at the 5’-terminal. 
2. A Tobacco Etch Virus (TEV) nuclear inclusion endopeptidase cleavage site 
sequence and a tetracycline transactivator (tTA) fusion protein both located at 
the 3’-terminal. 
3. The carboxyl-terminus sequence of the vasopressin receptor (V2) that are 
required for the b-arrestin recruitment. For the possible removal of this V2 tail, 




The use of modified HEK293 cells (HTLA cells): the modification of the HEK293 cells 
included the insertion of a vector comprising a b-arrestin2– TEV fusion gene, a tTA-
dependent luciferase reporter and puromycin and hygromycin B resistance genes 
for the cells’ selection.  
 
 
Figure 8.1: The PRESTO-Tango schematic design. The assay consists of the 1) Tango construct which made of 
the GPCR and V2 tail sequences; a tetracycline activator (tTA) fusion protein; a Tobacco Etch Virus with 
endopeptidase cleavage site; a FLAG epitope tag and signal sequence. 2) the HTLA cells which are HEK293 
cells with tTA- dependent luciferase reporter gene, b-arrestin 2– TEV fusion gene and puromycin and 
hygromycin B resistance genes. The permission to use the PRESTO-Tango assay design image (Kroeze et al., 
2015) was given by Dr Wesley Kroeze.   
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The PRESTO-Tango assay was found to overcome challenges of different G-protein-
dependent pathways by using the b-arrestin recruitment that is known to be activated 
by almost all of the GPCRs including the MCs as discussed above. All of the 
objectives that were planned for this research study were met by this cost-effective 
platform.  Furthermore, the PRESTO-Tango assay overcomes most of the issues 
raised by the complicated interactions between the melanocortin receptors, the 
MRAPs and the melanocortin ligands. Therefore, this assay was decided to be the 
method of choice in achieving the aims of this research study which were to: 
 
1. Determine the dose-response of MC3 to ACTH after transfecting the HTLA 
cells with MC3-Tango. 
2. Characterise MC3 β-arrestin recruitment in response to different melanocortin 
ligands (ACTH (1-39), NDP-a-MSH, (D-Trp8)-g -MSH and SHU9119).  
3. Compare the MC3 response to the melanocortin ligands in the presence or 













8. 2 Methods 
8. 2. 1 HTLA cells 
Permission for the use of the HTLA cells and transient transfections was granted by 
the University of Westminster Genetic modification panel (03/07/2017). 
HTLA cells were kindly provided by Professor Wesley K Kroeze, HTLA cells are 
genetically modified human embryonic kidney 293 (HEK 293) cells produced by stably 
transfecting the tissue transcription activator-dependent reporter, luciferase, and β-
arrestin 2-tobacco etch virus fusion genes (Kroeze et al., 2015). HTLA cells were 
maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% 
foetal bovine serum, 100 UI/ml penicillin, 100 μg/ml streptomycin, 2.5 µg/ml 
amphotericin B (Gibco®, UK), 2 μg/ml puromycin dihydrochloride (Tocris, UK) and 100 
μg/ml hygromycin B (Invivogen, UK). The cells were incubated at 37°C and in an 
atmosphere of >95% humidity and 5% CO2. They were sub-cultured every three days. 
The culture growth medium was changed after centrifuging the cells at 100 g for 5 
minutes to pellet the cells; the supernatant was then removed and replaced with fresh 
growth medium.  
8. 2. 2 Transforming E. coli (DH5a) with the different plasmids 
a. Preparing Luria-Bertani (LB) agar with ampicillin  
 
LB agar plates were made by dissolving 35 g LB agar (Sigma Aldrich, UK) in 1 L of 
distilled water and then autoclaving the broth. Under sterile conditions, a final 
concentration of ampicillin (100 µg/µl) was added to the autoclaved LB agar.  The 
ampicillin is added to select the DH5a containing the plasmid with an ampicillin 






b. Bacterial transformation 
To prepare stocks of plasmids, DH5a cells (Invitrogen, UK) were thawed on ice, 50 µl 
of the bacterial cells was mixed with 1 µl (about 1µg/µl of each of the plasmids (see 
Section 3. 2. 6. 3 for details on the plasmids including their respective maps) in 
separate 1.5 ml tubes. The DH5α: plasmid mix was incubated on ice for 5 minutes 
followed by heat shocking the cells with incubation for 45 seconds at 42°C. This was 
followed by incubating on ice for 5 minutes. Super-optimal broth with catabolite 
repression (SOC: 250 µl) was added to the bacterial transformation mix.  The resulting 
mix was then incubated with shaking at 37°C for one hour. Ten microliters of bacteria: 
plasmid culture was streaked onto the freshly made LB agar plates supplemented with 
100 µg/µl of ampicillin and the streaked plates then incubated at 37°C overnight. The 
following day, single colonies from the LB agar plates were selected, and each was 
cultured separately in 15 ml Falcon tubes containing 5 ml LB culture media 
supplemented with 100 µg/µl of ampicillin.  The culture tubes were incubated at 37°C 
for 16-18 hours with shaking at 280 rpm. 
c. Plasmid extraction from DH5a 
Plasmid extraction was conducted using Qiagen’s Plasmid miniprep kit and following 
the manufacturer’s protocol (Qiagen, UK). The falcon tubes with the bacterial culture 
containing the plasmids were centrifuged at 8,000 g for 5 minutes to pellet the cells. 
The culture media were removed and replaced with 250 µl of pre-chilled suspension 
buffer P1. The tubes were vortexed until there were no cell clumps visible and the 
suspended mix was transferred to 1.5 ml micro-centrifuge tubes. To lyse the cells, 250 
µl of the lysis buffer P2 were added and mixed gently by inverting the tube 4-6 times. 
To alkalinise the mix and precipitate the genomic DNA and the proteins, 350 µl of the 
neutralisation buffer N3 were added and mixed gently by inverting the tubes 4-6 times. 
The tubes were then centrifuged at 13,000 rpm for 10 minutes. The clear supernatant 
was transferred carefully to spin column tubes placed in 2 ml collecting tubes. The 
spin columns were centrifuged at 13,000 rpm for 1 minute, and the flow-through was 
discarded. To wash the plasmids suspended in the spin column membrane, 500 µl of 
buffer PB were added to the spin columns and were centrifuged at 13,000 rpm for 1 
minute, and the flow-through was discarded. To precipitate the plasmid DNA, 750 µl 
of buffer PE were added to the spin columns and centrifuged at 13,000 rpm for 1 
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minute. The flow-through was discarded. The spin columns were centrifuged at 13,000 
rpm for 1 minute to dry the membranes. The collecting tubes were discarded, and the 
spin columns were placed in 1.5 ml microcentrifuge tubes and 50 µl of the elution 
buffer TE were added directly to the membranes to elute the plasmid DNA. The tubes 
were left on the bench for 1 minute and then were centrifuged at 13,000 for 2 minutes. 
The plasmid DNA was measured using the Nanodrop 2000. The samples were kept 
at 4°C until used. 
8. 2. 3 Co-transfecting HTLA cells with pCherry and Green fluorescent 
proteins (eGFP) plasmids 
In order to check the transfection and co-transfection efficiency of the HTLA cells for 
the PRESTO-Tango assay the cells were transfected or co-transfected with 
fluorescent plasmids. A modified SignaGen Laboratories protocol (USA) was followed. 
A transfection reaction in a well of a 96–well plate consisted of: approximately 25,000 
cells; 5 ng of fluorescent plasmid(s) [pDNA3-enhanced green fluorescent protein 
(pCDNA3-EGFP) and/or pmCHERRY-N1] (see Figure 8. 4 for plasmids maps); 45 or 
40 ng of a control plasmid (pCDNA3.1) (Appendix 5 shows pCDNA3.1 full sequence 
map) to balance the transfection reaction; and 0.8 µl of polyJet™ (catalogue no. 
SL100688, SignaGen Laboratories, USA) in 10 µl serum-free, phenol-free DMEM 
(Gibco®, UK).  
The plasmid combination in the transfection reactions included was as follows:  
a. 5 ng pCDNA3-EGFP + 45 ng control plasmid 
b. 5 ng pmCherry-N1 + 45 ng control plasmid. 
c. 5 ng pCDNA3-EGFP + 5 ng pmCherry-N1+ 40 ng control plasmid.  
On the day of the experiment, the HTLA cells were transferred to 15 ml centrifuge 
tubes, were counted using a haemocytometer and adjusted to the required volume 
(25,000-50,000 cells per well in a 96 –well plate). The cells: media mixture was 
centrifuged; the culture medium was removed. The cells were then kept for 20 minutes 
at 37°C and 5% CO2 until used. The transfection reactions were incubated at room 
temperature for 15 minutes; each transfection reaction was then added to the HTLA 
cells and mixed gently by pipetting. The cells: transfection mixture was incubated at 
37°C and 5% CO2 for 20 minutes. The HTLA growth medium (100 µl per well) were 
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then added to the cells and mixed gently by pipetting. Finally, the cells were then 
seeded in a 6-well plate (1 ml per well). The cells were left in the incubator at 37°C 
and 5% CO2 overnight (16-18 hours) for efficient cell transfection. On the next day, the 
culture medium of transfected cells was replaced with phenol red-free DMEM 
supplemented with 1% of bovine serum albumin (BSA); and the cells were then 
incubated overnight (24 hours). On the following day, the transfected cells were 
visualised using an LSM 510 Axiovert confocal microscope. 
The concentration of the fluorescent plasmids (5 ng) was decided after examining the 
transfection efficiency of different concentrations (0.05-50ng). The concentration 5 ng 
had the most efficient post-transfection efficiency (See Figure 8. 2 for fluorescent 
plasmids transfection efficiency in the HTLA cells).  Figure 8.3 demonstrate the 









Figure 8.2: Transfection efficiency of the pmCHERRY-N1 plasmid in HTLA cells. The HTLA cells were transfected 
with different concentrations of pmCHERRY-N1 plasmid (0.5 ng – 1 µg) to test transfection efficiency in the HTLA 
cells. A: pmCHERRY-N1 plasmid (1 µg); B: pmCHERRY-N1 plasmid (500 ng); C: pmCHERRY-N1 plasmid (50 ng) 
D: pmCHERRY-N1 plasmid (5 ng) and E: pmCHERRY-N1 plasmid (0.5 ng). Images were taken using an LSM 510 
Axiovert confocal microscope. 
 
 
Figure 8.3: Transfection efficiency of the pCDNA3-EGFP and pmCHERRY-N1 plasmids co-transfection in TO test 
the co-transfection efficiency in the HTLA cells, the HTLA cells were co-transfected with pCDNA3-EGFP (5 ng) and 
pmCHERRY-N1 (5 ng) and were supplemented with pcDNA3 (control plasmid) for a total reaction concentration of 
50 ng. A: pCDNA3-EGFP expression. B: pmCHERRY-N1 expression. C: Co- pCDNA3-EGFP+ pmCHERRY-N1 
co-expression. Images were taken using an LSM 510 Axiovert confocal microscope. 
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Figure 8.4: Mammalian expression vector. A: pcDNA3-EGFP, the backbone size without the insert is 5446 bp. 
Insert size is 700 bp (Addgene, USA). B: pmCHERRY-N1. The backbone size without the insert is 5582 bp. Insert 
size is 1186 bp. Sequence maps obtained from Addgene (USA). 
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8. 2. 4 The MC3-Tango transfection 
The Tango constructs were developed to be used specifically with the HTLA cells. 
They were designed by Dr Barnea’s group in 2008. The Tango plasmid consists of two 
fusion proteins; the first fusion protein is made of a receptor (a melanocortin receptor 
in this research project) joined with a transcription activator (tTA) at its carboxyl end. 
Both proteins are separated by a cleavage site for a tobacco etch virus (TEV) protease. 
The second fusion protein is made of the TEV protease attached to human β-arrestin2. 
After transfection, the fusion genes activate the tTA-dependent reporter gene (Barnea 
et al., 2008) (see Figure 8. 5 for MC3-Tango map). 
 
The concentration of the MC3-Tango plasmid to use (5 ng) was decided after 
examining the transfection efficiency of different plasmid concentrations (50 ng MC3-
Tango + 0 ng pCDNA3.1 empty vector; 5 ng MC3-Tango + 45 ng control vector; 0.5 
ng MC3-Tango + 49.5 ng control vector and 0.05 ng MC3-Tango + 49.95 ng control 
vector). See appendix 6 for the optimisation graphs. 
The transfection protocol is similar to that mentioned in section 3. 2. 6. 2 On the second 
day, after changing the growth media to phenol red-free DMEM supplemented with 
1% BSA, the transfected cells were seeded in 96-well plates (90 µl per well) and 
incubated overnight at 37˚C and 5 % CO2. On the third day, the cells were treated with 
a range of concentrations of the ligand (1x10-6-1x10-12M) indicated in Table 8-2 in 
order to generate dose-response curves. Each stimulant was made in a total volume 
of 100 µl of phenol red-free DMEM supplemented with 1% BSA; 10 µl was added to 
each well to give a final volume of 100 µl. The treated cells were incubated for 18 
hours in 37˚C and 5% CO2. On the fourth day, 1 mM of beetle luciferin potassium salt 
(E1602, Promega©, UK) prepared in 10 µl of phenol red-free DMEM supplemented 
with 1% BSA was added to each well of the treated cells and left at room temperature 
for 30 minutes; during which time the luciferin reacts with the luciferase resulting 
following the activation of the MC3-Tango construct transfected into the HTLA cells. 
The plate was then read by the GloMax® multi-detection system plate reader using the 
SteadyGlo protocol (Promega©). The data were analysed using GraphPad on Prism 7 





Figure 8.5: The Sequences map of the MC3-Tango. A: The sequence of the empty Tango; the plasmid size without 
the insert is 6632 bp. B: The sequence of the MC3 insert; the size of the insert is 969 bp. (MC3R-Tango catalogue 







Adding the ligands on the third-day post-transfection was determined having 
previously characterised plates with HTLA cells stimulated 24 hours and 48 hours 
post-transfection. See appendix 7 for duration graphs. Table 8. 2 lists the ligands used 
to treat the MC3-Tango transfected HTLA cells in the PRESTO-Tango assay.  
 
Table 8-2: The ligands used to treat the MC3-Tango in the PRESTO-Tango assay.  



















* [Nle4, D-Phe7]-a-MSH or 
NDP-MSH 






* PG990 (Ac-Nle-c[Asp-Pro-Pro-DNal(2)-Arg-Trp-Lys]-NH2) 
(non-commercial MC3 agonist) 
1134.35 * * 
* γ1 –MSH (H2N- YVMGHFRWDRF-NH2) 1512.74 Tocris 3424 
*(D-Trp⁸)-γ-MSH 
 
1570.81 Tocris 4272 
SHU9119 (MC3,4 antagonist and agonist at MC1,5) 1074.258 Tocris 3420/1 
* BMS-470539 (MC1 selective agonist) 559.70 Tocris 4053 
The dose-response curve for each ligand 1 pM – 1uM (all prepared in phenol red-free DMEM supplemented with 
1% BSA). ACTH: adrenocorticotropic hormone; α-MSH: a-melanocyte stimulating hormone; γ1 –MSH: gamma 1 –
melanocyte stimulating hormone; NDP-MSH: synthetic α-MSH; PG990: non-commercial MC3 agonist; SHU9119: 
synthetic MC3 and MC4 antagonist. *: Ligands were a kind gift from Dr Stephen Getting. 
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8. 2. 5 MC3-Tango and MRAP1 or MRAP2 transfection 
After examining the effects of ligands on MC3 b-arrestin recruitment, experiments were 
repeated to examine the activity of the same ligands with MC3-Tango in the presence 
of the accessory proteins, MRAP1 or MRAP2. The same transfection protocol in 3.6.3 
was followed, and the cells were co-transfected with either hMRAP1-pCDNA3.1 or 
hMRAP2-pCDNA3.1-myc, kind gifts from Dr Paul Le Tissier and Dr Joanne F Murray 
(University of Edinburgh) and Dr Li Chan (William Harvey Research Centre), 
respectively. 
 
Transfections reactions started with a total volume of 50 ng of plasmid in 100 ul per 
well of 96- a well plate divided as follows: 
a. MC3-Tango (5 ng) +control vector (45 ng) only. 
b. MC3-Tango (5 ng) +MRAP1 (5 ng) +control vector (40 ng). 
c. MC3-Tango (5 ng) +MRAP2 (5 ng) +control vector (40 ng). 
 
8. 2. 6 PRESTO-Tango data analysis  
After reading the luminescence using the Glomaxã Multi System plate reader the data 
is exported into an Excel worksheet, labelled and then imported into GraphPad (Prism, 
USA).  
1. Using column statistics in GraphPad, the mean of five observations for each 
concentration of the ligand was calculated.  
2. The experimental values were base-corrected by subtracting unstimulated values 
of MC3-Tango which represents the background noise values (this is auto-
luminescence from either the samples, the substrate or the culture media).  
3. The concentrations used were then transformed into logarithmic values (log 10) and 
the log (dose) versus response non-linear regression curve produced. The EC50 and 
logEC50 standard errors were included in generating the curves. Each curve fit 
represents a summary of five Glomaxã  observations per well reading, each 
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concentration of the stimulant was added in 2-3 technical replicates on the same plate; 
and the curve fit was also generated from a summary of 3-5 experiments.  
The curve fit for comparison treatments (ACTH (1-39)/ MTI/ (D-Trp⁸)-γ-MSH; MTI with 
or without SHU9119; MC3-Tango with or without MRAP1 or MRAP2 using the different 
ligands) is showing a representative experiment. 
Statistical analysis using one-way ANOVA was carried out in the treatment 
comparison experiments to check significance following MC3-Tango stimulation or 
inhibition. This was established by comparing each concentration of the different 
stimuli using ANOVA (analysis of variance); including post-hoc a multiple comparison 
to ACTH (1-39). 
Unpaired two-tailed t-test analyses were also carried out on curves comparing MC3-
Tango stimulation alone to that with either MRAP1 or MRAP2 co-transfection to check 
statistical significance of stimulation and inhibition. 
 
8. 2. 7 HTLA cells Viability test (MTT assay) 
MTT assay (MTT is an abbreviation for 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) was used to check the viability of the HTLA cells after 
the transfection with MC3-Tango, MC3-Tango with MRAP1 and MC3-Tango with 
MRAP2. Through the mitochondrial activity of viable cells, the MTT compound is 
converted into purple formazan crystals. Therefore, it reflects the effect of different 
compounds on the growth and viability of cells in vitro  (van Meerloo et al., 2011). The 
transfected cells (100 µl) were seeded in 96-well clear plate and were incubated at 
37°C overnight. On the following day, 100 µl of MTT solution (a final concentration of 
0.2 mg/ml) were added to cells and incubated for 30 minutes (until the intracellular 
formazan crystals are visible under light microscope) at 37°C; then the media 
containing MTT were aspirated and replaced with 100 µl of 10% DMSO 
(dimethylsulfoxide) prepared in phosphate buffered saline (PBS) and mixed by 
pipetting to dissolve the formazan crystals. Plates were incubated at 37°C for 15 
minutes and then read using a spectrophotometer plate reader at 540 nm and then 
630 nm as a reference which was subtracted from the 540 nm reading to remove the 
cellular debris and other background noise. 
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8. 3 Results 
Preliminary PRESTO-Tango experiments were conducted to verify the transfection of 
the HTLA cells with the MC3-Tango plasmid. Figure 8. 6 illustrates a bar chart of 
relative luminescence readings of HTLA cells with only luciferin, HTLA cells 
transfected with MC3-Tango but with no stimulation and HTLA cells transfected with 
MC3-Tango treated with 100 nM ACTH (1-39). The luminescence light units were 
significantly higher (p < 0.0001) in the MC3-Tango transfected HTLA cells treated with 
100 nM ACTH (1-39) compared to both cells with luciferin only, and the un-treated MC3-
Tango transfected HTLA cells. Cells with the luciferin alone were also significantly 
lower (p = 0.05) than the untreated MC3-Tango HTLA cells. 
 
 
Figure 8.6: Bar chart of PRESTO-Tango assay of MC3 in HTLA cells. A significant rise in the relative luminescence 
units (RLU) observed in the MC3-Tango transfected HTLA cells treated with 0.1 µM (100 nM) of ACTH (1-39) 
(p<0.0001) compared untreated MC3-Tango transfected HTLA cells and cells with the only luciferin. The Bar chart 




8. 3. 1 MC3-Tango stimulation with the melanocortin ligands 
The MC3-Tango transfected cells were incubated with different melanocortin ligands, 
resulting in different b-arrestin transcriptional response. The concentration of 1 µM of 
Melanotan I (MTI, NDP-a-MSH) produced significantly higher RLU readings compared 
to D-Trp⁸-γ-MSH (p=0.001) followed by ACTH (1-39) (p= 0.05) while a lower 
concentration of MTI (0.1µM) was significantly higher than only D-Trp⁸-γ-MSH 
(p=0.01). Figure 8. 7 shows the response-curve of HTLA treatment with either ACTH 
(1-39), NDP-a-MSH or D-Trp⁸-γ-MSH. Table 8. 3 lists the maximal response, EC50, 




Figure 8.7: PRESTO-Tango dose-response curve of MC3 in the HTLA cells. The HTLA treated with ACTH (1-39) 
(black curve fit); NDP-a-MSH (blue curve fit) and D-Trp⁸-γ-MSH (green curve fit). The b-arrestin response of D-
Trp⁸-γ-MSH was significantly lower than ACTH (1-39) (p = 0.003) and NDP-a-MSH (p = 0.001). The Curve fit 






Table 8-3: PRESTO-Tango of MC3 response to the melanocortin peptides. 
Ligand Maximum response LogEC50 ± st. error EC50 (nM) R2 n 
ACTH (1-39) 1155 -7.37±0.339 43.0 0.93 6 
NDP-∝-MSH 2465 -6.217±1.479 606.4 0.96 4 
D-Trp⁸-γ-MSH 468.3 -8.155±0.6852 7 0.69 3 
The table represents a summary of 5 readings per well recorded by Glomaxã multisystem plate reader of ACTH (1-
39) (n = 6, EC50 = 43 nM), NDP-∝-MSH (n = 4, EC50 = 606.4) and D-Trp⁸-γ-MSH (n = 3, EC50 = 7). The data in the 
table was generated using the log (dose) vs. response non-linear regression curve in GraphPad (Prism 7.04, USA). 
 
8. 3. 2 MC3-Tango stimulation with the melanocortin antagonist SHU9119 
To test the antagonistic activity in the PRESTO-Tango b-arrestin recruitment assay, 
the MC3-Tango transfected HTLA cells were treated with NDP-a-MSH and the MC3/4 
synthetic antagonist SHU9119. Compared to NDP-a-MSH treatment, the addition of 
SHU9119 either alone or with NDP-a-MSH produced minimal or entirely blocked the 
b-arrestin transcriptional response respectively as seen in Figure 8. 8 which showed 
no recorded luminescence activity in both types of treatments. Table 8. 4 lists the 
maximal response, EC50, logEC50 ± standard error, the coefficient of determination 






Figure 8.8: PRESTO-Tango dose-response curve of MC3 in the HTLA cells. The HTLA treated with either NDP-a-
MSH (black curve fit) or SHU9119 (orange curve fit) or NDP-a-MSH+SHU9119 (dotted red curve fit). The b-arrestin 
response of SHU9119 produced negligible luminescence activity. Luminescence activity was blocked entirely with 
NDP-a-MSH+SHU9119 treatment. The Curve fit generated using GraphPad (Prism 7.04, USA). 
 




LogEC50 ± st. error EC50 (nM) R2 n 
NDP-∝-MSH 1178 -6.729±0.6025 186.5 0.94 6 




-283.8 -8.911±8.262 1.227 0.1799 6 
The table represents a summary of 5 observations per well recorded by Glomaxã multisystem plate reader of NDP-∝-MSH (n = 6, EC50 = 186.5 nM), SHU9119 (n = 6, EC50 = 7.444) and NDP-a-MSH+SHU9119 (n = 6, EC50 = 
1.227). The data in the table was generated using the log (dose) vs. response non-linear regression curve in 
GraphPad (Prism 7.04, USA). 
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The treatment of MC3 transfected HTLA cells with the MC3 selective agonist, PG990 
and the MC1 selective agonist (BMS-470539) blocked b-arrestin recruitment as the 
luminescence activity was below the level of detection compared to ACTH (1-39) as seen 
in Figure 8.9 A and B respectively. 
 
 
Figure 8.9: PRESTO-Tango dose-response curve of MC3 in the HTLA cells. The HTLA treated with either the MC3 
selective agonist (PG990) (A) or MC1 selective against (BMS-470539) (B). No luminescence activity recorded for 




8. 3. 3 The regulation of MC3 response with MRAP1 and MRAP2 
Preliminary PRESTO-Tango experiments were conducted to verify the co-transfection 
of the HTLA cells with either MC3-Tango/MRAP1-pCDNA3.1 or MC3-Tango/MRAP2-
myc plasmids. Figure 8. 10 illustrates a bar chart of relative luminescence readings of 
HTLA cells with MC3-Tango alone, HTLA cells co-transfected with MC3-
Tango/MRAP1-pCDNA3.1 and HTLA cells co-transfected with MC3-Tango/MRAP2-
myc (all treated with no stimulation). The luminescence light units were significantly 
lower (p = 0.004) in the MC3-Tango/MRAP1 co-transfected HTLA cells and MC3-
Tango/MRAP2-myc co-transfected cells (p = 0.001) compared MC3-Tango transfected 
HTLA cells.  
 
 
Figure 8.10: Bar chart of PRESTO-Tango assay of MC3-Tango/MRAP1-pCDNA3.1 or MC3-Tango/ MRAP2-myc 
co-transfected HTLA cells. Significant fall in the relative luminescence units (RLU) observed in the MC3-
Tango/MRAP1-pCDNA3.1 and MC3-Tango/MRAP2-myc co-transfected HTLA cells (P = 0.004 and p = 0.001 
respectively) compared to MC3-Tango transfected HTLA. The Bar chart was generated using GraphPad (Prism 
7.04, USA). 
 223 
8. 3. 4. The regulation of MC3 response with MRAP1 
The b-arrestin transcriptional activities generated by MC3 when treated with the 
melanocortin peptides in the PRESTO-Tango assays were repeated and tested in the 
presence of MRAP1. The response of the b-arrestin recruitment assays was found to 
produce different activities with the different melanocortin peptides. HTLA cells co-
transfected with MC3-Tango and MRAP1-pCDNA3.1 and treated with 1 µM of ACTH 
(1-39)   produced a significant rise in the b-arrestin response compared to HTLA cell 
transfected with MC3-Tango alone (p = 0.02: Figure 8. 11. A). Also, the presence of 
MRAP1 appeared to increase the sensitivity of MC3 to ACTH (1-39) as a lower 
concentration of ACTH (1-39) (100 nM) increased the response significantly (p = 0.01).  
 
Although the treatment with NDP-a-MSH in the presence of MRAP1 had an overall 
comparable response to that in the absence of MRAP1, lower NDP-a-MSH 
concentrations (10 nM and 1nM) produced significantly higher luminescence light units 
compared to higher NDP-a-MSH concentrations (1 µM and 0.1µM) (p = 0.02 and p = 
0.02). Figure 8. 11. B shows the curve fit of NDP-a-MSH treated MC3-Tango 
transfected HTLA cells with and without MRAP1 co-transfection.  
 
The same pattern of b-arrestin response was observed when HTLA cells, co-
transfected with MC3-Tango and MRAP1-pCDNA3.1, were treated with D-Trp⁸-γ-MSH 
compared to NDP-a-MSH treatment. Figure 8. 11. C shows the lower concentrations 
of D-Trp⁸-γ-MSH (10 nM and 1 nM) caused a significant rise in the b-arrestin activity 
(p = 0.002 and p = 0.03 respectively) compared to the D-Trp⁸-γ-MSH treatment of 
HTLA cells transfected with MC3-Tango without MRAP1. Table 8. 5 lists the maximal 
response, EC50, logEC50 ± standard error, the coefficient of determination (R2) and the 






Figure 8.11: PRESTO-Tango dose-response curve MC3-Tango and MRAP1- pCDNA3.1 co-transfection in HTLA 
cells. The luminescence activity was increased in with ACTH (1-39) (1µM and 100 nM, p = 0.02 and p = 0.01 
respectively) (A); NDP-a-MSH (10 nM and 1 nM, p = 0.02 and p = 0.002 respectively) and (B) and D-Trp⁸-γ-MSH 
(10 nM and 1 nM, p = 0.002 and p = 0.03 respectively) (C). The Curve fit generated using GraphPad (Prism 7.04, 
USA). 
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Table 8-5: PRESTO-Tango of MC3 response with or without MRAP1-pCDNA3.1 co-transfection. 
Ligand Maximum response LogEC50 ± st. error EC50 (nM) R2 n 
MC3-ACTH (1-39) 1978 -7.29± 0.311 51.24 0.96 6 
MC3/MRAP1- ACTH 
(1-39) 
3016 -7.451± 0.538 35.43 0.94 6 
MC3-NDP-%-MSH 676.4 -6.814±1.006 153.3 0.648 4 
MC3/MRAP1-NDP-%-
MSH 
768.7 -6.866±755.8 136.3 0.472 4 
MC3- D-Trp⁸-γ-MSH 694 -7.106±0.235 78.32 0.83 4 
MC3/MRAP1- D-Trp⁸-
γ-MSH 
824.6 -6.966±934.1 108.1 0.66 4 
The table represents a summary of 5 observations per well recorded by Glomaxã multisystem plate reader of MC3-
ACTH (1-39) (n = 6, EC50 = 51.24 nM), MC3/MRAP1- ACTH (1-39) (n = 6, EC50 = 35.43), MC3-NDP-%-MSH (n = 6, 
EC50 = 153.3), MC3/MRAP1-NDP-%-MSH (n = 6, EC50 = 136.3), MC3- D-Trp⁸-γ-MSH (n = 6, EC50 = 78.32) and 
MC3/MRAP1- D-Trp⁸-γ-MSH (n = 6, EC50 = 108.1). The data in the table was generated using the log (dose) vs. 
response non-linear regression curve in GraphPad (Prism 7.04, USA). 
 
8. 3. 4. B The regulation of MC3 response with MRAP2 
Before examining the b-arrestin recruitment to MC3 treated with the different 
melanocortin peptides in the presence of MRAP2, different concentrations of the 
MRAP2-myc plasmid were investigated and were shown to have interestingly 
paradoxical effects. The co-transfection of HTLA cells with 5 ng of MC3-Tango and a 
low concentration of MRAP2-myc (0.5 ng) was found to increase the b-arrestin 
recruitment response when the co-transfected HTLA cells were treated with 1µM of 
ACTH (1-39) (p = 0.04) (see Figure 8. 12). Whereas, co-transfecting the HTLA cells with 
5 ng of MC3-Tango and a higher concentration of MRAP2-myc (5 ng) had reduces 
response significantly when treated with 1µM (p = 0.02), 0.1µM (p = 0.03) and 100 nM 
(p = 0.02) of ACTH (1-39) as seen in Figure 8. 12 and 8. 13. A.  
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Figure 8.12: PRESTO-Tango dose-response curve of MC3-Tango- HTLA cells co-transfected with different 
concentrations of MRAP2-myc. The HTLA treated with ACTH (1-39). The luminescence activity was significantly 
higher when MC3-HTLA cells with 0.5 ng MRAP2-myc (orange curve fit) and treated with 1 µM of ACTH (1-39) (p = 
0.04). Higher concentration of MRAP2-myc (5 ng) had reduced the luminescence activity in the HTLA cells when 
treated with 1µM (p = 0.02), 0.1µM (p = 0.03) and 100 nM (p = 0.02) of ACTH (1-39). The Curve fit generated using 
GraphPad (Prism 7.04, USA). 
 
The sensitivity of MC3 to NDP-a-MSH in the presence of MRAP2 was significantly 
increased in the lowest concentration of NDP-a-MSH (10 pM and 1 pM, p = 0.04 and 
p = 0.04) compared to HTLA cells transfected with MC3-Tango alone. Whereas, the 
response of the co-transfected HTLA cells was comparable to the HTLA cells 
transfected with MC3-Tango alone as seen in Figure 8.13. B.  
The treatment of the MC3-Tango/ MRAP2-myc HTLA cells with different 
concentrations of D-Trp⁸-γ-MSH did not change the b-arrestin recruitment response 
from that seen with HTLA cells transfected with MC3-Tango alone as shown in Figure 
8. 13. C. Table 8. 6 lists the maximal response, EC50, logEC50 ± standard error, the 




Figure 8.13: PRESTO-Tango dose-response curve MC3-Tango and 0.5 ng of MRAP2- myc co-transfection in 
HTLA cells. The luminescence activity was increased with 1 µM of ACTH (1-39) (p = 0.04) (A). The co-transfected 
HTLA cells’ luminescence activity was lowered with NDP-a-MSH (10 pM and 1 pM, p = 0.04 and p = 0.04) (B) and 
was not changed when treated with D-Trp⁸-γ-MSH (C). The Curve fit generated using GraphPad (Prism 7.04, USA). 
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Table 8-6: PRESTO-Tango of MC3 response with or without MRAP2-pCDNA3.1- myc co-transfection. 
The table represents a summary of 5 observations per well recorded by Glomaxã multisystem plate reader of MC3-
ACTH (1-39) (n = 4, EC50 = 2.65 nM), MC3/MRAP2 (5 ng) - ACTH (1-39) (n = 4, EC50 = 5.051) MC3/MRAP2 (0.5 ng) - 
ACTH (1-39) (n = 4, EC50 = 2.921), MC3-NDP-%-MSH (n = 1, EC50 = 96.37), MC3/MRAP1-NDP-%-MSH (n = 1, EC50 
= 1.79), MC3- D-Trp⁸-γ-MSH (n = 1, EC50 = 18.64) and MC3/MRAP1- D-Trp⁸-γ-MSH (n = 1, EC50 = 18.27). The 












LogEC50 ± st. 
error 
EC50 (nM) R2 n 
MC3-ACTH (1-39) 1930 -8.576± 0.182 2.65 0.93 4 
MC3/MRAP2 (0.5 ng) - 
ACTH (1-39) 
2695 -8.534 ± 0.163 2.921 0.98 4 
MC3/MRAP2 (5 ng) 
ACTH (1-39) 
1033 -8.297 ± 0.585 5.051 0.81 4 
MC3-NDP-%-MSH 3437 -7.016 ± 0.191 96.37 0.97 1 
MC3/MRAP2 (0.5 ng)- 
NDP-%-MSH 1903 -8.746 ± 0.767 1.79 0.88 1 
MC3- D-Trp⁸-γ-MSH 3072 -7.73 ± 0.159 18.64 0.99 1 
MC3/MRAP2 (0.5 ng)- D-
Trp⁸-γ-MSH 2964 -7.738± 0.244 18.27 0.98 1 
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8. 3. 5 HTLA cell viability 
The MTT assay was carried out to check the cytotoxicity of the MC3-transfection and 
co-transfection with either MRAP1-pCDNA3.1 or MRAP2-myc. The MTT assay 
reflects the metabolic activity of the HTLA cells. This is through the reduction of 
tetrazolium compound to the purple formazan crystals that then is solubilised using 
DMSO. Therefore, the more purple crystals, the more viable cells. 
As seen in Figure 8.14, the viability assays showed, although insignificant, an 
increased percentage of cell viability in the transfected and co-transfected un-
stimulated cells. The viability percentages were 122.2% for MC3-Tango transfected 
HTLA cells. The co-transfection had increased this percentage furthermore to 175.8% 




Figure 8.14: Cell viability of transfected and co-transfected HTLA cells. The bar charts a for MC3-Tango transfected 
cells (n = 3), MC3-Tango/ MRAP1-pCDNA3.1 co-transfection (n = 1) and MC3-Tango/ (0.5 ng or 5 ng) MRAP2-myc 
co-transfection.  The absorbance readings were obtained using SPECTROstarNano microplate reader (BMG 
LABTECH, UK) and the Bar chart was generated using GraphPad (Prism 7.04, USA). 
 
 230 
8. 4 Discussion 
The PRESTO-Tango assays revealed MC3 has different responses to the 
melanocortin analogues depending on the presence or absence of MRAPs. The 
highest b-arrestin response was observed when MC3 was stimulated with NDP-a-MSH 
(MTI), followed by ACTH (1-39) and then D-Trp⁸-γ-MSH. Interestingly, the efficacy and 
potency of MTI and ACTH (1-39) was markedly increased when MC3 was co-expressed 
with MRAP1 in the HTLA cells compared to MC3 alone. Although the efficacy of D-
Trp⁸-γ-MSH appeared to increase with MC3 / MRAP1 co-expression, the potency was 
found to be reduced (about 30 nM increase in the EC50 values). The co-expression of 
MC3 / MRAP2 had different effects on the ligand potencies depending on the amount 
of MRAP2 introduced into the cells. A low MRAP2 concentration (0.5 ng) did not cause 
a substantial change in the potency of ACTH (1-39), and the same effect was observed 
with D-Trp⁸-γ-MSH. The potency of NDP-a-MSH was reduced in the presence of low 
MRAP2 concentration by about 5 nM. The co-transfection of higher amounts of 
MRAP2 (5 ng) caused a decline in both the efficacy and the potency of ACTH (1-39) by 
about 900 RLU and 3 nM respectively. The b-arrestin recruitment activity was absent 
when the MC3 transfected cells were treated with either SHU9119 alone or together 
with NDP-a-MSH.  
The surface expression of the MC3-Tango was confirmed by immunohistochemistry 
using an anti-flag antibody by Dr Kroeze and colleagues in 2015. This is the first report 
of validating MC3-Tango activity in recruiting b-arrestin by bypassing activation of the 
G-subunits signalling cascades (PRESTO-Tango assays); using different 
melanocortin ligands, including the peptides that were not be validated previously 
(ACTH (1-39), D-Trp⁸-γ-MSH and SHU9119). The main purpose of developing such a 
platform was to establish a functional screening of the GPCR-ome in parallel 
independent of the diverse second messenger activation pathways. However, this 
platform also enables the investigation of the efficacy and potency of ligands of almost 
all the GPCR family members as well as being useful in the identification of new 
ligands for the orphan receptors. In addition, the PRESTO-Tango assay could also be 
used in studying the effect of the heterodimerisation of different GPCR either of the 
same sub-family (such as the five melanocortin receptors) or different members of the 
larger GPCR family members that are known to recruit the b-arrestin as part of their 
different activated signalling pathways. 
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Stimulating b-arrestin recruitment via most of the GPCRs occurs through the activation 
of GPCR dependent kinases (GRKs). This leads to the phosphorylation of the 
intracellular domains (either the C-terminal or the third intercellular loop) of the GPCR 
leading to the desensitisation of the receptor and at the same time activating b-arrestin 
dependent signalling pathway, finally resulting in uncoupling of the G-protein and 
internalisation of the receptor through clathrin-coated vesicles (Lohse and Hoffmann, 
2014). MC3 was found to be co-localised in endocytic lysosomal vesicles after g2-MSH 
treatment. This internalisation was claimed to be mediated by PKC (Wachira et al., 
2006)and this could be the pathway adopted by the other g-MSH analogue, D-Trp⁸-γ-
MSH used in this research. However, other phosphorylation pathways were reported 
to be activated by the melanocortin receptors. These include b-arrestin recruitment via 
activation of the Pi3K/ERK1/2 and GRKs dependent pathways after a-MSH analogue 
treatment (Sánchez-Laorden et al., 2007; Rodrigues et al., 2012) Therefore, there are 
different pathways that could be activated by the different melanocortin ligands used 
in this research, since MC3 is known to have an affinity to all the melanocortin peptides 
(see table 8.1 for details of MC3 affinity). Stimulating the MC3-transfected cells with the 
selective agonist PG990 did not recruit b-arrestin and this might require further 
optimisation or suggest that the stimulation of MC3-transfectant cells with PG990 
requires the co-transfection of either of the MRAPs, this could not be achieved in this 
thesis as time did not allow. 
The efficacy of the melanocortin ligands was found to be modulated by the co-
expression of MC3 with MRAP1. Previously, MRAP1 was thought to mainly regulate 
the expression and signalling of MC2 in the adrenal gland (Metherell et al., 2005). After 
that, different studies had reported different MRAP1 effects on other melanocortin 
receptors such as MC5, which was found to have less surface expression in the 
presence of MRAP1 (Chan et al., 2009; Sebag and Hinkle, 2009). In this current study, 
MRAP1 was found to increase the efficacy of all three tested melanocortin ligands 
(ACTH (1-39), NDP-a-MSH and D-Trp⁸-γ-MSH), although the potency of D-Trp⁸-γ-MSH 
was found to be reduced. The decreased potency could be as a result of MRAP1 
affecting the number of MC3 receptors binding D-Trp⁸-γ-MSH.  
In contrast to the high dependency of MC2 expression and signalling on the 
colocalization with MRAP1, MC3 was found expressed on the cell surface after cell 
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transfection and without being co-expressed with any of the MRAPs (Kroeze et al., 
2015). These findings are consistent with (Chan et al., 2009) data that reported 
unchanged MC3 surface expression in MC3 / MRAP1 or MRAP2 co-transfectant CHO 
cells. Also, MC3 did not appear to rely entirely on MRAP1 for recruiting b-arrestin when 
stimulated with the different melanocortin analogues. However, MRAP1 did increase 
the sensitivity to these ligands and this could be translated to the requirement of the 
MRAP1 in pathophysiological conditions that cause alterations in the expression of 
MC3.  
Using different concentrations of MRAP1 in co-transfecting the HTLA cells with MC3, 
only 5 ng of MRAP1-pCDNA3.1-FLAG caused a significant increase in the 
luminescence activity when the MC3-Tango: MRAP1 co-transfected cells were 
stimulated with ACTH (1-39). Lower (2.5 ng) or higher concentrations (10 ng and 20 ng) 
of MRAP1-pCDNA3.1-FLAG caused a reduction in the luminescent activity of 
activated MC3-Tango: MRAP1 co-transfected cells (see appendix 8 for MRAP1 
different concentrations graphs).  
As already mentioned, MRAP2 did have different regulatory effects on the potency 
ACTH (1-39) which was reduced with a high concentration of MRAP2. This is in 
agreement with previous studies that also used higher concentrations of MRAP2 in 
co-expression studies with either MC2, MC4 and/or MC5 (Sebag and Hinkle, 2010, 
2009; Kay et al., 2015). Whereas, a relative low amount of MRAP2 plasmid co-
tranfsected with MC3 increased the latter’s sensitivity to ACTH (1-39) and NDP-a-MSH. 
Some physiological conditions, such as pregnancy, may cause alterations in the 
responses to the melanocortin peptides by the melanocortin receptors (Ladyman et 
al., 2016). The findings by Ladyman and colleagues might be attributed to fluctuation 
in MRAP2 expression and its effect on melanocortin and non-melanocortin receptors’ 
responses to their ligands based on the physiological requirements. Recent data that 
reported the regulation of non-melanocortin receptors by MRAP2, support this claim; 
for instance, GHSR1-a had increased response when co-expressed with MRAP2 
(Srisai et al., 2017).  
One unanticipated finding was the increased cell viability of MC3-transfected cells after 
the introduction of either of the MRAPs. Increased cell viability in the MTT assays 
could be related to increased mitochondrial enzymatic activity by the transfected cells. 
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However, as this group of studies was conducted only twice, further repetition of the 
MTT assay should be considered to rule out experimental errors. If the data obtained 
afterwards were matching the current study’s finding, further investigations are 
required to identify the effect exerted by the MRAPs on the HTLA cellular proliferation. 
This research study had shown the MC3 response is regulated by both MRAP1 and 
MRAP2. This regulation appeared to be dependent on the specific melanocortin 
peptides used in the PRESTO-Tango assay. Also, the introduction of MRAP2 plasmid 
DNA at different amounts was found to differently affect the sensitivity of MC3 to the 
melanocortin analogues.  
Some of the objectives planned, but could not be accomplished because of lack of 
time, were to investigate MC3 sensitivity to the different melanocortin peptides when 
co-expressed with both of the melanocortin accessory proteins, MRAP1 and MRAP2, 
as (Chan et al., 2009) has reported dimerisation of both accessory proteins. As 
mentioned earlier, the PRESTO-Tango assay permits examination of  the coupling of 
different GPCRs and if the time and sufficient budget allowed, this research study 
would have included examining the melanocortin analogues’ response after the 
dimerisation of MC3 with the other melanocortin receptors as previous studies reported 
MC1 and MC5 dimerisation (Kobayashi et al., 2016). This series of studies would also 
have examined the response of the MCs dimerisation in the presence of either of 
MRAP1 or MRAP2. Furthermore, the PRESTO-Tango studies could have also aimed 
to investigate the dimerisation of the melanocortin receptors with other GPCR such as 
corticotropic hormone receptor (CRHR), dopamine receptors (DRD1 and DRD2) and 
somatostatin receptors (SSTR2) which might help identification of the mechanisms 
through which specific regulatory networks (such as the paracrine anterior and 






























9. 1 General Discussion 
This research was set out to characterise the MC system in the reproductive axis of 
the female C57BL/6 mouse and to examine the effect of age and pregnancy on the 
expression of the MC system. The RT-qPCR expression studies have demonstrated 
the expression of most of the MC system members at all levels of the female mouse 
reproductive axis (the hypothalamus, the pituitary gland and the ovary) as well as the 
uterus. This research reports, for the first time, the expression of MRAP1 in the 
hypothalamus and the pituitary gland. The hypothalamus and the pituitary gland of the 
female mouse had higher expression levels of the MC system compared to the ovary 
and the uterus. Age and pregnancy were shown to regulate the expression of some of 
the MC system member in female reproductive axis (MC5 and POMC) and the uterus. 
The RNAscopeâ identified the expression of MC3, MC5 and MRAP2 in the 
hypothalamus, the pituitary gland, the ovary and the uterus providing information about 
expression in specific cell types and areas related to controlling the reproductive 
function in organ. The RNAscopeâ confirmed MC3 (although non- significant), MC5 
and MRAP2 expression to be affected by age and pregnancy The RNAscopeâ studies 
enabled double expression of MC3/MRAP2 in these tissues which indicated a potential 
regulatory role of MC3 by MRAP2. Following the expression studies, in vitro cell studies 
focussed on MC3 utilising the PRESTO-Tango GPCRome screening assay which 
showed firstly that MC3 responded differently to the melanocortin analogues and 
secondly that MC3 responsiveness was affected by MRAPs.  
The gene expression of the MC system studies was preceded by GeNorm reference 
genes expression stability analyses to select the most stable reference gene(s) for 
each tissue. The GeNorm analysis had shown a fluctuation in the expression of some 
of the most commonly used reference genes such as ACTB and 18S, in agreement 
with previous studies suggesting the requirement to select stable reference genes 
according to experimental conditions and tissues (Siegert and Nitsche, 2004; Pfaffl et 
al., 2004; Andersen et al., 2004). Furthermore, the expression stability of each of the 
reference genes varied between the hypothalamus, the pituitary gland, the ovary and 
the uterus.  The most stable reference genes were CANX and YWHAZ in both the 
hypothalamus and the pituitary gland; ATP5B and GAPDH in the ovary and ACTB, 
ATP5B and YWHAZ in the uterus. These genes were used in the normalisation of the 
data obtained from the RT-qPCR expression studies of the MC system and are 
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recommended for future RT-qPCR analyses of these tissues over the commonly used 
ACTB, GAPDH and 18S. 
In the hypothalamus, the cellular characterisation of MC3, MC5 and MRAP2 revealed 
expression in the preoptic areas and the arcuate nucleus. These areas are known to 
contain functionally different GnRH cell populations and the preoptic area is known to 
mediate the ovulatory function of GnRH by stimulating the LH surge (Herbison, 2014).  
A direct role of a-MSH in mediating the medial preoptic GnRH firing activity was 
suggested after the detection of MC4 in the mPOA GnRH cells (Israel et al., 2012). 
This function could also be mediated by either of the melanocortin receptors identified 
in the current research, as Israel and colleagues were using non-selective 
melanocortin peptides. The arcuate was also reported to control the pulsatile release 
of GnRH through kisspeptin (Clarkson et al., 2017). However, a recent study reports 
the inadequacy of kisspeptin to control the GnRH pulse generator by itself (León et 
al., 2016) which might indicate the requirement of other neuropeptides and their 
receptors, such as the melanocortin receptors, to maintain the pulsatility of the GnRH. 
The RNAscopeâ assays had shown the consistency of the MC3 data with that of the 
RT-qPCR and in both studies neither age nor pregnancy affectedMC3 expression.  
MC5 had much lower expression in all areas of the hypothalamus compared to MC3 
and the results were consistent with low expression detected by RT-qPCR. Murray et 
al. (2006) reported that LH release stimulated by the administration of MCH in the 
preoptic areas was mediated by activation of MC5, further investigations are required 
to elucidate the exact role of MC5. A developmental, behavioural or weaning role might 
be mediated by MC5, since MC5 expression was higher in pre-weaned female mice (2 
weeks) than older animals.  
Global hypothalamic expression of MRAP2 was observed at the level of the mPOA 
and was higher in pre-weaned and pregnant female mice. The co-expression studies 
showed a high number of cells expressing MRAP2 alone, as well as cells with double 
expression of MRAP2 with MC3; this possibly implicates novel regulatory pathways 
mediated by MRAP2 in the hypothalamus which might be MC independent, as 
reported by (Chaly et al., 2016; Srisai et al., 2017). 
Expression of the melanocortin system suggests it has a regulatory role within both 
the anterior and intermediate pituitary gland. Both MC3 and MRAP2 mRNA transcripts 
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were co-localized in both somatotrophs and gonadotrophs indicating direct 
communication between the melanocortin system and the anterior pituitary cells. A 
previous study had reported the expression of MC3 in the lactotrophs of immature rat 
(Lorsignol et al., 1999) and more studies had identified different roles of the 
melanocortin peptides in the anterior pituitary (Lorsignol et al., 1999; Matsumura et al., 
2003, 2004). The detection of MC3 in the gonadotrophs support a role for MC3 
regulating of LH and FSH expression (Jiang et al., 2017). However, Jiang and 
colleagues had hypothesised this role to be mediated through a paracrine mechanism 
via lactotrophs: the results described herein suggest a more direct role.  
Age and pregnancy were found to regulate MRAP2 expression, with a rise seen in 
older female animals and during pregnancy, indicating increasing demand for MRAP2 
by different receptors during those stages. A mild reduction in the double expression 
of MC3 / MRAP2 during pregnancy was observed, which might indicate a role for 
MRAP2 independent to that of MC3. (Chan et al., 2009) had reported that MC3 
expression was not affected by the absence of both of the MRAPs. The detection of 
MC3 and MRAP2 in the intermediate lobe of the pituitary glands implies an 
autoregulatory pathway of MC3 on melanotroph functions. In contrast to the 
hypothalamus RNAscopeâ expression study, the pituitary RNAscopeâ showed MC5 to 
be higher in older females. Previous studies had shown expression of MC5 in the GH3 
cell lines and rat pituitary (Langouche et al., 2004, 2001) but an exact role mediated 
by the MC5 had  not been determined.  
RT-qPCR, revealed relatively high levels of POMC expression; the pituitary gland 
produces POMC through two different cells, the  melanotrophs and corticotrophs, and 
both produce different POMC fragments (a-MSH and ACTH respectively) (Mollard et 
al., 2012). Interestingly, AgRP was found expressed in the pituitary gland, which 
supports the previous report of AgRP stimulation on prolactin release (Langouche et 
al., 2004).  
Compared to the hypothalamus and the pituitary gland, the ovary and the uterus had 
lower expression of melanocortin receptors. Interestingly in both ovary and uterus, 
MC5 expression was detected in all compartments. In the ovary, MC5 was detected in 
the follicular cells and in the interstitial tissue of the stroma. RT-qPCR showed a mild 
rise in the expression of MC5, and to a lesser extent MC4, in the pre-weaned animals, 
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which might indicate its contribution in the ovarian proliferation during the postnatal 
period. Furthermore, MC4 and MC5 could be involved in ovarian steroidogenesis and 
this is supported by reports of the lipolytic action of both receptors through their 
selective agonists LY2112688 and PG-901 respectively (Møller et al., 2015). In 
pregnancy MC4 was detected at very low levels whilst MC5 was not detected at all.  
The detection of MC2 in the ovary, with a significant reduction in pregnancy might imply 
a role in regulating the corpus luteum function through progesterone as reported by 
(Guelfi et al., 2011) in pseudopregnant rabbits. Since the expression profile of MRAP1 
was opposite to that of MC2, the regulation of MC2 might have been mediated by 
MRAP2 which does not appear to be affected during pregnancy.  The Guelfi study had 
also detected MC1 and MC3 in the ovaries of those rabbits. These findings bring back 
the argument about the specificity of the antibodies used against MC1 and MC3 in 
several studies (Kathpalia et al., 2011; Ahmed, 2014; Dowejko, 2014; Holloway et al., 
2015) and the use of anti-MC1 and anti-MC3 should be carefully considered.  
The uterus had few members of the MC system expressed, and those detected were 
at low levels; however, both MC4 and MC5 had a similar pattern of expression (with 
MC5 showing a significant rise in the pre-weaned animals) implicating a similar role 
that is either mediated separately or through dimerisation; considering MC4 is known 
to form heterodimers (Kobayashi et al., 2016). Several functions could be mediated by 
MC5,  including the proliferation of the endometrial epithelia and stroma through either 
the activation of growth factors released  from the uNK cells as suggested by (Lantang 
et al., 2015); or through  the Pi3K signalling pathway, essential for uterine gland 
development as reported by (Chang et al., 2018). Even though the RT-qPCR analysis 
could not detect MC3 in the uterus, the RNAscopeâ showed MC3 in all compartments 
of the uterus of neonatal mice but at lower levels compared to that of MC5. The roles 
suggested for MC4 and MC5 might also be mediated by MC3. 
In the mouse ovary and uterus, full-length POMC gene was not detected by RT-qPCR 
study, a shorter 5’-truncated gene transcript of POMC was detected at low levels in 
both tissues. This POMC variant is devoid of the signal sequence that directs the 
transcribed mRNA to the endoplasmic reticulum to be translated into functional protein 
(Ivell, 1994). Therefore, the MCs expressed in the ovary and systemically derived 
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melanocortin peptides most likely activate the uterus but more investigations are 
required to outline the function of truncated POMC in the ovary and the uterus. 
The PRESTO-Tango assay (Kroeze et al., 2015) has revealed interesting effects of 
MRAP1 on the MC3 receptor;  differences in MC3 responses to the melanocortin 
analogues were observed, with NDP-a-MSH having the highest potency, followed by 
ACTH(1-39)  and D-Trp8-g-MSH had the lowest potency. Those effects were altered in 
the presence of MRAP1 or MRAP2. The co-expression of MC3 with MRAP1 caused a 
significant increase in the sensitivity of MC3 to lower doses of NDP-a-MSH, ACTH (1-
39) and D-Trp8-g-MSH. The co-expression with MRAP2 had a different effect on MC3 
than MRAP1; the level of the expression of the MRAP2 with 5 ng of MC3 affected the 
response of MC3 to ACTH (1-39)  with a higher amount of transfected  MRAP2 causing 
a significant decrease in the potency and efficacy of ACTH (1-39), whilst lower MRAP2 
DNA in transfections caused a mild rise in NDP-a-MSH and ACTH (1-39) compared to 
the responsiveness of MC3 alone contradicting (Chan et al., 2009) findings. In MC3 / 
MRAP2 co-expressing cells NDP-a-MSH elicited half the maximal response seen in 
the cells expressing MC3 alone, this may indicate that the MRAP2 alters the saturation 
of the MC3. 
In conclusion, both RT-qPCR and RNAscopeâ demonstrated the expression of the 
melanocortin system in all levels of the HPO controlling female fertility. These findings 
provide further support for a role of the melanocortin system, potentially through 
stimulating GnRH activity, in modulating the anterior and intermediate pituitary 
functions, stimulating folliculogenesis, steroidogenesis, stimulating uterine 
proliferation and modulating an anti-inflammatory function. The exact mechanism of 
these processes is still a mystery. This research project is the first comprehensive 
study conducted to examine the MC system family members at all levels of the 
C57BL/6 female mouse reproductive axis. This series of studies has provided further 
understanding of the functions of the melanocortin system and lays the groundwork 





9. 2 Recommendations for future work 
 
Further expression (both the RT-qPCR and the RNAscopeâ) studies are required in 
these tissues using more stages of the reproductive cycle to include different stages 
of the mouse estrous cycle; earlier and later stages of pregnancy, lactation and post 
weaning maternal samples. The localisation of the non-examined melanocortin 
receptors (MC1, MC2, MC4 and MRAP1) using the RNAscopeâ expression studies 
either by singleplex or duplex to determine the localisation and the colocalization of 
MC1, MC2, MC4 and MRAP1in the mouse hypothalamus, pituitary, ovary and uterus. 
The RNAscopeâ duplex expression assay would be enhanced if MC probes could be 
used in conjunction with well-known cell-specific probes, which could include: GnRH 
in the hypothalamus; prolactin, TSH and POMC in the pituitary gland; CD31, CD56+ 
and B4galt2 in the ovary; and VEGF, PI3K, CD10 and CD56+ in the uterus. 
Finally, the PRESTO-Tango assay was established to study the regulation of MC3 by 
the MRAPs.  Additionally, this assay could be used with cells co-expressing other 
melanocortin receptors, particularly MC5, and with either of the MRAPs the expression 
of which has been characterised here but, still has many questions left unanswered 
about its role and regulation. These studies could also include imaging studies using 
confocal microscopy to examine the receptors’ expression and protein-protein 
interactions since the PRESTO-Tango constructs contain FLAG-tag epitopes which 
lend themselves to such studies. Future studies should also be conducted on human 
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Appendix 1: Example of the RT-qPCR expression analysis the MC 
system (POMC in pituitary gland) 
Calculating ΔCT (normalised raw data) by subtracting the geometric mean of the CT 
values of the reference genes:      
ΔCT= CT gene of interest – CTreference genes geometric mean 
ΔCT= CTPOMC – CT geometric mean of YWHAZ, and CANX 
= 19.46 - 22.58 
= -3.12 
As there are no control samples used, two-week samples were used as a reference 
sample or a calibrator; this was used to calculate ΔΔCT by subtracting ΔCT of the 
gene of interest from the calibrator: 
       ΔΔCT= ΔCT gene of interest – ΔCT calibrator 
= (-3.2916) – (-5.17) 
=2.05 
Converting the log-2 ΔΔCT to a linear scale was used to calculate the fold change 
which is the measure of the relative expression used to compare between the 
examined age groups and the pregnant samples. 
 Fold change = 2-(ΔΔCT) 
=2(-2.05) 
= 0.241484 
To carry out statistical analyses for expression significance assessment, the log2 ΔCT 
of the replicates were converted to the linear scale; that is, equal to 2-ΔCT 
2-ΔCT = 8.693879 
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The optimisation of the pre-treatment conditions of the RNAscopeâ included different incubation periods of the 
hypothalamus sections (negative control- left side panel Figures) and positive control – right panel Figures) in the 
slowly boiling RNAscopeâ target retrieval reagent. Those time periods included 15 minutes (A and B), 17 minutes 
(C and D), 20 minutes (E and F) and 25 minutes (G and H). Incubating the slides for 17 minutes generated the 
most specific expression signal in the positive control section with no background staining in the negative control 
sections. Images were taken using a Nanozoomer slide scanner (Hamamatsu Photonics) at King’s College London.
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Appendix 3. A: Reference genes expression stability- C57BL/6 female mouse hypothalamus 
 
The analysis of reference genes expression stability in the C57BL/6 female mouse hypothalamus was examined in hypothalami of mice aged 2, 6, 9, 10 and 14 weeks old and 
pregnant (14 ± 1 dpc) mice. The results were different according to the analysis software used. A: Delta CT method showed GAPDH and YWHAZ to be the most stable whereas 
ACTB and 18S were the least stable. B: BestKeeper software showed 18S and CYC1 to be the most stable whereas SDHA and UBC were the least stable. C: NormFinder 
software showed ATP5B and GAPDH to be the most stable genes whereas ACTB and 18S as the least stable. The last graph shows the comprehensive ranking of the reference 
genes expression stability after analysing data collected form the mentioned software as well as GeNorm with GAPDH and YWHAZ being the most stable whereas ACTB and 
UBC the least stable (D). The software Delta CT, BestKeeper, NormFInder and Comprehensive ranking is available from http://150.216.56.64/referencegene.php?type=reference.
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Appendix 3. B: Reference genes expression stability- C57BL/6 female mouse pituitary gland 
 
The analysis of reference genes expression stability in the C57BL/6 female mouse pituitary gland was examined in pituitaries of mice aged 2, 6, 9, 10 and 14 weeks old and 
pregnant (14 ± 1 dpc) mice. The results were different according to the analysis software used. A: Delta CT method showed CANX and EIF4A2 to be the most stable whereas 
SDHA and B2M were the least stable. B: BestKeeper software showed GAPDH and EIF4A2 to be the most stable whereas SDHA and B2M were the least stable. C: NormFinder 
software showed CANX and EIF4A2 to be the most stable genes whereas SDHA and B2M as the least stable. The last graph shows the comprehensive ranking of the reference 
genes expression stability after analysing data collected form the mentioned software as well as GeNorm with CANX and EIF4A2 being the most stable whereas SDHA and B2M 
the least stable (D). The software Delta CT, BestKeeper, NormFInder and Comprehensive ranking is available from: http://150.216.56.64/referencegene.php?type=reference. 
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Appendix 3. C: Reference genes expression stability- C57BL/6 female mouse ovary 
 
The analysis of reference genes expression stability in the C57BL/6 female mouse ovary was examined in ovaries of mice aged 2, 6, 9, 10 and 14 weeks old and pregnant (14 
± 1 dpc) mice. The results were different according to the analysis software used. A: Delta CT method showed EIF4A2 and GAPDH to be the most stable whereas UBC and 
B2M were the least stable. B: BestKeeper software showed 18S and CYC1 to be the most stable whereas CANX and B2M were the least stable. C: NormFinder software showed 
EIF4A2 and GAPDH to be the most stable genes whereas UBC and B2M as the least stable. The last graph shows the comprehensive ranking of the reference genes expression 
stability after analysing data collected form the mentioned software as well as GeNorm with EIF4A2 and GAPDH being the most stable whereas ACTB and B2M the least stable 




Appendix 3. D: Reference genes expression stability- C57BL/6 female mouse uterus 
The analysis of reference genes expression stability in the C57BL/6 female mouse uterus was examined in uteri of mice aged 2, 6, 9, 10 and 14 weeks old and pregnant (14 ± 1 
dpc) mice. The results were different according to the analysis software used. A: Delta CT method showed CYC1 and SDHA to be the most stable whereas ATP5B and CANX 
were the least stable. B: BestKeeper software showed 18S and RPL13A to be the most stable whereas B2M and CANX were the least stable. C: NormFinder software showed 
SDHA and UBC to be the most stable genes whereas CYC1 and RPL13A as the least stable. The last graph shows the comprehensive ranking of the reference genes expression 
stability after analysing data collected form the mentioned software as well as GeNorm with CANX and EIF4A2 being the most stable whereas SDHA and B2M the least stable 
(D). The GeNorm was substantially different from the results of the other three software in the reference genes expression stability analysis in the uterus. The software Delta CT, 
BestKeeper, NormFinder and Comprehensive ranking is available from: http://150.216.56.64/referencegene.php?type=reference.
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Appendix 4: The RNAscopeâ 2.5HD brown assay: the expression of 
MC3, MC5 and MRAP2 in the intermediate lobe of the female mouse 
pituitary gland 
 
The RNAscopeâ 2.5HD brown assay in the C57BL/6 female mouse pituitary gland had revealed the expression as 
brown expression signals in the intermediate lobe of the pituitary gland (IP) of mice aged 2, 10 weeks old and 
pregnant (14 ± 1 dpc) mice. A: Expression of MC3 in the intermediate pituitary. B: Expression of MC5 in the 
intermediate pituitary (outlined in the black circles). C: Expression of MRAP2 in the intermediate pituitary. Images 
were taken using a NanoZoomer slide scanner (Hamamatsu Photonics) at King’s College London. 
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Mammalian expression vector (empty backbone) pCDNA3 vector with added FLAG tag epitope. The backbone 








Appendix 6: PRESTO-Tango: choosing a transfection concentration for 
MC3-Tango 
 
The luminescence activity of different concentrations of MC3-Tango used in the transfection of the HTLA cells. All 
of the reactions had a total reaction of 50 ng (B and C were supplemented with 45 ng and 49.5 ng of pCDNA3.1 
respectively). The MC3-Tango concentration of 5 ng (B) was the concentration to be used in the PRESTO-Tango 
assay due to optimal luminescence activity compared to the luminescence activity generated in A and C. This was 
repeated twice and summary of results are represented in these graphs 
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Appendix 7: PRESTO-Tango: Determination of HTLA incubation period 
post-transfection and addition of stimulants 
 
After transfection with MC3-Tango the HTLA cells were incubated for either 24 hours (A) or 48 hours (B) before 
adding the stimulants (ACTH in these experiments) in humidified atmosphere at 37ºC. The luminescence activity 
produced by MC3 stimulated 48 hours (B) was about 10 folds higher than that of the MC3 stimulated 24 hours after 
HTLA transfection. Therefore, the stimulants in the subsequent PRESTO-Tango experiments were to be added 48 
hours post transfection. 
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Appendix 8: PRESTO-Tango: Determining MRAP1 concentrations to be 
used in the co-transfection with MC3-Tango 
 
Prior to co-transfecting the HTLA cells with MC3-Tangoand MRAP1, the concentration of MRAP1-pCDNA3.1-FLAG 
needed to be determined for the co-transfection. A range of concentrations [2.5 ng (B), 5 ng (C), 10 ng (D) and 20 
ng (E)] of the plasmid was used in co-transfection with MC3-Tango. The luminescence activity was found to be 
higher with only 5 ng of MRAP1-pCDNA3.1-FLAG compare to MC3-Tango (As) alone and to other examined 
concentrations. This was conducted twice and summary of results are represented in these graphs. The 
concentration of 5 ng of MRAP1-pCDNA3.1-FLAG was determined to be used in the co-transfection of MC3-Tango 
and MRAP1. 
